var title_f15_41_16016="Distal clavicle fracture type III";
var content_f15_41_16016=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F66402&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F66402&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Distal clavicle fracture type III",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 418px; height: 383px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This picture depicts a type III distal clavicle fracture, involving only the articular surface of the acromioclavicular joint. No ligamentous disruption or displacement occurs. These fractures present as late degenerative changes of the joint.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Rockwood CA Jr, Green DP, Bucholz RW, Heckman JD (Eds). Rockwood and Green's Fractures in Adults, 4th ed, Lippincott-Raven, Philadelphia 1996. Copyright &copy; 1996 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_41_16016=[""].join("\n");
var outline_f15_41_16016=null;
var title_f15_41_16017="Digitoxin: International drug information";
var content_f15_41_16017=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Digitoxin: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4369794\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Carditoxin (HU);",
"     </li>",
"     <li>",
"      Coramedan (DE);",
"     </li>",
"     <li>",
"      Cristapurat (AT);",
"     </li>",
"     <li>",
"      Digicor Neu (DE);",
"     </li>",
"     <li>",
"      Digimed (DE);",
"     </li>",
"     <li>",
"      Digimerck (AT, DE, HU);",
"     </li>",
"     <li>",
"      Digipural (DE);",
"     </li>",
"     <li>",
"      Digitalina Nativelle (IT);",
"     </li>",
"     <li>",
"      Digitaline Nativelle (BE, BR, CH, FR, LU);",
"     </li>",
"     <li>",
"      Digitasid (BE);",
"     </li>",
"     <li>",
"      Digitossina (IT);",
"     </li>",
"     <li>",
"      Digitoxin AWD (DE);",
"     </li>",
"     <li>",
"      Digitoxin Didier (DE);",
"     </li>",
"     <li>",
"      Digitoxin Streuli (CH);",
"     </li>",
"     <li>",
"      Digitoxin-Philo (DE);",
"     </li>",
"     <li>",
"      Digitoxin-Tropfen (DE);",
"     </li>",
"     <li>",
"      Digitrin (SE);",
"     </li>",
"     <li>",
"      Ditaven (AT);",
"     </li>",
"     <li>",
"      Mono-glycocard (DE);",
"     </li>",
"     <li>",
"      Tardigal (DE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list synlist drugH1Div drugBrandNames\" id=\"F4088990\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Index Terms",
"    </span>",
"    <ul>",
"     <li>",
"      Crystodigin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F4088991\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antiarrhythmic Agent, Class IV",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F4088992\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of congestive heart failure, atrial fibrillation, atrial flutter, paroxysmal atrial tachycardia, and cardiogenic shock",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F4088994\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rapid loading dose: Initial: 1-1.5 mg over 24 hours in divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Maintenance: 0.05-0.2 mg/day",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821203\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F4088995\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet: 0.1 mg, 0.2 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10449 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-213.134.24.46-FA3CAE7412-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_41_16017=[""].join("\n");
var outline_f15_41_16017=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4369794\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4088990\">",
"      Index Terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4088991\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4088992\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4088994\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821203\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4088995\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10449\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10449|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_41_16018="Acute Raynaud phenomenon";
var content_f15_41_16018=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F66438&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F66438&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 568px\">",
"   <div class=\"ttl\">",
"    Raynaud phenomenon",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 548px; height: 299px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Panel A shows sharply demarcated pallor in several fingers resulting from the closure of digital arteries. Panel B shows digital cyanosis of the fingertips resulting from vasoconstriction in the thermoregulatory vessel in the skin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Fredrick M Wigley, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_41_16018=[""].join("\n");
var outline_f15_41_16018=null;
var title_f15_41_16019="Ultrasound normal fetal brain transthalamic view";
var content_f15_41_16019=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F61130&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F61130&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 500px\">",
"   <div class=\"ttl\">",
"    Transthalamic plane",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 480px; height: 407px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_41_16019=[""].join("\n");
var outline_f15_41_16019=null;
var title_f15_41_16020="Calcium lactate: Patient drug information";
var content_f15_41_16020=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Calcium lactate: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/38/16996?source=see_link\">",
"     see \"Calcium lactate: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?12/7/12405?source=see_link\">",
"     see \"Calcium lactate: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F12855593\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10014161\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691572",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to help growth and good health.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691525",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to put off or treat soft, brittle bones (osteoporosis).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691408",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower high phosphate levels.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691428",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop and treat low calcium levels.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10014160\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701689",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to calcium or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: High calcium levels, kidney stones, or low phosphate levels.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10014165\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697716",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Try to space other drugs from this one by 2 hours. This drug stops many drugs from getting into the body.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696888",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take iron, zinc, or folic acid within 2 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10014166\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10014168\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10014163\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695907",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug with food.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695813",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take 1 hour before or 2 hours after a high bran or fiber meal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705494",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Soft, brittle bones (osteoporosis):",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10014164\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10014169\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10014170\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11307 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-183.1.191.153-B28792CD2A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_41_16020=[""].join("\n");
var outline_f15_41_16020=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12855593\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014161\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014160\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014165\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014166\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014168\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014163\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014164\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014169\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014170\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?16/38/16996?source=related_link\">",
"      Calcium lactate: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?12/7/12405?source=related_link\">",
"      Calcium lactate: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_41_16021="Pentostatin: Patient drug information";
var content_f15_41_16021=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Pentostatin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/9/40086?source=see_link\">",
"     see \"Pentostatin: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?23/60/24518?source=see_link\">",
"     see \"Pentostatin: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F182953\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Nipent&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F182954\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Nipent&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10029312\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700752",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause very bad nervous system problems including great sleepiness, seizures, weakness, or numbness or tingling of the feet or hands. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700696",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause liver problems in some patients. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700695",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause kidney problems in some patients. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700735",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause lung problems. Closely read the part in this leaflet which lists when to call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10029314\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691928",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat leukemia.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691947",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat lymphoma.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692154",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It may be used to treat graft-versus-host-disease (GVHD).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10029313\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702711",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to pentostatin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10029318\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10029319\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697876",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia, low white blood cell count, and low platelet count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698085",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flu-like signs. These include headache, weakness, fever, shakes, aches, pains, and sweating. Mild pain drugs may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698261",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698984",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not hungry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698316",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Runny nose.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698191",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Itching.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698243",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mouth irritation or sores. Using a soft toothbrush or cotton swabs and rinsing the mouth may help. Do not use mouth rinses that have alcohol in them.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698306",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Rash.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10029321\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure or a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699064",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699018",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea), even after drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10029316\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10029323\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11408 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-222.190.118.195-3C09538E6E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_41_16021=[""].join("\n");
var outline_f15_41_16021=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182953\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F182954\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029312\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029314\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029313\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029318\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029319\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029321\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029316\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029323\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?39/9/40086?source=related_link\">",
"      Pentostatin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?23/60/24518?source=related_link\">",
"      Pentostatin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_41_16022="Acetylcysteine: Pediatric drug information";
var content_f15_41_16022=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Acetylcysteine: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?20/1/20504?source=see_link\">",
"    see \"Acetylcysteine: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?7/12/7365?source=see_link\">",
"    see \"Acetylcysteine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F130167\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Acetadote&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F130168\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Acetylcysteine Injection;",
"     </li>",
"     <li>",
"      Acetylcysteine Solution;",
"     </li>",
"     <li>",
"      Mucomyst&reg;;",
"     </li>",
"     <li>",
"      Parvolex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1056251\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antidote, Acetaminophen",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Mucolytic Agent",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1056243\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?20/1/20504?source=see_link\">",
"      see \"Acetylcysteine: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Acetaminophen poisoning: Infants, Children and Adults: Begin treatment within 8 hours of ingestion to optimize therapy in patients whose serum acetaminophen levels fall above the &ldquo;possible&rdquo; toxicity line on the Rumack-Matthew nomogram. Treatment is also indicated in patients with a history of known or suspected acute acetaminophen ingestion of &gt;150 mg/kg (child) or &gt;7.5 g (adolescent or adult) total dose when plasma levels are not available within 8-10 hours of ingestion or in patients presenting &gt;24 hours after acute ingestion who have a measurable acetaminophen level.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: 150 mg/kg (maximum: 15 g) infused over 60 minutes; followed by a 4-hour infusion of 50 mg/kg (maximum: 5 g); followed by a 16-hour infusion of 100 mg/kg (maximum: 10 g); equivalent to a total dose of 300 mg/kg infused over 21 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: 140 mg/kg; followed by 17 doses of 70 mg/kg every 4 hours; repeat dose if emesis occurs within 1 hour of administration; therapy should continue until all doses are administered even though the acetaminophen plasma level has dropped below the toxic range",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Nebulized inhalation:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants: 1-2 mL of 20% solution or 2-4 mL of 10% solution until nebulized, given 3-4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: 3-5 mL of 20% solution or 6-10 mL of 10% solution until nebulized, given 3-4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adolescents: 5-10 mL of 10% to 20% solution until nebulized, given 3-4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Patients should receive an aerosolized bronchodilator 10-15 minutes prior to acetylcysteine",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endotracheal: Children and Adults: 1-2 mL of 10% to 20% solution every 1-4 hours as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distal intestinal obstruction syndrome (previously known as meconium ileus equivalent): Varying regimens have been reported (polyethylene glycol has become more widely used for this indication):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children &lt;10 years: 30 mL of 10% solution diluted in 30 mL juice or soda 3 times/day for 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children 10 years and Adults: 60 mL of 10% solution diluted in 60 mL juice or soda 3 times/day for 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Prior to treatment, administer a phosphosoda enema. A clear liquid diet should be used during the 24-hour acetylcysteine treatment",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Rectal enema: Children: Varying dosages; 100-300 mL of 4% to 6% solution 2-4 times/day; 50 mL of 20% solution 1-4 times/day and 5-30 mL of 10% to 20% solution 3-4 times/day have been used; rectal enemas appear to have less favorable results than oral administration (Mascarenhas, 2003)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Prevention of radiocontrast-induced renal dysfunction: Adults: Oral: 600 mg twice daily for 2 days (beginning the day before the procedure); hydrate patient concurrently",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F130142\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]: 20% (30 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Acetadote&reg;: 20% [200 mg/mL] (30 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, for inhalation/oral: 10% [100 mg/mL] (10 mL, 30 mL); 20% [200 mg/mL] (10 mL, 30 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, for inhalation/oral [preservative free]: 10% [100 mg/mL] (4 mL, 10 mL); 20% [200 mg/mL] (4 mL, 10 mL, 30 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F130127\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1056255\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Parenteral: I.V.: Three infusions of different lengths: Dilute first dose (150 mg/kg) in 200 mL D",
"     <sub>",
"      5",
"     </sub>",
"     W and infuse over 60 minutes; dilute second dose (50 mg/kg) in 500 mL D",
"     <sub>",
"      5",
"     </sub>",
"     W and infuse over 4 hours; dilute third dose (100 mg/kg) in 1000 mL D",
"     <sub>",
"      5",
"     </sub>",
"     W and infuse over 16 hours; for children &lt;40 kg and patients who are fluid restricted, the manufacturer recommends reducing the diluent to a &ldquo;proportional&rdquo; amount. See table for manufacturer's recommended infusion guideline for patients &lt;40 kg. Or as an alternative to proportionally lower the diluent volume, a reasonable approach might be to utilize the concentrations resulting from using the recommended dilution for the dosage in a 50 kg patient. The calculated concentration would range between 5 mg/mL (maintenance infusion) to 37.5 mg/mL (loading dose).",
"    </p>",
"    <table border=\"1\" frame=\"border\" rules=\"all\">",
"     <caption style=\"text-align:center;\">",
"      Infusion Guide by Weight for Patients &lt;40 kg",
"     </caption>",
"     <col align=\"center\" width=\"65\">",
"     </col>",
"     <col align=\"center\" width=\"85\">",
"     </col>",
"     <col align=\"center\" width=\"60\">",
"     </col>",
"     <col align=\"center\" width=\"85\">",
"     </col>",
"     <col align=\"center\" width=\"60\">",
"     </col>",
"     <col align=\"center\" width=\"85\">",
"     </col>",
"     <col align=\"center\" width=\"60\">",
"     </col>",
"     <thead valign=\"middle\">",
"      <tr>",
"       <th align=\"center\" rowspan=\"2\">",
"        <p style=\"text-indent:0em;\">",
"         Body Weight",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         (kg)",
"        </p>",
"       </th>",
"       <th align=\"center\" colspan=\"2\">",
"        <p style=\"text-indent:0em;\">",
"         LOADING Dose",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         150 mg/kg over 60 min",
"        </p>",
"       </th>",
"       <th align=\"center\" colspan=\"2\">",
"        <p style=\"text-indent:0em;\">",
"         SECOND Dose",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         50 mg/kg over 4 h",
"        </p>",
"       </th>",
"       <th align=\"center\" colspan=\"2\">",
"        <p style=\"text-indent:0em;\">",
"         THIRD Dose",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         100 mg/kg over 16 h",
"        </p>",
"       </th>",
"      </tr>",
"      <tr>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Acetylcysteine Dose",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         mg (mL)",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         5% Dextrose",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         (mL)",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Acetylcysteine Dose",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         mg (mL)",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         5% Dextrose",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         (mL)",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Acetylcysteine Dose",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         mg (mL)",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         5% Dextrose",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         (mL)",
"        </p>",
"       </th>",
"      </tr>",
"     </thead>",
"     <tbody valign=\"top\">",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         10",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         1500 (7.5)",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         30",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         500 (2.5)",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         70",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         1000 (5)",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         140",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         15",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         2250 (11.25)",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         45",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         750 (3.75)",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         105",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         1500 (7.5)",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         210",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         20",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         3000 (15)",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         60",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         1000 (5)",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         140",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         2000 (10)",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         280",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         25",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         3750 (18.75)",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         100",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         1250 (6.25)",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         250",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         2500 (12.5)",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         500",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         30",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         4500 (22.5)",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         100",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         1500 (7.5)",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         250",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         3000 (15)",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         500",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: For treatment of acetaminophen overdosage, administer as a 5% solution; dilute the 20% solution (inhalation formulation) 1:3 with a cola, orange juice, or other soft drink; use within 1 hour of preparation. If patient vomits within 1 hour of dose, readminister.",
"     <b>",
"      Note:",
"     </b>",
"     The unpleasant odor (sulfur-like) becomes less noticeable as treatment progresses. It is helpful to put the acetylcysteine on ice, in a cup with a cover, and drink through a straw; alternatively, administer via an NG tube.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral inhalation: May be administered by nebulization either undiluted (both 10% and 20%) or diluted in NS",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rectal: Dilute the inhalation solution in NS to the desired final concentration and administer rectally",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F130220\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Inhalation:",
"     <b>",
"      Incompatible",
"     </b>",
"     with rubber and metals (particularly iron, copper, and nickel); do not mix with ampicillin, oxytetracycline, erythromycin.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Intravenous: Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Incompatible",
"     </b>",
"     with metals (particularly iron, copper, and nickel);  cefepime, ceftazidime",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1056246\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution for injection (Acetadote&reg;): Store unopened vials at room temperature of 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F). Following reconstitution with D",
"     <sub>",
"      5",
"     </sub>",
"     W, solution is stable for 24 hours at room temperature. A color change may occur in opened vials (light purple) and does not affect the safety or efficacy. Contact with rubber, copper, iron, and cork may inactivate the drug. I.V. acetylcysteine is hyperosmolar (2600 mOsm/L) and compatible with 5% dextrose, 0.45% sodium chloride, and SWI.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution for inhalation: Store unopened vials at room temperature of 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F); excursions permitted to 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F); once opened, store under refrigeration and use within 96 hours. A color change may occur in opened vials (light purple) and does not affect the safety or efficacy. Contact with rubber, copper, iron, and cork may inactivate the drug.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1056254\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Inhalation: Adjunctive therapy in patients with abnormal or viscid mucous secretions in bronchopulmonary diseases, pulmonary complications of surgery, and cystic fibrosis; diagnostic bronchial studies [FDA approved in pediatric patients (age not specified) and adults]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, Oral: Antidote for acute acetaminophen toxicity; prevention of radiocontrast-induced renal dysfunction [FDA approved in pediatric patients (age not specified) and adults]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Has also been used orally and rectally to treat distal intestinal obstruction syndrome (previously known as &ldquo;meconium ileus or its equivalent&rdquo;)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F130222\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Acetylcysteine may be confused with acetylcholine",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Mucomyst&reg; may be confused with Mucinex&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F130219\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Inhalation:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Chills, drowsiness, fever",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Nausea, stomatitis, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Irritation, stickiness on face following nebulization",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Bronchospasm, hemoptysis, rhinorrhea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Acquired sensitization (rare), clamminess, unpleasant odor during administration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Intravenous:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Edema, flushing, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Pruritus, rash, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Pharyngitis, rhinorrhea, rhonchi, throat tightness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Anaphylactoid reaction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Anaphylaxis, angioedema, bronchospasm, chest tightness, cough, dizziness, dyspnea, headache, hypotension, respiratory distress, stridor, wheezing",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1056259\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to acetylcysteine or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1056242\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with asthma or previous history of bronchospasm",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1056241\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serious anaphylactoid reactions including death in a patient with asthma have been reported after I.V. use; in an open-label study reported incidence was 17%; acute flushing and erythema may occur 30-60 minutes into an I.V. infusion, resolving spontaneously; the infusion may be interrupted until treatment of allergic symptoms is initiated; if acute hypersensitivity reactions occur which do not respond to medical management (eg, antihistamines, H",
"     <sub>",
"      2",
"     </sub>",
"     blockers) or temporarily halting infusion, discontinue use and pursue alternative management. Since increased bronchial secretions may develop after inhalation, percussion, postural drainage, and suctioning should follow.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Acetaminophen overdose: The modified Rumack-Matthew nomogram allows for stratification of patients into risk categories based on the relationship between the serum acetaminophen level and time after ingestion. There are several situations where the nomogram is of limited use. Serum acetaminophen levels obtained prior to 4-hour postingestion are not interpretable; patients presenting late may have undetectable serum concentrations, but have received a lethal dose. The nomogram is less predictive in a chronic ingestion or in an overdose with an extended release product. Acetylcysteine should be administered for any signs of hepatotoxicity even if acetaminophen serum level is low or undetectable. The nomogram also does not take into account patients at higher risk of acetaminophen toxicity (eg, alcoholics, malnourished patients) or individuals ingesting higher than recommended acetaminophen doses for extended periods of time (repeated supratherapeutic ingestion).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298677\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F130136\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F130138\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F130152\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Based on limited reports using acetylcysteine to treat acetaminophen poisoning in pregnant women, acetylcysteine has been shown to cross the placenta and may provide protective levels in the fetus.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1056250\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     When used in acetaminophen overdose, determine acetaminophen level as soon as possible, but no sooner than 4 hours after ingestion of immediate release formulations or 2 hours after ingestion of liquid formulations (to ensure peak levels have been obtained); coingestion of acetaminophen with other medications which may delay GI peristalsis eg, antihistamines, opioids, may require repeated serum levels to determine the peak serum level; liver function tests",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1056240\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Exerts mucolytic action through its free sulfhydryl group which opens up the disulfide bonds in the mucoproteins thus lowering the viscosity. The exact mechanism of action in acetaminophen toxicity is unknown. It may act by maintaining or restoring glutathione levels or by acting as an alternative substrate for conjugation with the acetaminophen's toxic metabolite.",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1056257\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Upon inhalation, mucus liquefaction occurs maximally within 5-10 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration of mucus liquefaction: More than 1 hour",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1056258\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 0.47 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 83%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Reduced acetylcysteine: 2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Total acetylcysteine:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Newborns: 11 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adults: 5.6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: Oral: 1-2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Clearance: Adults: 0.11 L/hour/kg",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1056248\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?7/12/7365?source=see_link\">",
"      see \"Acetylcysteine: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Clear airway by coughing deeply before aerosol treatment",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Hanly JG and Fitzgerald MX, &ldquo;Meconium Ileus Equivalent in Older Patients With Cystic Fibrosis,&rdquo;",
"      <i>",
"       Br Med J (Clin Res Ed)",
"      </i>",
"      , 1983, 286(6375):1411-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/41/16022/abstract-text/6404483 /pubmed\" id=\"6404483 \" target=\"_blank\">",
"        6404483",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mascarenhas MR, &ldquo;Treatment of Gastrointestinal Problems in Cystic Fibrosis,&rdquo;",
"      <i>",
"       Curr Treat Options Gastroenterol",
"      </i>",
"      , 2003, 6(5):427-441.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/41/16022/abstract-text/12954149 /pubmed\" id=\"12954149 \" target=\"_blank\">",
"        12954149",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rashid ST, Salman M, Myint F, et al, \"Prevention of Contrast-Induced Nephropathy in Vascular Patients Undergoing Angiography: A Randomized Controlled Trial of Intravenous N-Acetylcysteine,\"",
"      <i>",
"       J Vasc Surg",
"      </i>",
"      , 2004, 40(6):1136-41.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/41/16022/abstract-text/15622367/pubmed\" id=\"15622367\" target=\"_blank\">",
"        15622367",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tepel M, van der Giet M, Schwarzfeld C, et al, &ldquo;Prevention of Radiographic-Contrast-Agent-Induced Reductions in Renal Function by Acetylcysteine,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2000, 343(3):180-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/41/16022/abstract-text/10900277/pubmed\" id=\"10900277\" target=\"_blank\">",
"        10900277",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Walson PD and Groth JF Jr, &ldquo;Acetaminophen Hepatotoxicity After Prolonged Ingestion,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1993, 91(5):1021-2.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/41/16022/abstract-text/ 8474802 /pubmed\" id=\" 8474802 \" target=\"_blank\">",
"        8474802",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13239 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-109.230.63.219-AC07DF7577-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_41_16022=[""].join("\n");
var outline_f15_41_16022=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130167\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130168\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056251\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056243\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130142\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130127\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056255\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130220\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056246\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056254\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130222\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130219\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056259\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056242\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056241\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298677\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130136\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130138\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130152\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056250\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056240\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056257\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056258\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056248\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13239\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13239|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?20/1/20504?source=related_link\">",
"      Acetylcysteine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?7/12/7365?source=related_link\">",
"      Acetylcysteine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_41_16023="Apical 4 chamber color flow Doppler MR II";
var content_f15_41_16023=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F55534%7ECARD%2F77039&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F55534%7ECARD%2F77039&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Apical four chamber view showing color flow Doppler of mitral regurgitation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 286px; height: 460px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAHMAR4DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5X69a6XX/AARr2g+GtH13VLIw6Zqw3WsvmKd4xkZAORkHIz1Fc/YfZ/ttuL5plszIvnGEAvsz820EgE4zjJHNez+Ovi34d8W+GPEuhvoV3ZW8s0M+kSRvv8toVEaeYjPhMxKFOzPJPXrQB4oelB9+lMzRmgB5578+tAx/9amZPrSUWAk568mimE0q9KVgHYFJ3PoetLn8qMjvQAd+KCOTk5o6/Xv70E/5FABxnp+FJ9DRu9qOpyOtAC4LEAcn2rrrzwBrNr4Es/FjQO2nXEzQkCNsxYAwzcfdPY13PwO+Esnii6i1PXF8nSUkULE/DT556dduPz4r691/SrNvCv8AYyGNbXyBbiJwDGyDjGO3TFQ6ijoKSdrpnwn8Mvhlr3xDvLiHREgjhtgpnuZ22xx56D3Pt7VQ+IngTWvAetjTdejjEjp5sUsTbo5EzjINe5W/iH/hSGuzf2Lp0l/oF9Gv22B5fmjnUnDRkDhdpwM5ryX4yfEi8+IuvQXtzax2dvax+VbwIc7VJySx7k8U4zbdktAWqTR59gr1HNHbOetIcduc0D3qhinr6UfzpDjFAAoAcR69M009OuPal7jj8KP50AHTIyPoaDz0JwPQf59aXHYZpAcg+lACHrx1HtSrnHf6etB6e9AHX+lACdufTFGeBjpS555xn0zQOKADr15J9aM9MmkOMDsK9L8AfD3SvFPg/V9Tn1m6tNRsYpZUthagpMEUEBXLAsxPUKDtHJ6ik2krsDzT8cD1oJORn8q9F8efC3VPB2jaJd35E1zqIffDD84hIUMqgg/MSpyccD1rldD0C71fVbPT7KLdd3U6wQqx2guxCgEnjqRzRzIai27IxAcDFe//ALFnPxR1T/sDS/8Ao+Cqp/Zr8c7cfZ9OZh0/0oY/lXZ/s3+CdV8C/GzUtM12OOO7OgvKPKkEilWnhwcj3B49qegrHypRRRTAKKKKACiiigAp6/dxTKcPunpmgBeuKXg4o7e1JyScHFIAOeeKDyT60ox+FIeMUAITxjFdr4H8FTa5fwLePHaxy/NELhtgceufT24z2rOh0N9MsItS1VVjLbZbeCQjEoByQ3cZHT6Gt3xB41h1G7046fbjEW3duUAkDoh9cdM+mKl3ekQ2PbPDkV5bWZlWaJ7W2ILIjZOVIIG31BGcr6dq6C9+I9zZ3G27AlifjzJVySoOV5PAPrwcV4yvjjS5oJJozd292iqVQnIzkg4I7Y7GudvtevLzVGEbiRHQKGuOfn6jr0/+tUPC1GnKz0JVRN2bPpR9S0bV4xJ9lhnVo9ksD4KP0LBecEd8nBr55+K/g2SLW7jUPD+myJp0g3PawRFRAcc4Ufw8Zz25q54d8R3emRr9onb5QTcRTJlcYGCPxyMda6WfxZOwivUvZHtivlQSIxibawOVxnOz3pU24O3QUofajufPeCKBxXW6t4PvjBq2padCG02wCyTkuB5Qd9oUc/Ng9cdK5Pr/AEre91fuWpJ3S6B0Jz1pR2xjFB68UA4/wpAw4/Ol6++aTt2oz09KAFHIPPFIcDNHPHrQehHXFACk/kP1pV4J/wAKaevXHvQPbrQApxTc9u1OPXOOKb29u9ACN1rsvB3inXLKxOhWeqXcGkXkn+kWyPtSTOAw/EYBx1xzXHEZ54rS0KTbfwkL0cdPrUVY80GjWhZzSZ9r2PhPw/ZC0ex05IWgVjC0czr5e9QG288ZHWpfD/gbwtZ6xYXFpottDPFcRyRupOVYMCCOfWsKLxCPJjXeD+7X9BWhoXiBZNWsI88vcxLkEZGXXrX5Dh3jvbQvUla6+0+/qfY1sqlGLfLse4V5RZHP7T1/6jwuB0/6eEr1c5yMfjXkWmPu/ai1dc52+G1H/kaI/wBf1r9dqbx9f0Z8SfBFFFFagFFFFABRRRQAU4dOabTh0oAUY6dKO/Wjbzj9aUgUgEPfjNeifCXRbS6fUdTuYDdXFgiyQw/KVJORkg9SOw9R3rh7GPaGnJkjCnCSBMoG9D9a9T+CMMFzNqltPcBBdW52EqoxIvbr0/n6HFTJ6AcL49ns7jUo2skuEbaTKJXLKWJJyoPI75HrmsnS4iD5mCGJwp7GtvxnaTLdxxyTRS7G2JsJJCnngYGR1qFLdUaMRup2jjBJHH8utejltB1Hz9jnxFTlXKWRHE0UagKWUYJC9e/PrUF/EZEYr8jghhyTgjt+grRtrIByQDtOOc457H2/Oq15wZUJwxzz0xX0VSinTtJbnmxqPmumU7GCa8vLgM88pWN3dnwcHGQRk9etbng3V1ld/wC0CuyKLyEIBZkUjH0AyOp9a5mXVPs1yywRxywsBlZBkN7ew/Kooo3vGuLqGHZAG3ypEMLHzxjNfI16ShNxTul1PYhJySbPR5rKe8hvrdl8uNG2uAABHGwwSB3JyT/kVy2v+DYdK8NLqSaks16bkobNY+Vh25EhbPqQCB0zXfeHyNZ8Oxw2UkAuFHnSyyny4+B35yfoM9fz4DxXrDzq8DKpJxudSSGPQgf3R9OuPrXPBtOw2m+trHHg8+tLitXW30c2umJpNteQ3aQbb5p5FZZJc9Y8Dhcev/1zlKO/OK2fkEXzK+wdO1IMZ5pcYxRnI4pDA89f8mhunpThjBz1pG79MUAIRzx+lHbjoOlGM5pep5oAToaTtSng/MaDnB6UAJkAYxk1oaZb3Bbz0glaGNl3yBCVXPqeg/Gs8+o7V7R4G1iaP4UPp1vd+I7Nma+b7PYaeJbfUAYkyHkJwNgB3HBIBzUzdol03aVzXXU920hjyBzknt/n862vC2p7vEujhiSTf2/ByDzKvH1rx+DWsRRrvBwBjr6euK6z4dT3eoeMNHFtFJJ5N5BNIY0LeWiyplyccAdz9K+bjlfJJStsff18+pzpSj3TPuvNeOaLJu/aq15Om3w6v4/vIa9daRckeYo5/vCvHPD7Bv2r/EeCCR4fUcH/AG4K+hbvJLz/AEZ+fLqfC5B70bacOcEccUA4571qIaQR1o2mlwfejqSaAG4pcU7OTnvSDr/SmAmOcUo6EdaOxweakt7eW5uEht0LyyHaqgZJJpAR5waXIJwencirN7braAQyrKl6jlZUcDaPTH61VHXtigD2RtCtJNCsbNruCfRru2zFd24BkjlHISQH3zirvw1Dafrlpb5iU337pyqB/MOdoLKfxz9a8f0q/vILi3ht7uWKMyDgcgZ46HivX/DNhFaeIrK6kMVxH5oNwNpEpz/Hx0H5c1k01uBj/E/TZtL16fTbu3xLHJujZRj5f/1Y4rm7K23QrlSZPReOlew/GWGFdQZ/sUypcIGRyu18jv79q8/sbROqrtB6DOBX1OQUfaUtF1PJzCpytXKQIFuflAZhjp/T9awtf2QlJUYkZ+YAc4966++06VbcTfdjb7pJ+U/U+lcRrTFhMoLEgZJ29f8A9WPxr1sxvCk0/kcmEanNNGDPJ5krMOQe+OlTaddi2l2y7jbOR5iLwSAfqK9C/ZssrTUfjV4dtb+2hu7V/tO+KeMOjYtpSMqcg8gH6iuh+HPgW9nPiL4deKNLi0zXtUsk1HSZrpFEiSROcqrDJ2uquD/uGviJvmbbPoErKxieBNYhn16ZRboNLJQszRExoAOBk9McfWtaUeHtJ8RTxT2lvqN1Mp8hpANoJ7Y6cfpXL/E3V7A/EG7tNChRNC0opYwRRAKswhXZ5j44YswY7jyQa2762Wa30vX7xI5/JVXFt5exZRxnPcjmuaa5R2uckngvXNS1eU2Vg0kBLSC42bYAo5J3EYwK7L4map4U8U6bplv4a0qaXxlLKqXL2kAWOQhcFQq8NkgFdo6A55rvtf1u+8c+EFmnTUm0sLiHTdNjEMTKOuSOSo96+eRJfWXiON9G821vopf3CWzEyRMOBgjvWlOd7oxq0faNT2a2/wCD5GRLG8EskUyMkqMUZWGCpBwQR60h7D+ldC/hvUbmTWZ9SvLS2vLKL7XPHdz7ZZix+6nXc/OSK504qjRST06oUZAyKPTjI7D1oyDz+NHfn8c0FCHAPOPwpc9TmhevTPrRjjrQAZxj9DSGl65ozj/9dACH1zXrfw48Z69B4Nn0DQtNurqwt7a+n1Ix7Qux4sK24j5QpByM/MMCvJD+teseFfDfiPWvg5qE9nrNtaaHbTyzSWSRtvuWVVJ8xkHQfwhjjOfrUyV0JnLeGrq98Pana6ppEqw30AzHI6LJ1GCdrAjp6ivVfBfxS8Uz67BaapcwXttfzRWsim2ji2hpV5DIoOevB45rgxYDGQDtwCOmRWloFs0Ot6dIvylLuE544/eLX1OJyaKpylbZM8qGN5pJH2299GGJ2nG4/wAs15L4Qm839rHxQcED+wV6/wC/b11janMZj88YOSpBIrg/hrO1x+1L4okdlYnQhyBjI329fIU17x6UHqfGox+VAzg55NJ09Pxr3Dwt4knh+Aut6gNO0SS906+trG3mk0uB2ETKc5JTLH/aPNdFjQ8QCjNGPyr6r8b6Lpcvwt1CHTdP0281OHw5p12LCPT4oprYNzJdrMBvk4BDL2xz97nx/wCGOn2Oo+B/HQu3ntpIbe2c3KSfJ5bXCKQyY5xktnNAHmh/SjHP0r6eufh74K8O+KvDDppF1NZnWoLVbi6fzLS/gkVgGLt8jHdtbCfKRlSB1rxfxj4YvJ/iTrOl6ZokuliKYn7JIxIhTAO4nAwpHzAY6MAM8UAcTgk/KM54rd0UtZWb6jbxRzywsGDbsNCwP8Q6MhHFaev+GpNLVYNMuEuxJCXlKZDuARkbfQdcdaxru48vR7dDCBMwIW4jYAle6Pj7w9OhHvU3T2An8U68NbFsEt44vKBO4KA3POM9wOa5/Bzj1oJx0r6W8QeAfDFr8JBqkWi2L3SeFrDUd1rJMb5LqXIMzqW8vyDtOeM8P0wKpKwHzZBIIpo5MbtjBsZxnmvZ/Afit9Q8XQalZhUuLaNQBMQxwOowB8wrU8Q+DfDFp4ZvfiDbabCvh6+0OEWFl5rFY9TkYxMoyckRlHcgnnn6V5j4Dljt7nzhFm5iPysHy2D/ALHf6ipmtLgfS/xBA1vTF1CW1it41XpAxx0z90ngZ+nP1rzXSLZbqzDKPnA/eEDOffPT8a9J020nm8D3N9KYVhaPeJUUSbO33MdPpzXmHhLU2+0yQ7w0RYjcjbVbn+6a+m4XqW9pA8DO4y5FKO6NTWTCmiPayxROx5w4OFPtjvXkmvWm2F3jQmUAnP1P/wCuvXdWEboqbFDDJBZMDnsDXB+JdPElqjXHlJF12IuNv1NfR46j7Wk+55eWVeRrzZ5eBz9OaMckjvV27s1SWUWz74oxlmYbfwGetU1x/ECRjoDX59UpSpytI+xjNSV0LGGJVecZzx/OvXNL1iIaA39my3F3JAm1Um2uyjGOew749P0ryIDKsSyjHY9/pXovhTT45PBl7IHAdhjcm7K4/wBkdT+QrmqrS5R7P8C7rWNY8B3OnGK00nRy7LJeyqWmnJ5xGnVsfgBXI+KLnT/CM95H4ftI47uAsft1zHmUsRywH4+v4dKl+Blzfw6nNZajf/ZreNN+cZldfQdkH05o+JfhUXWtx34HkW8pyI5E2tIO3H3sZ/P8KwfxCduY8J1D7TeTT39yGIZvmkc/eb09zVoQaQPCjSOupDXvtAK/Kv2X7Pjrn72/d+GK9F/4Qv8AtLU1fVZAtvEOVBCJAoPQgdD7Vz3xCvLCVBDp6bLKI+XAgG0uR1dv6Ct41FokKS5jhB+tKfw4rU1bVLO90zSbW10m3sp7OJo57iNmLXbFshnz0wOOP5YAz7qGa2mMV1FLDKACUkUqRkZHB9RV2HGV99GRAjgd/wBKcvP/ANem9x3pV7EZ/DrQMU8DFNzx6ClzkAUhP4kc80AGOMV2Hhvx9rmieH7jw/YParZXJcGRrZGmQONrhZCMjIrjxwcirOmrv1G1HXMijGcdxQlfRik7Js+iR4bHyjauAoxjgdOlNl0U20ImZQEjkR+B6OOeteutpIzgKPp+FZviHTfL0DUXCgMsLMv4DI/lX3lfMFOlKPdP8j8rw2aVHVhfuvzKr6xb7iwWY8nAIX/H3/Ssb4MXAuf2lvEcigqP7Cwc4znzLesVr6YHG7JzjPAq3+z9IZf2ifETsQSdEbp0/wBZb1+ewWp+pQVjg/Emo6Hd/BOQtceFW1W4nWeGxs4fKubQNKWbLYy7YbaQcAKB1rxHpnvV/XbuK91vULm2EghmuJJU343bWYkZI6nBqgOlaxVkaMTJJ966fTPEWoR+FLzw9aX6WtndyB7iEwxr5+CCAZtu/AIB2k7c1zI606BPNkVMgEnGaJJvZl0pqEvejdFu20yabUYrOXbbPI23fNwoPufSvevhMlvpGh3NjLYhjuBumVgXJ7Op7r9On515lvgttDXTvJW7iJWSJy2GVu/I49celd74A0STRtcjvbydvIutpS6OQEB6q2OB17gdawlVdrS0Oh4aNRXoO/k9/l3+WvkkZXxXuLDTNegu7O2Mcsfy4bjeCO5HQ+hryK6lEtzLJGhSN2LBCc4r6P8Aj/4QnI025lXcCuIrpEyGH91iOCenv7V4R4ss7K0uIkslZJNmZ4ypwreqn0P6VpTaOPoYPU1sReJvEEcitFreqrItoLBSt3ICLYdIRz/qx/c6e1Y4xXpemeDtH1bQYdV0s6nI8AX7bDHGGAz1KNxgjryCPpWkpKNr9SowlL4VscC+rajLpMely392+mRSGaOzaZjCjnOWCE7Q3J5Azyav+DRGddg8xJXIPy+UcMD2wO/eugfwLZX6Tz6D4j0+aOM/NDeH7POo/wB08N+BrZ8DeALt9TW4tLy3muYD/q4LlUkUnoyk8HjtScotWuS9Nz2BPEt7p3wzureEk7FJZJ4xjHQbSOQeteUeF4UkbzC8aybs7R6nngH+Veh6xol5ptv5WtxTEyIShuGwH59Bzx69Oa8vsp2tmMShTIAQNh9O4PpX0HDsoQnLm3PJzKMpQtE7Fr7ZLKg/eRAbnYY2n2x2rE1F7S+At4yUjLbgSufoAfpUkaG3giN4FDTLkIcn88kYq3c6Vd2mnw36WvytJ9wcKuRwfXr3r6zE4iFGlKpUdopanh4ehz1Y06espOy82cvd+GbSWGSO6upIoYxuwqY57HpXnd/aNZ3LRtyOoJ7ivdtf8S6joHhWKw+xKbLVXP2idwsgYKeAp65H4d643WvCOhy2Meof8JTaieZRssFiYvu9BjI/Wvz/ADGo54uVRP3JJcvpb0VvTX9D7DDSisMqMo2qRbTfnezT9PRHmQxuHGfUV654Rtri+8L2FjGpitZrkGSMybRJz/E3YfWuDg8L3wkDXKLbwltoaUcnnHAFet6PNDoGgIurz3sFsGWO3JVQXPv0wPzrgqso1fCq2o+KO22eLZGFRIo0Zo1I/uj+I16F8QUunmmTULVYDIvynHzqvqSBwx7DPFecaBqEem+ObGeW5jhtpSCJz8xH0UA5Ne0eMdU0TU9OYWhEmotjE12SBHju2eP+A856Yrmbs9f6/r1E0eBPZy2DtB5QS127iMk7Fx952Pc9ce9ea+KUWe5mkt4WaN+RcONq7P8AZHvXtOv6dJJeSvNcPNbxqGfzYwqs3uo/ka851ewudYnkigEiszjzLicYx7KoHX8q1i7Mdzy856Gtya51vxt4kt1uZn1DV7xo7aNpGVS54VQTwPQZNa2v6LpekWzFrgGcDESqdxJ7k++fwFceCVwVyCOc10Jp6kuPXqWNTsrjTNTurC9jEd3aytDMm4Ha6kgjI4PIPSq/TpnFamh2el3ceotq+qNp7w27SWyi3ab7TKOkeQflz/ePFZajsaYRd9HuheM+o6U33xS4xmg9+v4GkUA6nOMd69r+F2m+HLj4U+IrrXbHQGuIo5ltrqa4xdJLsG3KZBwP4doOTnPSvFMe/NOIyc4/SlK7VkB7b4xsNC1HT/C1p8O/Eskt3MLgXM97dvA0nlorbpCzYXuFUDmvJrLWL9tQthPf3bRGVfMDTMwYbgTkZ5rJ4yM496fE5jmjkXGVYEfWklYzVKC6Htj6tbGQ48zPbjr9PXpXV/sxTLP8efEDx52nRnxnt+9t68UOtXIOGSEkZPQ+v14/yK9a/ZCna5+MetzPt3No8n3en+ut6mC1LSsfOg4604HnPAoHB56YpD0ORWgxc56cV0nhDw8+vCUW1ykV3GwKJIvDj2bsfasC0tZrybyraNpJMZ2ryTiu78Oql9YtFGwsNWgUxyEDG9ezEeo9qmTsgLOl+HLK+1Jkj2w6hb5Mtiz7BLjqVPr6V1t38TYtGtTZRwSCeNcBynJGMEMp4x9Pf1ryzVDqM1/cefiW9thhpYmwzAdGB9f51gXNxNcSF7iR3k7ljk1Ps+fdj2PZZ/jIF0ibTUgMljPw1u8e6JfcKTlCD/dIHt1rkpptQ8RyF45bZbWJSIpR87HI+42ef++hx71wPbFb+ieJJdMtRbrbxPGCTnJDEn3/APrVz1aM6cP3G/me3llfBVq6/tT4e6vdvs7b+u/nbQyZ45YL547iMJIrfOuOnuP519TfDvwR4ii8F6ZClwp0y8icxRNEr+UXwS+5eSDj149Opr5w1nVbPV2ilW2lhvFIUYIZXHoT1/SvrP8AZ00/UvD/AIbtleUahpt6AUa0nL+Qx7SRtynfkeoqp0quIpKWkZRd7NXUmtbfPdarVWOTGVaWXVJrDy54PaS0aT0vZ9V10fpY8G+LHwruvBMxknlV7V1DpNksCx6hsgFTnPqDXmFjeT2M4e3do5AeGU4Ir7T+Ovha51OwnnhaS6aXO2ynYFNqgAFG7EnnHua+MNR067sZmN1btCNxGCRx+VetXw8YUoVoSupfg+3+R4OFxksROdOSSlDe3bo2j2LwN8Z7iO3i0fxXbDVNOLBRIXO+LnqjHJX6ivWfE3hXwHrXhl7+y1qez3YYecvmgNjOOBuH1zXx3DNtUjarFs9R/n2/KvW7mdIPAtoIdQjWRkzgLnBI6Z615y5qMlKDsdjipLXqLbXMFhrMMdncQ39t5giZri427SSBkcEhe/Nd98ZpY7HSNNsUluZ5XZJZWMREUQ9nB29xjvXiGjNLpV/HcQ34iuGcbxJHkbfdsHj6V2fjzxQNb1+xjtp7K30+3WLdbQXhnjmZcD0GM4zjHGa2ljsxr1IxjJOntJPfXay8vLfS5csvwFNKdVNVY3cbW8t3+j26H0j8KbDR77wFDb21l9sIjeMz3MO8Fm59eAOOmDx2r5d8f+BZPCt3eTR6tZkxSFR5TkMeeqgcj86+ovAfiO2n02FDbw2ayRf6i0tmZVIxhhng5GcjtxXL/F7wpdapHPcJAUtJZPljkT5gcdAM8D9K9bC4Gq8TVo4t35l7smktddFZ30+7sfN1c2pQcfq6tG75ldvtrflW/f7z5Th1q9tZYXS4eSeJgUaR94Hpx3rXttZ1HxRewQaxIxgRt7tt6HPYdqd4w8JT6FElzLHLEGboexzz9K5y1uPszlYZQGkODKckivOxmDnhp8lRant0MRCvHng9D6D8NNZjxHpkmi29shhAMtzcAkIo+8TkHn2HNei/EHVdIlsY3tt93eohWO7IQKgPXaOuewAHp0rzT4a6fHfQQW13eF7dcOVwCz+oycAA+tbPxNk0qxjAsd0KhDulUdT6KcY/KvMer3NbK9jml1K3gkbzJ5DsP7vzJCFyeMhQMnvyawfGGuNFCBaFV3gqi54z3dj3wPSuA1q5uoGlVrgv5uSFI3FRngZ6Z/lWVJfNcRGOS8lJK/vC3cD+EHr/AEraMGy7akGrXaXlwGTzHwMGSRsl/wAOgHoKpdQRS/u8twwHYUjEHOOPrzWy0FYOB36fjWrBcaSvhq6tptPmbWnuEeG9E2EjiA+ZCnck9/8AJycnJ9jSg44yKfoKSuKc7QDwKRjzwPetK/1u+vtE0zSbmSM2Wm+abZRGqlTI25ssBk5I7nik1/Q9R0Ce3g1e2NvLcW6XUSl1bdG/3W+Unrg8daduqJUtbStfX+v8zPycED+dBPcYxim8jOCeKMYxx9KRYexP5UE5/lSZpe/f270wF7cnivff2K+Pijqg/wCoNKf/ACPBXgJ+o4Ne/wD7Fmf+FpaoCemjS8Z/6bwUAeA/QVJbgNKiuo2dGJ7D149KixipraF5ZD5YJZRnA6j/ABoGbtjpkltdRZdom+8k0Rz9GB9PUc16Xp+kX2r6fILqDy9QjXMV2E2pLxxkjgE/kaxvBvh2O7t0hu7kfZJyDG7DHlP/AHWHYHswwfavfPh5o8ugwNZylZg3+rG4OrepHp+HB74Nc0prcHofKmoR3+l6mstxbyWt4GIYHhZB3APTPtXP3oH2h3VjksSQwwQfpX2t448G6PrNm1ve6ebe4kB4CbVf/aXtn1HWvmr4geBLvRW3Rzi6tTxHKTyR6EnqR6VpCpFk3ueb9jQeAOtK6lSARg10lj4I8R33h861Z6Dq1zpu1nF1DbM8W1SQx3D0IOfTBrUa1OaAPGOSa98/Zxur+51Gaz1GC91HQph5ckUfVTjORyD1I4U5rxW20LVbrRLrWbfTruXSbVxHPdpETFExIADN0B+ZfzHrXoXwO1DVY9a+w2WuXenWt3iKREkIifthgeM849eTzWtKh9ZfsektH6dTOrXWHi6vY+r/ABlpdlpfhS6klkuYbVEAjbdISRjCqwYHnJ6f1r4W8WKI9Zudl2lyrsWDpuAI+jAEHr2r7h8e6DPH4clE+ranNFs2T2ztlZ8A54OBt6nqfzr4a8RS276hcJbxGNVkYDJOQATwc806MeTBJRqupDmdr3uraNa7rtv5HHQnCpiZtx5alve1unfb0e99jLRsSAt0ByeK7nUfEttcaAsVvC4ZFVCzIAQfYg8/jXBnrTy5YBSSfTua55RuegnY1J9YbyVEDSCUE5c9SPSnWF+8syRusYUOHJVAM4/Ks64tnhjVpInQN0JIINaHhuW0gumkvZ1iTbgHYzHP4EGl7tNc0dTo9+vNQm7X010PszwZ5l/Z6c2lagrQiFVfyj5mzI5yFGfbrXfa5olvq+hWlnOrzmBhhhGxbOOSVOCPxNfMXw0+JF5oFztgguHtGlRyGcorY65HfIPU9K+hvDfj611fVAqWl1DEyHdcyuxQYGQACo78dq1xeNzDGxhUwkbST961rx37rW/4dez+djkmFyqpUjiJ80J7N6XWjez01+b6Hlfxq8F6vH4elt4BFHpaElRwCzD369D3NfLbRfZrtPOJAVsny2BPXnHbNfoL4u8QCw0GW/8A7Pvr2wZsmS225AUYJZGPKZz0Hb8a+V/ipFoviy/hutEtZtMYA+aJNpX/AICqgYH1JqcVmvtHyYyPLOPVap+vVNdd9We7kHDeKxFHny9c9Nvq0mvx1vunpprqaHgp451tb/TvJtbOD5mN7KCWPbCDlqx/iZ4ta6MhDzS3QbapmUjA/wBlcDH4ivOvD3ii90VJRbXDrvGMheVHsT0/Ksi+uZtQvHkdpZppmyS3LMSfx/rWCp66kjrzU7m8KtO4ZkGAcdB9KrxOUnV3+bBz/nNH2eYeZmKTMf3/AJT8v19KdLbTwxq80EsaE8MyEA/jW1l0FuNf5mJGeeTzk03APap4bS5mtri5it5pILcKZpUQlI9xwu49Bk8DOKr9RQAh6nt9aUDjI9KOPalGD2oAD9T+NT2ca3d/bQXV0IIpJEjaeXLCJM43EDkgDnA9OKgOCMYFJng9PxoBl7XLO30/WLy0s76LUbeGQol1EpVJVH8QBqiRnrnNavh650i2ubptdsJr6F7aSOFIp/KMcxHyOT3A547/AKVl56etDJi38L6ddNRp69qXGB2FIeO1KOW70yhf09q99/YsGPilqn/YGl/9HwV4GCOOOte+fsW/8lS1Xjro0p/8jwUgPASMen1qxp+77dBtZ0csArKcFT2NV+pGe9SW0wgfLRrJGfvRv3/w+tAHu/g+7LWPl3kUUwGAJQMHPoy9j15rs9HuRNeLJZL5hj58lJSrFc9UbsfavDvDPigrOkEhkkymFk/ix/db+8O2a9O8DeJbTTtVW3ljkPmHKEoNyD0GeGH+eK5JJrRlNa6H0DaeIIpba3Y3ErADYxli3bf9mRfT/aFUfEPgXRfFttKumXEVtcyLukijfdG3owH59PWmabNp2tQK+nT20k+4K0JYqJG9Bno3bacGrHhOO2fVbi2kt5rOaNz8rNtKnrlfSsoy5fQm3Q+M/iX4JvvCPiKewvIiATujbHUH0/OvU/APxE8IaX4B8IaPfXptNatLHVrf+0hBNJ/Zck8uUJQDbIHX0DFSB0ya92+Kvw+/4TfSlWGeCa7gXCR3cYB/BgNwz78V8c+LvBF5pdzOot33wuVkjT5tp9u9dsZoR6b4P8ceAtF8H6d4JvtRu5NNvtNuU1S9hgb7OlzPhgzRlPMZo/LRVYDHJ614Tpmq3mjXMjafdvHklSy8q4z6Ecj6iqckZUkMr7s80xlG3AP4E9Oa2jJwfNF2ZMoqStJXR0Ou+N9e1qOCO+1GZkhG1FRyoH4A4rmyxYlmOWPJJPWkI6cEfWiicpTd5O7CEIwVoqyF25AI5Pp3qwsKzRoI1VX5yS+K2PC6pHDdzyRu2IzgqFPtyD/Ssi6iQXGIGVgx4GcH/wCtWbd3ZGsdNWQEsRhmJA6c5FNBwcjqK734LeDrTxl8SNJ0TWTKNPufO80wSBX+SF2GCQe6jt61Z+CPgay8Za9fNraX50TTrfzrk2KkyszMEjVeD3Jbp0Q00Jprc5xvFF/FaRRxXEiOo4IfIPet/wAMfE7X7C/iN1qUj2xYeZuQMxHpmsD4heF5fCXjfWNBlz/oVwyIznBeM/NG34qVP41lafpV1fyFbZQxHVs4A/GtMPP6s+am7d/P1IxqWOjy4n3ktFfW3p2PofXP2hp4bDyfDEkMIjU7GubbzJBnnHPGMn8jXidx4w1O7N7LMIpJrgs+9EEewk87VUYx6VLYeD753UySWvPoc7c/kK7Cy8OQ2Nlsn1W2jVh8yw24JP8AwI/0rHEypVneUV306vu/M0yurWytWwtSS0tv07f5duh5cb/fgXVrBN/tbNjfmuP1zW58OLq1tfib4WupnS1tIdWtJZHmkAWJBMhLMxwABycnpS+LNN0+J99hJLkDHMRVT+PU1yvOCdvTgmiKjvE0qYipVVqjv52V/v3/ABPp/X/iD4U1Xw98TLXTja2eo38DvdSvKii9mSRYoxBz8wKK0hxnJkJqx8TfFeh6v8OvEGlaT4itbi//ALN04ta3WoRtbGNAGf7KM4E4YYZckkAYGa+WOopcHvj0qjE9V+Glpptz8MPG8ut2eLS1m012vIwwkCPdIsigg4PyA4GM5JNemnUfAegeOPC9/pUfhqC2g1nZFe215E220eJwDJGrFgVbYd8mCCT1FfNp1jUzo40n+0rz+yg/mizM7eSG/veXnbn3xWfzxjFAG546P/FW6odumqDKcDTZVkt8YB+RgSD74J5zWEBle+KUduM/pUskDJGr8svcjoPbPc/SgCLvx6c9qTr1p3ToO3cU08n0BOaAD9TXqnwn1T4e2fhjxBp/j5b9ptQeNIvstuGaJU5Dq/UHJOR0wO9eWd+eaCOP8aTv0dgaT+JXJb8QJfXC2UkktqJGELyDazJk7SR2OMcVDwDgfn60HJH60oHPFUAHoM5/Kvff2LP+Sp6p/wBgaX/0fBXgeOh4/OvfP2LP+Spar140aX/0fBQB4ED69PSkNLnnPHFIOgGaQx0cjI+5CQfatyz8R3kYRJZyyqR1HI9wf8awepOM80rCk0nuJaHt3hbxyn2iA3D4mICrMpKbsfwucYP49K9etfG39q2yQXY2zwqNssg3YH1znHHrXyh4J0+41fxDaaZZxyS3Fy4SNF5GfU+gAySe2K9e13UtDtPEKadoskcsOnr9mkkVxvuJBnc/XHXIAHYfSsJ0UlzEuqudU1vv6f1t959L+F/EAKRRTT8bfkEueR7HuOnvTfE3hXw/4xaQxvHa6uq4EkYHzf7y/wAQ/I14fpviWC0s32TMI/4on7Z69eldD4V8ZC4uUL3CsB/qi6cp+PWsIuUNtjSyZ5l8T/g7rmjTS3Nvp4K5yZIHJR/cZ6H26141dafPBIwkiljkU4wynj6/rX6GaT4mN3CLe5gSdCvJL43D6nrVHWvBOh61byLFpulzyMCdl2hSRc+kic4+oP1rphXi0RZn57GJhkNjJ5z1qxZaZd3sojtYXnYDOI1Lfyr6b1r4RW2j3Dyv4av4gW3B7RluovxBGR+QqfStbTw2UFr4ct7lhjcLm1EbH3FaOpboC10R4hZ+BtQGkNLMZoQTgoAW+mRxmuNu4Z9Lu5Lck46OGBAI9xX1he+NNY1CF4BpVjDbtzhR79ME15P8QPDovYHvFKpck5MflYH55qIzvuhqTTPMfDviXU/DOv2us6BMljqNru8mVY1fbuUo3Dgg5ViORW3f/EfxjrNvNaNqWxJzGZFsrSG1Z9hYpkxIp43t37+1crc2csEpWVArdCMcZqbTpZRMFhMmW4wH2Z/GtemgN3Z6NbW2reNtTt77xMwv7xII7dZHiEZ2KMANgDcR0y2T65r3DwF8ILWG2iv9SvbSO1HzGBWLYyO+MV5l8PNfuNFaKVrO1cKB80u6Y/4V0Hjr4v3LoYDDBFEediIEz/Xua5ZTk3sVb7j1rUdC+HMUYhumiG0fM0cgUn687v8A9Vc7PY/DOGUDT4YZ7rs1xPK4H1AP9a+b7nxs8wZkjkRuqgPx6+nNVrfx9eWs2Yk8vqM8FsfkKXLUYcseh7r4sl0TTopIBb2MAZeZIrMdPYHcTzXh+t+FReyvLoccrQZLSXFztQA9eOw6Hjk16L4R8RJrLiN5497j5nmYu2eecD+pqtr+rjT9SEOjPb3tyh3JHJGrjd7Rrxn61UZNaEKNjx+Tw7qYm2Q27yoBnzVBWP8A76bAqje2hsyqtcW0jnqsT79v1I4/Wus+IWs+J7yRIvEV1tLjP2aPau0D+8q9K4nOfb/CuhXYx3bnp60E5JPPFIeCP8aDx07UwAcHjg0u4lRySAOBn2pmOvqKXd+dADzhiT1pvXjtSnrjH503IOO496AF7c4z65px5HH86YDznv7UA8YxxRYBW4b6Uo64JwRxmmGlzjoPemA/OBxyPY175+xYP+Lpap/2BZef+28FeAZ9a9+/Ys/5KnqvXP8AY0v/AKPgoA8CPf1o7cnil9PY96RQD/hSAO3I7d6PXFKPfoaQ8g0AXdE1e+0LVbfUtJuHtr23bdHKnUdj9QehB6g11HiHxzB4gFvJqHh/Tbe9UsZbqyUxNMeMEjoDwenXNcVjGaTocYovpYh04uSm1qup2SeLY3RUkSQADapzyv4/lXXeE9V84qttcxKV7SgofT6Yrx/jrxU8F5cQYMUrKR0weRWTpJ7GvN3PoW58ZalDdRQ3A3bMIHh7j19DXbaT43mNrGrzLImOcjp9R2r5Xt/EV4kys88gwc5+9/OvR/AHijT77VrZdV1CS2k3Y3kYB575z+WawnSsrtDT7H154V8TC8sov3iyt3BDA/geQav38ejapOtveaeJnOTnA49e+f0qLwppekyafFNZmzugVBMkaKCe4yV4P4iofEn2GzRpEiUTrwDjp+PrUpyjG8XoTJXfvIrTeAtKWTdYP5DkHbG4DD8Ohrz3xv8ADy7aGQf2ZcMnOJbCTefxQjNek+H7k6nbK0t26lMEq4DhfTkjH+e9bd7BebR5OoxRnHG9MZ/I1cJ8yvb8f8yXE+ItX8JTx3zR4tZMHmO6h2Sj6mup8A/D2G61mNriPTo4yM5ZNy4z9fevTfidcSW9vIbiC3unUHLxkAn06gfzNedaX4jhSHZLpVzsONuyXH64Pt370c7a0Bao+jrHw/omkaJJCbPTJAq9URBk18zfHMeHY7oOmnADOC8TIuCfp1rQ1bxIws5I7PT5EDqSDPdLnA64yfpxXius+fqd673azRqpyGlYkY+p/wD1U4Ober0Hyx3SMyXUILVj/ZyuA33vNbdjr0wKLnWI54kVbC2Djq5BJzVGQC3m3IY3KngZ3D8sVAWLOWbGT+FdPKtxkv2qZCxikaNW6hCQK1buDW/DP2UTiayF7bpdwspx5sTgFWDD2/KqGkabd6vqtpp+nRmW8uXEcSAgbmPueK9I+KGnvYfD/wAI22r3NmNesGntZLeK5WZ2gLbkc7WIAB3Dt19qtRTTujnqV+SpCCe/37PX79Dy2V2mYySMzuxyWYkkmk6etHfpQOuecetSbsMe/NB6HI5pwGc8ZpG6DmgBCDwOPoKQjnPGKXvyc0D1HamAmPT6UE9MU4jrz9fWmnBz6UALjnPtSYHbrTh9PrSd+MZ9hSuMaR6U4ZJHfNIfvHGc9qXPX0piDGBkfzr339isf8XT1X/sDS/+j4K8EGMAA175+xZ/yVLVCe+jS/8Ao+ClcDwA89KMeh70vbFIKAFH6fWkPI7Zpce35UoBPQcd+aAEXtij6g5+lHXHOSaPpmgA65NIOuM0vU+hpBwB6dqAAc4z0pASDgflTvTt9KQdxQBsaL4n1jRWZtK1K9tCw2nyJmTI/A10un/FfxZaTmZtVe6YkZW5G4H69DXB98k/nTfY1m6UG7uKuVzy2ue36D+0Dq1jJEb3RdJuyoO5sPGxPrkH/OK09a/aPu9TgVW0OK3lB6w3TAY9K+fSMUo9v0qXQh/TYc3kel6/8Sk1WzKxx39tckfMyzB1/WqGneOWgh2T3upv9AnP45zXCD3z+FAFUqUUFzstX8ZJcBvssUpY/wAU4yQfzNcte3k97JvndjjsScD6Z6VWOc4xj1pPrVKCWwriggc8UYGcH8TS+mc001QgXI5BpeAMn8Pek6Z65p2O54oATJ7emabnrzTiOO1ID79PSmAoOSc/40hOeaB1oIx9KADr3+uaO3tQV7UYJzznvQAE/lSGnY7j86Q9B2oATOPanE46Hg5NNxSk/wD1hQAmeuKcf8/4U0cHilGR3GaADOa9+/Yr/wCSp6r/ANgaX/0fBXgZzwevvXvn7Fmf+Fp6rnr/AGNL/wCj4KAPAwCxAClmJwAB1NdF/wAIXrpQFrWGMnnZJdRI657FS2R9DWPo2oy6TqtrfwJG81tIJEEgypI6ZFQXc8l1czXE7bppnMjn1JOSahqV9DKftXL3LJff+qN3/hDde3ALZo/dmS5iYKPViG4HueKoahpV5pMvk3yRpKV3BUkSQgcjnaTjv1rMHH405JNiup704qS3CCq396Sa9Lfqzah8J67LGskOmTyI4BQLgs4PcDOSPfpT/wDhD/EJYq2k3SY6mRQgH1JwBWCHYHIdgR3zSvNK64eV2X0LE0rSJarX0kvuf/yRt3XhPXbaIyPpszr6wlZcdudpOKsaZ4J1u9uUjmtG0+JhkT3oMUYJ+6MkdScADrzWFZXl1ZOz2VzPbuRgtFIUOPQkUsl9dvOJpLmaSUMH3O5Y5Bznml7/AJCca7TXMvuf+Zo2vhbXbu3aa20y4ljVimVXJJBxwOpGc8jipv8AhDfEQlMTaRdBh3K4Xp/e6dvWoNd8RXur6x/aRcWs2xY1W3YqEUDGBzxnr+NZZuLhoRE08piHRC52j8OlC532JgsQ1dtL5N/jc2h4Q8RGMuNHvODyvlnf/wB89f0qP/hFPEAGTomogf8AXu+P5VnDU78XTXQvbn7SV2GbzW3lcYxnOcY4p41bUwqqNQuwq52jzm4z1xzR7/kO2I7x+5/5lubwzrkcYZ9Hv1GQuTA3U9O1St4S8QK2DpF3nZv4jyMD+vt1qlFrmrROrx6neoyoUUiZgQpOSOvTNVRdXATb9omClvMxvON3r9fej3/IaVfuvuf+Zdj0DWZd2zSb9thw2Ld+D6HitLUfBuq22o21jaxfbriW3E7C3G7yz0ZSfVSME1nP4i1twA+rX5+UpzcN909utS/8JDcr4XXRVRVj80yGYE7ih58v/d3fN9aT5/Ih/Wbppr+uu/TsJL4b12OR0fSL/cpwcW7ED8QMUsPhfXZmZY9Jvflx96Ij8s9aqw6zqlvAsMOpXsUK52ok7BRnrgZqvPeXU6ok9zPIEyFDyEhfXAPSmufyLSr919z/AMy8+gawjENpV8CCB/qGPJOB255qUeF9dYtjSb3hPMOYj0/H+XWq8WuarEhSLU71VZBGVE7Y28YHXpwKrG9u9gX7VPgP5gHmNgMe/wBfej3/ACHav3X3P/Mup4e1pmAXSL/kj/l3fr+VMl0XVIblbeXTrxZz0TyTlvpxyOP0qNtY1R1cNqV6VfhgbhsHPrzU1t4g1q2tPssGqXsVuBgIszADPYelHv8AkK1ddV9z/wAyzJ4U1WHRZdTnt/JjSQR+TKCszAnG4Lj7uSBn3oXwf4iZQw0a+IIyP3R6Umg+JbzSdSnvWJvJZYGhPnuWIz91vqpAI+lZMl1czSPJJcSs7nczFjkknk0vf8iUsRzNNr1t+G/Q2f8AhD/EXbRrzqBwnf0qO48K6/bqrS6PfAOeMRE/yrI+0TY/1sg/4GalttQvbRt9rd3EDY27o5WUkdccfQflT9/yLca/8y+5/wDyRoW/hbXrk/utHviQejQkfzxSz+FdetwvnaPfDcMjbCx/lWfdaje3b7ru9uZnyeZJWbGTz1ottQvbYN9mvLmAt97y5WXP1waPf8hctfuvuf8AmXbvw5rVoiNc6VeIrgEHyiep46e/rVvSfB2s6heeTLaTWMQBLz3UbIinsCcdScD8ayrDVtRsHd7G/ubdn+8YpWXd9cGhtWv5LqK4mvbmWaKTzUaSQttbOc80e/5ClHENNJr1s/yuVHRo5GRxhlO0j3pOcjt2zSyyNLI8jkb3YsfcmkJ9cZqzpW2o2lAxn+lA65oHA/mKYD8YPXmve/2LP+SpaoOv/Ell/wDR8FeA54xnpXv37Fpz8U9U/wCwNL/6PgpAWtW8EfATSNVvdN1Dxt4khvbOZ7eePymbZIjFWGRakHBB5BIqp/wjH7PX/Q9+JP8Avw//AMi15T8WP+Sp+Mv+w1e/+j3ro/iP8H9T8C6VdX15q2m3S2tzHaTxxCVGDum9dpdArjbydpOO/Q4YHZnwx+z1/wBD34k/78P/APItH/CMfs9f9D14k/78P/8AItfP1FAH0D/wjH7PWf8AkevEn/fh/wD5FpP+EY/Z6/6HvxJ/34f/AORa+f6KAPoH/hGP2ev+h78Sf9+H/wDkWj/hGf2ev+h78Sf9+H/+Ra+fqKAPoH/hGP2euP8Aiu/En/fh/wD5FoHhn9nr/oe/En/fh/8A5Fr5+ooA+gf+EY/Z6/6HrxJ/34f/AORaP+EY/Z6/6HrxJ/34f/5Fr5+ooA+gf+EY/Z5/6HrxJ/34f/5Fo/4Rj9nrH/I9+JP+/D//ACLXE+MvBNnF8YrHw/p6tYaTqs9r9m+YyNFFNtH8XJIyeD3GM10Op/CDTNStb2Twfqkwk0/UJtPuU1NlXcYyAzptHIyy8H1pXj3Cz7Gr/wAIz+z1znx34k/78P8A/ItH/CMfs9f9D34k/wC/D/8AyLXMa98MtO0bwf4nku7y4/4STw+LWSdI2D206XDIFKkqGGA/PvXkx4JFCaew2mtz6A/4Rj9nr/oe/En/AH4f/wCRaP8AhGP2ef8Aoe/En/fh/wD5Fr5+opiPoEeGP2eR/wAz14kP/bB//kWj/hGf2ev+h68Sf9+H/wDkWvn6igD6B/4Rj9nrP/I9+JP+/D//ACLR/wAIz+z1n/kevEn/AH4f/wCRa+fqKAPoH/hGP2ev+h78Sf8Afh//AJFoPhj9nr/oevEn/fh//kWvn6igD6B/4Rj9nrj/AIrvxJx/0wf/AORaP+EZ/Z67eO/En/fh/wD5Fr5+ooA+gf8AhGP2ev8Aoe/En/fh/wD5FoHhn9nr/oevEn/fh/8A5Fr5+ooA+gv+EZ/Z6xj/AITvxJ/34f8A+RaT/hGP2ev+h78Sf9+H/wDkWvn6igD6BHhn9nof8z34k/78P/8AItH/AAjH7PP/AEPfiT/vw/8A8i1z3wqtNOu/BGuyX9hobW9vDceY90A11PJ5LMgjJ5jVMBiR3Fcf4a0ZNK8X+FH8QW0V1pupNHcRosgKyRtI0Y3egDqcg9gfWo51r5FuDVj1H/hGP2ev+h68SY/64P8A/ItH/CM/s9f9D14k/wC/D/8AyLWv4l0vwdbTa5e6zZaNJYLp0P7ixRYp4n+0Ou5SpPJAC9fTNN1TRfA1tr+mi50+zjaS5vTbRQxp5EgFpAyiY5yANwK4/iLVHt4f1/X9dSvYyMr/AIRn9nr/AKHvxIP+2D//ACLXp/7Pej/CzT/Gl5L8PPEur6rqx090lhvI2VFh8yMlgTCnO4IOvQnjuPGviNYWmmfCXTILa20C5nMsTz6haxpHMm4ylYwoyW+6ctxwo4rV/Yp/5Knqv/YFl/8AR8FaQkpq6InBwdmeVfFj/kqfjL/sNXv/AKPeu4+Jfxr/AOEz0fXbGHQ57T+2JbeSY3OpG6jg8kDb5EflqIy2PmPOcmuH+LH/ACVPxl/2Gr3/ANHvXKVRIUUUUAFFFFABRRRQAUUVpaLpsepG+Et/bWf2a0kuV89secyDIjX/AGj2HtQCVyDSRZtqlmNUaZNPMyC5aEAyCLcNxXPGcZx71JZ2ceoa3BZ20hihuLhYY3m6qrNgFsex5xVCuw+EVvBcfEjQftsSyWcNyJ5wwyoRPmJPsMUn3Gj3f9o+xmtYNH8ZaWViv9HvlAymflLblY+ysoGOnzV4zefFXWrjW4b+O3sraNZpJ5bWCMpFcO7BmaQZ+Ykgc+1fRIu38XeHtY0nUo5Iv7QheIlADtZlLoBkjOCnFfG7qyOyOCrKcEHqDWMFGortFRlKCO71j4oa1q3h7V9Ku4bNjqxhN7deX++m8sqVyfYqMegyBXBUUVrGKjohSk5O7CiiiqJCiiigAooooAKKKKACiiigAooooAKKKKAPb/hlpGial8KdYmGm2rajCl0Jry6ijcIwhZk2lm3LwB0B5qX4jeC9PT4a6I2ixoJ7L7PHuKBpLp51BKq/UgOzEAgYDV474eb/AInmnKwDRm6i3I3KsNw4I719V6lr3k38sUGmaYixNgA26nntgY/D8K8rG4+ODmozu76/p3Xc78PQliI2gj5R1jS77RtUudN1KB4Ly3fy5YjyQeuOOvavYvh78GbXxb4M03W7vW7uB7vzD5KQhgm2Rk6k99gNemWniJp71UudP09gSAp8hd2fQV2PhZk/s+VI4oIY0uGRI4V2qgwDjA+tGEzWnip8kE0/Mzr4Wph7qZ4b4v8AgTYaH4U1bVoddupJLK3acRPbqA+McE7uKl/YrBHxU1X/ALAsv/o+CvXPitz8MvFGDx9hf+YryX9jHP8AwtnV93BGjS8en7+CvTUm9zl3R5P8WP8AkqfjL/sNXv8A6PeuUrq/ix/yVPxl/wBhq9/9HvXKVQgooooAKKKKACiipvs832U3PkyfZw/l+btOzdjO3PTOOcUAXLHRru90fU9TgEf2XTvK88s4DfvG2rgd+RWbS5OMZ4pKACum8Baj/ZWo393tLbbCdMDr8y7f61zNTWszW86TR4LowIDDIPsR3FKSumhxdmmz6A8PeIdOh1G01eWa7bSneW0SLzB8rRFRDJuJzyGbjvXk3xU07+zvHOpbYzHHdMLxFz0EgDn9SR+FZCXl7q1+LcFXFxOXWAuI497dO4AHP0rr/G+lOPBGkX13dxXmqRTywzeSS5jiyNokPqGOB/vd65oR9lNeZcmpI86ooorqMwooooAKKKKACiiigAooooAKKKKACiiigAooooA0fDq7/EGmL63UQ/8AHxX0Z4gu4LfU7tppVRPP2c8EnOAM+pNfOvh1wmtWRPQTxk46/eFeveIr2K5ubqK5iSRXuTIMN3Vzj8a+bzqj7WvT7Wf5o+kyOhKpGTidjojA3sZjKbiwAVxnd/hivQvA0hbR5vmDAXTgEHovH/1+K8Y0LUliv13SDblRk8Y57mvXPhu/meGvMZQvnXUjhSe3HP6VhlFF068m+xedUHTpc3p+o/4rAD4Z+KMYx9hf+Yryf9jMg/FrWSpyDo8xH/f+CvVfit8vwx8TNgZNiw6+4715R+xd/wAlW1bp/wAgabp0/wBfBX1EOp8yvhPKPix/yVPxl/2Gr3/0e9cpXV/Fj/kqfjL/ALDV7/6PeuUqxBRRRQAUUUUAFXDqV4dJXS/tMv8AZ6zm5Fvn5PNKhS+O5wAPbn1NTatrFxqlvpkNysIGn2v2SJo0ClkEjuC3qcuRn0A+tZtABRRRQAVYsjCLqE3KloQwLgHBIqvXQeIorSDStAFjGmJLMyTyZBZ5TIwYHHQDCgUmxkc1hBczm9WeCK0lZnESt86DqFx+QzXbeGLBHs7y7LmODULB4tQij+ZYt43JJz3LKpx2zXnracyWts77zPO2VhC/Ns7MB1OecfSvQ9I0m7nvrmTSrOSDTJrGOHFzMN3CAh2CnkkrkfWsKu25orPc8udWRmV1KspwQRgg02uh8Z6RLpl9ayyOZBeW6Tl9pA34w4yepDA5x61z1bxfMrozas7BRRRTEFFFFABRRRQAV1nw40DTvEOtXkWszXUVlaWE96/2Xb5j+Wudo3cD8fSuTr0D4MW0l34h1i3gjkkmk0W+VEjXLMTEeAPfp+NKTsmyoJOSTOQ17+yv7Vm/sD7d/ZuF8v7bs83O0bt23j72cY7YrOr1K70PwhriLbHz/BGvW0cST2upFmgmJByykjepI2nnjn8apr8M4r4yRaB4u8P6ndrjbbiYwtID/dLgAn2zU88Vo2V7OT1R5zRXZj4YeNGvZrRfDt8ZYV3MdoCY9nJ2n8DWyfA+ieFbHz/iBqMw1CRR5ekaa6mePOCGldgVXg5x1NU5KO7JUXLY8zr0X+w/COqfDrWtV0Ua1Dq2kpamYXTRtFI0jhG27RkDO7H4VJ/wkPw4t5Fjg8GX1xHFjbNPqLB5CB1ZR8vLdh2Nb0sU8nw58fakvhN/D1lcW9iIkCSiOTNwh3Av19sYGD+NTzN7DSS3MbwZ4S0Y+F9P1nWTq8lxqFzLFarp8askflDP7zIzknoBjgE1VluxNcSSA8FyQB9a6n4O+H9YvPCxudO8S3Gm2NxPPBeWygEtGIvvRjuxOVOMYzmvMxfhGCkZydoI7c4rz61KVSbd7n02S42nhou+mx1FretFOC6l1BBIJ9697+D0scvgyxuJA253mQkkn5B/9fPSvFI/Bk0jxK3iTw6vmOsZzfLkZx279fzr3jwVpa+GtIfR4JzMlpK675B98soJOB068UUKag7poeeY+GIpKMd73GfFqVf+FX+J/lZitsAfxcdPYV5l+xZj/haurEdP7Gm7Y/5bwV6L8VJmPwy8TkbSxtVHzcHG8ZH4e3rXnP7FfPxU1Xt/xJpf/R8Fd9Pax8ql7v8AXkeVfFj/AJKn4y/7DV7/AOj3rlK6v4sf8lT8Zf8AYavf/R71ylaAFFFXdGWwfVrRdYknj04yL9oa3AMgTPO3PGcetAFKtHXbjT7rUfN0iyaxtPKiXyWkMhDiNRI2TzhnDN7A4qpdeT9pm+y+YbfefL8zG7bnjOOM4qGgAooooAKKKKACupubU6r4aOs/L51my28kUSbVVBtCsfckmsDTrS5vr6G2sLWW7uZG+SCKMuznrgKOTVzSrbWTdXljpdteyXDRslxbwxMzbB97coGQB3J6VMk3sxo6fUteWOLQb9LaO1FnFGLZIfm84DIkV2OSOcDHbJ4rqPC/iPUNPt2vbVbZrC6lZBDccOuc/Lk8HHGMV5za6VchJbs2l3d2dmqu0luheKMHuzdF59a6jwl4jaw0XU7WGMahbbPtDRTsihWyM4B+YAEjJB5xXLUirXRqk07M1/HUGpX/AINlj1yO3e+sZftNrIhChLUkKyAccklT+FeQ177oV5F4hms5ZIIW+1furiSVGEcw+4Y4kzn+LOeRxXjfjDSG0HxTqmlsGH2W4eNdwIJXPynnnkYNVhp3vFkzXUxqKKK6jMKKKKACiiigAq3puoXmmXQudOuZrW4CsokhcqwBGCMj1BqpRSaTVmNO2qLep6hearfS3mpXM11dynLzTOWZuMck+2Kqg4ORwRSUUJJKyBtt3ZsyeKNektFtZNZ1FrdcYjNw+0Y6cZrKmlknlaSaR5JGOWZzkn6mo6KShGOyG5N7sK1LvX9XvLFLK71O9ns0VUWGSZmRQoAUAE4wABj6Vl0U2k9xKTWzPR/hoPE2pG0OnX0Wn6TojSzG9nT93C0q7SMDl3boqjJyfSuPurV4ryZJVAk3HKg5wc/547V33w88F634o8EyvBrQs9MhvjJFaiJ3DzhBl2Kj5BtAALH8utZMmjusglClDICSrnkEOQT+OP1r6DI8LSqSlKdro58XiPYwV2crb2waeNfLB3Hp6/Svpz4Q315qHgC0u7+dp52mlLuRlnx8oz64CgfhXiVrpS+eodSScFCGHHPWvX/hehtvAlovmYxcSgKeuCecfTr+NLiDDU4QU4K2pz4TGKrNwRr/ABQk3/DLxGVBKmAAgjB4da4X9in/AJKnqv8A2BZf/R8FdZ8S7gf8Ky8QMz7maFIgO5AcfN+tcn+xT/yVPVf+wLL/AOj4K+aw7bjqelNJaI8q+LH/ACVPxl/2Gr3/ANHvXKV1fxY/5Kn4y/7DV7/6PesXTdIvNSstSurSNWg06AXFwS4XahdUBAPX5nXgVuQO8P6SdZv3tVu7W0KwSzb7l9qnYhfaD6nbge9ZlFFABRRRQAUUUUAFFFFAHo/7PYb/AIWzojKCSpkbIHT5GGf1rQ8JazdeGfjnc6jdCSK0n1Oe1u5HXC+XJIQ2T6cg/hWP8KF1izfXNb8PS263mn2mAJWAbDnGVzwSMdPeqevfEzxfr2lT6bqusyzWU2PMiEaLvwcjJCg9ay3k0i0421PRvilYJ8OvhzqPhu0Ywz67rs04UHcWsIseWrHt82w+vBry7+xPI0TzLqT7JJMnnq8oI8yIdFA7kkj9KqeKfFeteKby2uddv5LuS2iEMW7oij0HqTyT3NZ9/qd3qF0lxfzPcyIoUGQ5+UdB9KOWTSQ+fXU7/wAP+I7610rTLXWAsenpuMACbWC4PT2JxzWX8TIZb2XT/EDsv+nxCOROhR4hsxg8kbQvPfmuw8EHSPEelOLK0NtqlukcctzL82FC5+VugyV9Ku+PdJlvvB0q39xpkE8UbXttGsoDOR1AHum449cVzKap1C5ao8KoorU1TQNX0q1t7nU9MvLS3uQDDJPCyLICAw2kjngg13GBl0V1/wAPfAOseONQ8rTkENmhHnXkoIjjGf8Ax5v9kV6v8V/BvgfwV8OGtIY428Qvs+zzyuWnlO752Kg4Vcbu3oOaXMkOK5nZHzzRRRTEFFFFABRRRQAUUUUAFFFFAHe/DfxvqXhsJp9nb2ssM90sm+VWLRsQEJXDAdPUGvS9f0oW2p3EHlIjCVsEckn1b+fHrXhugELqVkzAFRMhIPf5hX0741tEi12/Ybg2/fnrjI6fSvpcGlh4wcd5J/hb/M+b4hxEoUorpc4iOxZc/NkI/KjA6AHrW94ZZYNO1C1lbyHTUJO+eDGmQKW2tw0iszHAIyu3Bz1qhdzLb+JNctgGLLqLsBt6jy0zx2+vauLPK3NRseXkNZyxN/REvxBnVvAGvAvjcilSxyW+df8ACs79in/kqeq/9gWX/wBHwUnjm5jfwFrKlWdgiDc3clxzS/sU/wDJU9V/7Asv/o+CvnsLrC7Pvq1r6HmXxZsrofETxjfG2n+xHXr2EXHlnyzIJmJTd03YIOOuDXHpI6K6o7Krja4BxuGQcH1GQD+Fdp8WtTvT488X6WbmQ6eviC9uVt8/IJDKylseuABXEV0mIUUUUAFFFFABRRRQAUUUUAevfDXw/pt18P5NQ1CENNcauttHIJCu1URGYt/sjzP1rzzxja2ln4kvotPkSS1D5Rk+7yM8e2a761uG0T4RaLPbX5tGmuriSe2dcmbeVQOh7YWID8K8qlwZXIYsM5BPesKd3UlLoU3pYtvp5TR478zw/vJTGIQ3z4A+9j0qpEEJPmFsAcBep/wqzDZiWxe4+1QIUOPKZsMfoPzqouV+YZBHQg1qne5J2Wh6tJBpUdpNb2scBZXJLbWcY6sO+eDmu5OvWEGr6fDNJDNdXVuEjdDuitzjH4HGRXlVndi50saZKywqHMiskeWdj0BOeldN4Ftmub+3t7RpBfiVYo98e8ltwGB6KBk/hXFVp6tv+vM0i29Dqvhh8LHvfiHdDUdk+j6Q8csjr92ZmUOkYPrg5P0I717f8SPBMPjqPSLW8uTBZWdw88saDDSArgKp7cj9au31jf6H4Vubfw5apc61IuxXyqBpSMGRi3AC9geOAK1dJe6i0W0OstAl7HCq3DiQFWcKAzZwByQT7ZrqV1FOQONo86a7efrY81+IPxF0P4caVHoXhq2tZdQiTbHbRj91be8h7t3xXzDrusX+vanNqGr3Ul1dynLO5z+A9B7V7D8fpvArWEUfh1bE66LndM9oCQVI5DHoTmvD8HNFP3veer/D5CkuXbqNopaStSAooooAKKKKACiiigAooooA7zwD4O1rW7M6zpqWi2VlcBXkurhYlLqu/bz7CvUfFXivUTpI8Sano32OyvJPLjjdwJTxgkL1K8E59Oe9effDb4i2fhTwvqWkX9hdXqXMzSqiTBYiDEUZXXHIPGfbNXvFHxVste8BzaG2jPDcP5SJibMUSI2cqMZDY+X6D8K6nmVZpRaXu6LR7fecWLyyjjElVb+8li+KNlayB4rEyBedn8LY9c+tPh8SPruo3mspbeTFfXTuyb8lfkUbc49q8v8AEMmly6vO+gQ3MGmkL5UdywaQfKN2SOPvZP0rofCt3NDoahHUKLlwFI6kqtcmMqyrxvNmOHynD4Zp01bW+52Hi3UFl8JarG8bKzIgVgf9sZ/A8Vu/sU/8lT1X/sCy/wDo+CvO9e1G4fQ7yOQgxuFBAGP4hXon7FP/ACVPVf8AsCy/+j4K58Kmou57FWSk9Dyr4sf8lT8Zf9hq9/8AR71yldX8WP8AkqfjL/sNXv8A6PeuUrpMgooooAKKKKACiiigApcUD8q9A0/4earp3jDw5BqtuJtKv9Rt7Zby0ffFKHZSQjeu00nJIEj2UfBPT7/w7o1pqmqXyzWdtsdYsFd7Es2M9MbsfhXOp8ANPklix4lnVHPI+xgkD0+/1r0qPxjBaz3s1yy/YvtEnmHJzEMKB8uP/wBdZfgrXbArONR1WWeUyPLFnIDqf9noMcce9edh8xws6bnKXK101NMRg8bFJ04XXV9jj/8AhnvT4/mm8Q3Tpv8Aux2w3Y7/AMXWu3s/h14Q0rR44Do29du57uaMNKMddx7Z9K19D8RW2rS3PlxhI48su1ixZR1OMcVatLyW9LQvDHPFPCWGRtUqcDOfxrnrZxhrqKu76bP/AIcn6tioyan7p51p/hLwnqF3JeaL4Yv544yw3yTbIiy91GD1p3g3xXIuuSNYeE7S10iNCHmtrbDF/wCI+YevPtXoenJcadZpp1rDHCYW/dLy0e0qSfmI659qrWl7LqYubPUCPsyxjc0Ue3dhhhvoMVis4pQajKLT79Pz/Qv6pOTfv3S/L0/4JX0LxhdavqiWp04adA5MayTHLNuBCnbjj5iPqK+aPFGqeMPEWvTaNqN7fajeQTSx/ZQSRld2SqjsFGa+uNKs7W2dlAWWdeWlx97PII/DFee/EHWLLwL4lmmk0h5ovEij7VfQyFJUCgI0at6EDcR6E16kZXjzvX8f6+Rn8N1c+UiCCQRgg4NJyOeldLcWD61r0kGj2091LcSsI4okwSASFGB7Ada9p8B/AKzFqs/jOaVriQgi1tpNojX0ZvX6V1RdyVrqfOPbntxSVt6vorp4l1HT9HimvYoJ3jjMSFyVDYHQfrV6/wDAHirT9GfVb3Q72GwRQ7yumAFPcjrTTuuZFOLTscrRXeL4Y0xtViKee2nNa+aDuwWbHr9azn8Pw/2cypHIdRlvzawIW4C8cnjoM4z71yRx1KX9f1t1PSllGJjHmtp/wL/j0OUorq7HwlMmo2i37RvZysVaS3kBwcfdzjrVXWdMs7bRUu7cTCV7ySHDMCAijI7e45q1i6cpKMXe/wDwf8jJ5biIwlUlG1t779P8znqK6FdDE+g6ZPaxyte3dy0Odw2ADoMY4/OrFj4QuX1G3ju5I/sbth5oXDYx1Az39qHi6UU3J2tf8BRy/EStyxve3prsctRVzVrRbLUJ7dJBIiN8rZzkds+9U66IyUkmjlqU5U5OEt1oFFFFMgKvWd4IIgjKWAYsCDggkDH8qo0vGOtKUVJWYmad3fNJbOjSyNvAIU8jANe2fsU/8lT1X/sCy/8Ao+CvAK9//Yp/5Knqv/YFl/8AR8FKMVHYErHlXxY/5Kn4y/7DV7/6PeuUrq/ix/yVPxl/2Gr3/wBHvXKVQwooooAKKKKACvZ/hd8HLTxf4Xh1q91mSBZGcCCCJWZQrEcktxnHpXjFbHh7xJrHh2cy6LqNxZs33ljc7W/3l6H8amV/siaufSN38J/h34ZsBe66bo28bANLNK5BY9BtQGvRvDn9kXej2d1pFnDBp6kvbDyRGoCnG9QenQ8nBrM8JvL4v+HekyeI4kuJdQgEk8SAorfMduQO3AJrK1bxPbeIF8TeHtDmgWOxs1tjdKQVE0mVSNO2BtwTWVWrGEOeXqbQhBwsr81/l/w/9emd4t13QZH1GCys7O7uWjVPlJAYZOM4HP8A9avOtGe4uLu+N05VbZioSIYCHsffvXY+HfD9lp0c1u15G88paRpXGwcAcZHQDt9aVvDEmjPcX9tqFkWnP76GRsiRB3U+vPSvkq2IjX55RSv30R9Lg1CiuVyd3b5/gZkt7c6VHaW+ms0CgES+WeXPvjue/wBK9B8JX7SwxyahJtfZhQuQpx247gdc15zotjqUWtS3ktuDYM5Ysi/fHsa7Cw1S0iS6gtEuTDExlFlGSDLIeCCfQ57elZ4fD05STc0mtdm7jzOnzU+WmuZ90+/9eh1/9s293cBbJ45iMjDMVHpn6VUttJvYXvLi7nBV42UInOBnJP07gVh6S1vcJHZXWkyWWp3L7YIZHJIABPJPYY/HFdDc2N0sscZvywkUK8ceOOOT7DP6Vdb61WvKvFyS2tok/RrX/LyPCUadJ+67N731/FXQ62uW+zCHSnWaVXjwJCfmXYMk1R+IvhGLxvpEFg1wttNa3CyrJjdsyAHBHclSR+VRaSLzT5Lky2zu6ylY9i4XGCM564zXS6XaGytIUWRXDuXncsSST6euDxz2Fejks6tS8ZRsvwXa336meKhBJ63/AFOatNK0X4aeHJJNG0u5u5+VPkpvnnbGcMey/wAvQ10HhvUG1vw9aX1zam1luUYy27Zyh3FcHPsAfxrxnxL8X/EvhbxDqWl3dtY3D2c7IXVdu5Cu5DwPQiqsX7Q19nFzoFs75A+SdwcevIr3VVvpyv8AD/MwhOn7PlS1vvf8DtPGvxL0v4dXbafbeHLuKUj5WSNYYpB1yrAknrXjvjn40a54o0q70xLW1srC4G2REG9ivpuNV/ir8U38e6XYWUmlJZfZJ2lDLMXzkAYxj2rzUnnPJ96rk5viv/XoHNyr3Uv6/rodVJ4hhPhGC13E6hH+4XC4AiGTkn8R+VXrrxFpr+KLSaKRzZQRSASFSN0jRkbiOuN2Pyrh+55HNNPvXO8DSd/O/wCP9aHoxzfERioaNLl/8ld1/wAE7ZNe02N9NRZZCkF2JZGWIINnfAHUjHXrWNq2p21zokNtHvM63csxyuAEIAH48GsInNFXDCQg1JX0/wCD/mFbN69aDhJKz06+Xn5HcwTrpPh7w9LexsEM7OQPveWTncB/npUMWv2NpeaX5c0ksEV2LiUCAIAO4xnmuRnuZ7gRieaSURqETexO1R0Az0HtUVZrBRd3N6u/43/zNXnNWMFTppWSW++lr/fYt6qbdr+ZrN3khZiwLrtPPPSqdFLXbFWSR5NSftJudrXEopaSmQFFFFAC17/+xT/yVPVf+wLL/wCj4K8Ar3/9in/kqeq/9gWX/wBHwUAeVfFj/kqfjL/sNXv/AKPeuUrq/ix/yVPxl/2Gr3/0e9cpQAUUUUALXdfBDw9p3in4m6RpOtQmfT5vNaWMOU3bY2YcjnqBXC11/wAJvFFt4N8eafrl9FNLb2yyhkhxuJaNlHXjqRSlsFr6I52eD7VrMkFjblPOuDHDApLYy2FUE8nqBzXtHxU+G2g6F8PEu9EXOr6VJDFqb+YzMxkQZyvRcEg8etZWneK/hXYaza6lb+GPEAuYbhbgO12jBWDbvu9CB2FWofjc2qf8JLa+J9MRtK1W1khjjsURJY3I2qzORlyB3OeQO3FTKWuhaim7lCb42aoPBFv4f02xgsZI7dbY3qyMzbQMEgHoT69u1dF8Bra3h8Caze3UBf7TqMUSsSP33lgNtGey78k/7QrwQEcZGa+iPAnhy91H4eeFrfS52SVEu9QkIA2sZH8tU564EWT9a4MyjbDyUd3p3/r/ADNcK06sVJ2RcF2L64lt40i+zyqUAySRnqM+1bsvhXT2gS9u9QlRNgA2KDGvXAHvWT/YPMDXsN9DA0ZkeeNAFVzxyOuePpWnpvhYta3eb59U0Tc5W3VzGysMYbORnvXzmEyytiHakrX76fPzPpsRiadKN1U5V103+ff1scVJ4ku0NxDp32m4ghPlBSuAqg9OP51tP4wsfI+2WlvtuVB/dpJkKRwGyT6E1PeXVuPMtdL0u6trSCMI6ucFi38RPfOPxrzrxHoupJbqLG0Z4ZF8wFE/1QBGRgcnIyea+knwnVjyypvX7n/X3HhR4uy6tiPYSpuy6/5o7jRfH0t/qdvbSFEvHZQl5KQWTb8oAzxypP416jBfWFreJCpd7hiWUrEW8xemA2OvOTz2rwq48KR6Rf6Rqd3YeZpsirL9mN380ispKk7Tlex7V7Roeo2uraHbrbNNYImF8gsC5IGTgnnHv6V6UMsnTpqVZJro97eu55udZrhKk7YVcsu3f7zpFkRZ2L3GHWPd5e7jb1/Oq3hkbtJieLOxmkcbjnq7Hr+NRNYWDRr9pG8RjeJHkKhc+rZ54qLwtcSR6ZLb3MM0f2V2IcpgSoSWBUDsAfxxXnUsTVdV05Wsr7X+V/61M4UYumqut159/wA+h5H+0loBTVNN1qJVAvITaShR/wAtUy6sfqMD8K8FnLoobI8zGzuT17GvsX4maOPFXgDUbeFZI51T7Xbnb8xeMbgMf7QGPxr5IvtM1ERM0mnXcTZDENCw2k/UetdV7yv0E/i0MYKQQWXjOCCaTqCfanSDEjbg24Hnd1pmMdjg1qagaTFKTjI4PbNFMYhGDQRiikoAWikooAKKKKACiiloASiiigAr6A/Yp/5Knqv/AGBZf/R8FfP9fQH7FX/JUtV/7A0v/o+CgDyr4sf8lT8Zf9hq9/8AR71yldX8WP8AkqfjL/sNXv8A6PeuUoAKKKKAClpKKACl70lKKAJoV3ZzjAGfrX1/okVnpWi6Lam7WwvLfSoVyGGza2Wxg/xfNnPfNfKHh+0fUNUsLKFBJNczpCiFtoJZgACe2SetfVviu3tru4guLEtPOR5ZRVBxtUDaPb3r1adGnyU03vdniZxXnSotwX4/0y7ez3C2qCw1D7U+d7OzxlWz2A9sVkaZ4pNjAYbq02wtkhmG35u2B09axLqCLZGRut5TksHb5T9KWPRJfNtbmadbpHwoBbcAp9RXXHDUVG09flY+Qjja0p81NuNul2/zuM8QXU+pQvc20uIULMC2eSCMAevBrKjs72e1RoJbm3ZiVXYC5bI+7xn9a7q18IwuIXjvkljB8wBRg9OhHb8qSx8P3NiySC7FuUbkqGYsP/r1bx9ClB6rTuawwuKUleDbfXRkfhPwfZRWFncyW1z5seGBu2X6Yx6ema35bEwzS32oGHTbaFjub5SHTPqenHGBVO61ywmh2TNLHboxDHOSSP5YPrXKeNvFGiXmny6Taxy31y6KWufNOyM5B4GcGvia3Ek8RUnGCTS63f4K3+S8z7rC8Muryuad932063/4P37FJPGt9eeKmgtLWG40+OQrGzhhHIBkJx7DHX0r07w94mt9QuP7Ou57dNTQcRpICH47eh9q+YfGPia8hljtrWeO2j6MICCzDpk46c1ylp4guYrqKWR2JiIZXQkMSDkZPWscDh5Ul7Wmt+l9/M9Fzb/dVLadUj7Fub/xNB4zsrFbHT5dBuQ7fbgJDLEVUsVfDYBOMA4wdw5znG3q11HaWE1zPbPcqgyY44vMdvoMc1zHww8QX+v+DrLUtYaLfcAlJIwcEBiMN/tcUz4l+Lb3wTb2OrR2i3emNIYLtCCrRkjKMrdASeOcjiu9VlOHMr/5dOoVGpSUbLTt18z5S+I+o/2v431bURYSactzMXW2kTa0Y6cjj0rm/f8AWvrWDxF8PfiZAlvqkVvHfEZ8u8XypFPtJwG/OuH8X/s+3EMcs/hW+FweNttdYRj67W+7jp1raElay6feYvuzwLPTikPNamv6Dqvh+8NtrNhPZy5OBIuFbHdT0YfQmsqtBIKWkooGFFFFABRRRQAUUUtACUUUtABXv/7FP/JU9V/7Asv/AKPgr5/r6A/Yq/5Knqv/AGBpf/R8FAHlXxY/5Kn4y/7DV7/6PeuUrq/ix/yVPxl/2Gr3/wBHvXKUAFFFFABRRRQAUtJS0Ad18GrUXHxH8P5B2wXAumAGeIgZCPx24/Gvb9R1DVra5dbpEhLrvVUH8OSRyPrXkvwZtz/xVeqJ8r2Oi3AiI5YSyKUTH613Gg3eo31lF5sM95dKFQuQWBxzkEdAM19DQ5Jaq2iS8+58vxApyhHk7m3JfedbxoQZhD90beRn6/SpLNYns38uaeK4ztjhC5AHbH15/KqVveNHckyQTWrRlmKuuD2wferdlrdlFqIGoBHSVPLLIuGDH+LHXtWtX91Fu2x8dGnNz5Xv5nQ+HbO5t0uLu6eaNdu3JG3HPOM/h1rq7O8gub+SzTeJkbYFK8kjrXmuseLYoNX8y2tyE37BPe7trIeThBjnIGDzW3aLpWuwXNxc6zHFLcEs7QSBSpzztB5Gc18DmGOr18WnRa5dPL113P0fI8HSpYZqd999/u6HlvxG1uxtvGGp3kVxNc2jusQWHCBHVT5nynqN3cdazPA6aX4n8Z6Vpl0kkNhKG8zHylmILKM9u1dt4k+HvhgS+XaXCXMkhZgWmyy5PIznFUp/hpoUduGs9XEF3GysgWdWMRHQjHPXBrOHsovmb1/D/gnuyxE4ycaN1B/5G34j+AWk3a7tA1K4sJgDxOPMQn6jmvI/E/wf8XaCHkNgL63B4ks28zj12jkflX0xplzP4m8K3Vmb+SDWIo/LNzF+7ZZVGUk+hIBOPU4xxW54ft76z0i1g1O+e9v1QCadiPmbvjgcema9enJTipR2MHFKN29b7fqfIHg7x9rXgy98sq0kcWVFrNkLGxGNwH96vT9F1jxF44stQ03xBavDp+uWsi6U0/yIbqIeYhXPXJwKtfH/AMVeG20qfTVs2XxNbzxyQySWmwpggs24j5gQMc5FePp401281PT9XvtSZpNNmWe3U/dDphlUKOACQAa5Hh4Sn7SEde+q/Db5lxqeyhyv8tfl27nLSrLbyNuLLIrFHB6qwPIrsfCPxS8VeGCiW+oNdWg5Ntd5kQ/j1H4GpfjTplvp/jWS5sCn2DV4ItVg2chfNB3AHv8AOHrgeQM9q7OWM0m0c6uj0n4qfFOXx9pmnWcmlxWf2VzIXWQuSxABAyOBxXmtKeelNq4xS2HcKKKKYBRRRQAUUUUAFFFFABRRRQAV9AfsVf8AJUtV9P7Gl/8AR8FeAV7/APsU/wDJU9V/7Asv/o+CgDyr4sf8lT8Zf9hq9/8AR71yldX8WP8AkqfjL/sNXv8A6PeuUoAKWkooAKWkooAUdaB1oH0zQO9AHvf7MtmDY+I57iEtbXBtrUHrubeSwx6AFc17ybGxR1lMUMbgbcj5RzXinweux4b+HelzqS0mq3t3IQflJEaKo2nuMqcn6jtXXaV4mn1DV7gXUF1BpKwYhuBH5kbSjO5SRjI6VlapOTVNXsc1WrTpe9UdkekxpF5ahEiZAMcKD9efSs/WYrKS0mWS2hlfsBECc+2Oa8/1lIdKgg1qDV5ri3urgNJaIhC+X/EFGflI465rutHs7Iwx3aLI5cbg7nOc/wBKicqqbjJWFCpQq6RaZy7aVaztMp0VpUz95UIJHoc5pp8PaS7Fz4NHmqoIcyFdxHtmvQJJUj3MwO1emBVKXV4oZNkkQRuTh5AD9cYrndNR3l+B0xaaskjxTxNDrI1FrfR/BIjiY+UJkZm2knJJOeOM1paT4dmhgZ7q1SIou0mEncCTjvnPpXqJ1yOZXEEtu23O/wCbdt+tFg8d0RgLGOdrpxn/AD61g4Rk/ddyndK7R5lpVjrnhnxKup2FiBZYEd55j/NJH/I7evA6iu2+I3ie60HQbLVNDEd2DcLvi6+ZGRnHsf61r6hosN6pSS5mUY5UN1J71h33hO1ureOCIzvAh5aQHHXj8jWijOCcY7f12KjOL1ZUkXwf8YvDpUj/AEiEcg4W6s39D6rnj0PtXhOu/DDWPC2vWttJAdSVpBJEttGzLOgbo/8AdJxjHpX0TofhXRfD959vsdMX+0thDTqTzng57dKm8R66Y4hDbRyTTA5PlMFC/ViDit3Wajq9f6/rQzajPSJ4L4x0m6ufhfC2o2i22o+HLzCwDJP2Gc/Jz6CRWHPqa8eKlTzkY9a+mbDVI9V1j7BfBY7LVIJdNunC5yZRtgXPfEhY+3Wvm/U7ObT7qW0uo2iuIXaKWNhghgTW1JiRU7e9JTjjt+VJnNbFAetJSmkoAKKKKACiiigAooooAKKKKAFr3/8AYp/5Knqv/YFl/wDR8FfP9fQH7FX/ACVTVf8AsDS/+j4KAPKvix/yVPxl/wBhq9/9HvXKV1fxY/5Kn4y/7DV7/wCj3rlKACiiigAooooAWlTIYEAHHODTatadZzahewWlqheedxHGoOMselOOrE3ZanuEuiaq9t4IstG067u5rDSIbkzRplI5JZpHIbtgAge+K9L0u51K2cQasbiyhVgVhjh2r/tHPoK5nxHrFn4L8VaTf6za6ilyLG3tE+x3QltpxEBkYwMYJzj3962Yfi54L1HdFPdTwBYzuea3+Uk/eUEE89K1oZgpL2CpbdbN3872t/W55GOwMqz9pGpZ9uno9TSvNYkhsrl9M0u51JED7Mx4jYHrz68V574f8dzWttb2Im8iSOPYxknCgNnoBj/OK1tX8R6TqllPZaP4rsNJsyykvLGYpFPOcHnOa4O68FaQzB2+IOiRO7FmJByfp6Vni+SS5Xp8/wBDjy2lWU027W+70Xl26nY3Xj54pvIkurdmKk4MvHUd8UzUPFB/s6S7WG2ukB3FS+Oe7Zrjn8GaXsHk/ErSE/hbBbGPw+lWJPCmlywPBJ8U7GWPGXXLY9yOa8d4d9ZH0zqJIi0vxVcXN8XluYdLt1LEYG5ic/e9sj9a7TQ/FsGqSpbWyXUluqHddy8A884Xv+dcE/hbwBbjy5fG073CkjzEtCyEA8hTnn2rb0/xT4F0Aq1rqPiG/RSFELII9v8AtZ3c8dqv6q3rBfh/w5Cq66s9XstcgkhWG3t7+7cHAXy9mMDr3rprS+C26GWLyBgnDLjoOTXik/xx0u1QR6RpErhSdsl1L1B9VA9PeuY1D45a/cQlLSOxsPnOJLeACTb2AJPFawoVIr+v+HIlUTvZM+iRfvqiutrbTz2xJAkP7uM8ep6jPFYmv6z4csdPuIdb1iyVPLw8ED+ZIQeMADvnIr5d1nx74j1iV5NQ1a7m3ZypkIUjGBwOK5x7uZwwdzgjB/PNWsNLeT/r8P1HzTeyse7an8QvB9te27aXpRuZ0uI2jur37kbA8SeWOu3APWuH+MI8OXWuJqnh/XTqEl6xku4zEQY5DjLg+h7L2xXneabW6pqL0CMWndu4tJS0laFhRRRQAUUUUAFFFFABRRRQAUUUUAFfQH7FP/JU9V/7Asv/AKPgrwCvf/2Kv+Sp6r/2Bpf/AEfBQB5V8WP+Sp+Mv+w1e/8Ao965Sur+LH/JU/GX/Yavf/R71ylABRRRQAUUUUAFLSUUAPZ2ZssxY+/NIpI6UlH86FpsA8yNktuOSMHnrSFiSSTkmmj3o7U+ZisS+dIAcSNnnPPWmmVywLMxYep6UyijmfcOVC5PNBPpSClHJ5OBRdgB60lHrRSGFFFFACUUU5VJztBOOeKAG0U4gqSCCCOCDTaACiiigAooooAKKs2qhlkyoJwSCfZWqtSv0FcK1/CFhBqvivRdPu932a6vYYJdpwdjOA3Pbgmsit7wLKkHjTQZpZBHFHf27uzHACiVSST6Uyoq7sjtfEg8F6T4g1Gwj8MSGK2uXgBfUZNxCsRnp3FO8Lr4J1zxRpGkjww6i+u4rfeupyEqHcLnp70/xb4MuNZ8Waxc2ms6GkNzeTTRmS9VeCxxSeAvBdxovjPQNTvNZ0H7Pb38Esmy+ViqrICTj8K4YzjZSdT8T2alCz5I0fnqef8AifT4NN1q/tbbeYobmSNd/XaDgD6+te0/sU/8lT1X/sCy/wDo+CvH/Gjedr1/OkoljluZHV8/eBbINew/sWD/AIunqmD/AMwWX/0fBXVSbcE2edi6ap1nFKxyPxMi8Gn4keKzeXWvC5/ta7MoigiKB/OfIUls4znGa5pY/AoALXPiQ8dPIhH/ALNTPix/yVPxl/2Gr3/0e9cpQ6bf2n+H+RycvmdeV8ChWAl8RE5XBMcP4/xU1R4IErgv4gMXVTsiDD2IzXJUUvZv+Z/h/kLk82dkT4DCqAPERPdsRc8+metKNS8FQ/u18P6jcqM/vZbzy2bnrtXIFcbSUvYvrJv+vJBydbs7NZPAQIDQ+ISuASQ0WcnqOvapLOXwCLuCaaHXhFA/mPAfLYXAGMJuyNue5GeDXE5pKapyX2n+H+QvZ+b+89GuPH2n60J9P8QaDZx6KTutY7CFYpbIjpsYfeB4yD1qhHc+Ah9/T9bbAA4lXn1P1rie1OKjeq9jj9al0e0mvn/mNwTO1F54BKt/xLNaDZGAZ1pftfgFs7dK1zhc589Ov+FcPnNKwwB7jNP2T/mf4f5C9mu7+87U6t4JtWxb+Gr2/VuSbm+aMr6gBOo9zzxTvt3gDHOkawSeu25HFcR1xnvSA0vY/wB5/f8A1+A+XzO6W/8Ah+CS2ja03GB/pSij7f8AD8qo/sXWOOS32kc+xFcLmlPGMfWn7J/zP8P8g5PM7WXUPAfy+VomscE7t10OlH9r+CoSFh8M3dxG33zcXrKw7fLt49+a4pgBge2aB0NHsr7yYuTzO1m1zwbF+5g8IyTIp4nl1GRXce4HA9OKjXWvCU8mJvCjW0Od+YL+RnP+yN3GK43NFL2C7v73/wAMVynbR6n4FCkP4e1NjnIP2zHHpU8HjPSNDsLlPCWjyWWoXW1JLu5lErxxgklY+Pl3cZPoK4KjtVeyTVm20LkV73/E72/8XaJr6x3fibQxNq6jbJPZuLdZwOhdQMbvcelU/wC1fBe9v+Kcvtn8I+3H9eO9cd2pKSopaJv7w5PM67+2fCsOPI8LvMTnPn3z4HpgLSDX/DY6eD4ff/iYTVydJS+rxerb/wDAn/mPlOtHiDw50PhCAAjBIvpsjPce9OOteFoI2W18LtKWXaXub1yR7gAAZrkKWhUIrZv/AMCf+YcqOqutZ0e7s5xaeHIbObyiiyR3UjbTtPzFTweM1ylTW7lWYDBBVhz9DUNXTpqndL82/wAwW4U5SVOVJBptFaFbFn7bcYx5rYpPtk/9+q9FTyR7G31ir/M/vHySPIcu2TXvv7FX/JU9V/7Asv8A6Pgr5/r6A/Yp/wCSp6r/ANgWX/0fBVGTbk7s/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Panel A is an apical four chamber view in systole showing color jets of mild mitral regurgitation (MR) and mild tricuspid regurgitation (TR). The jets are central and do not penetrate the left atrium (LA) on right atrium (RA) beyond the mid cavity. Panel B shows an apical four chamber view in patients with severe MR; the arrows outline the course of a jet during systole that adheres to and follows the contour of the LA. Such wall hugging jets are typical of severe regurgitation. Since their area is smaller than central jets, the use of wall hugging jet area as a sign of MR severity is not recommended.",
"    <div class=\"footnotes\">",
"     LV: left ventricle; RA: right atrium; RV: right ventricle.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Color flow Doppler of severe mitral regurgitation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 364px; height: 277px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The color flow Doppler signal, as seen in the four chamber view, shows the typical features of severe mitral regurgitation; the first is a large proximal isovelocity surface area (PISA) and the second is a broad crossing jet from left ventricle (LV) into the left atrium (LA).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_41_16023=[""].join("\n");
var outline_f15_41_16023=null;
var title_f15_41_16024="Complete tumor necrosis of osteosarcoma";
var content_f15_41_16024=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F87015&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F87015&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Complete tumor necrosis of osteosarcoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Histologic appearance of complete tumor necrosis of osteosarcoma following oncologic management; the specimen&nbsp;shows woven bony trabeculae with no viable osteocytes or osteoblasts.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of M John Hicks, DDS, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_41_16024=[""].join("\n");
var outline_f15_41_16024=null;
var title_f15_41_16025="Approach to the care of long-term testicular cancer survivors";
var content_f15_41_16025=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to the care of long-term testicular cancer survivors",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/41/16025/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/41/16025/contributors\">",
"     Clair J Beard, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/41/16025/contributors\">",
"     David J Vaughn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/41/16025/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/41/16025/contributors\">",
"     Larissa Nekhlyudov, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/41/16025/contributors\">",
"     Patricia A Ganz, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/41/16025/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/41/16025/contributors\">",
"     Don S Dizon, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?15/41/16025/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H7365582\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Testicular cancer is the most curable solid tumor and the most common malignancy in men between the ages of 18 and 35. The overall survival rate after diagnosis and treatment of testicular cancer exceeds 96 percent at 10 years. Following treatment for testicular cancer, oncologic follow-up is guided in part by the probability of relapse over time. Although most relapses occur within the first five years, late recurrences can occur.",
"   </p>",
"   <p>",
"    During the period of oncologic follow-up, after active therapy or any time thereafter, patients with a history of testicular cancer may develop symptoms or have abnormal findings on clinical examination. Both primary care clinicians and oncologists may be challenged with questions related to whether or not these symptoms or findings are due to prior treatment.",
"   </p>",
"   <p>",
"    Because of the young age at which men with testicular cancer are diagnosed and success in treatment of testicular cancer, issues of cancer survivorship evolve as men mature. This topic will cover late treatment-related complications in testicular cancer survivors. The discussion is intended for the management of patients who have completed the active phase of cancer therapy and have transitioned to receiving almost all of their care from their primary care clinician. Acute treatment-related toxicity and posttreatment follow-up of men treated for testicular cancer are discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/49/20250?source=see_link\">",
"     \"Treatment-related toxicity in men with testicular germ cell tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/45/9943?source=see_link\">",
"     \"Posttreatment follow-up for men with testicular germ cell tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A general overview of cancer survivorship is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/6/32873?source=see_link\">",
"     \"Overview of cancer survivorship care for primary care and oncology providers\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H773414376\">",
"    <span class=\"h1\">",
"     OVERVIEW OF TREATMENT FOR TESTICULAR CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Testicular cancer affects less than 9000 men in the United States each year and usually presents as a nodule or painless swelling of one testicle, which may be noted incidentally by the patient or by his sexual partner [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The vast majority of testicular cancers are germ cell tumors, which are classified as either seminomas or non-seminomatous germ cell tumors (NSGCT). Approximately 90 percent are detected with low stage disease (stage I to IIB) (",
"    <a class=\"graphic graphic_table graphicRef82117 \" href=\"UTD.htm?35/13/36061\">",
"     table 1",
"    </a>",
"    ) and most (60 to 80 percent) will have clinical stage I disease [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H876749810\">",
"    <span class=\"h2\">",
"     Primary surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary treatment for testicular cancer is an inguinal orchiectomy. The information from pathology is used to determine pathologic tumor stage (",
"    <a class=\"graphic graphic_table graphicRef82117 \" href=\"UTD.htm?35/13/36061\">",
"     table 1",
"    </a>",
"    ). Following diagnosis, treatment is based on the likelihood of recurrence in order to tailor treatment and minimize the long-term side effects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H536925901\">",
"    <span class=\"h2\">",
"     Fertility preservation",
"    </span>",
"    &nbsp;&mdash;&nbsp;When testicular cancer is suspected in men of reproductive age, counseling regarding sperm banking as a means of fertility preservation is routinely performed prior to initiation of any form of treatment. However, less than 30 percent of men actually choose to bank sperm and an even smaller proportion (10 percent) actually use banked sperm to father a child [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Despite this, many patients treated for testicular cancer go on to become fathers naturally with recovery of spermatogenesis achieved in 80 percent five years after diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H30007340\">",
"     'Hypogonadism'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H876750257\">",
"    <span class=\"h2\">",
"     Primary treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Key elements used to determine the treatment plan include (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/7/13432?source=see_link\">",
"     \"Overview of the treatment of testicular germ cell tumors\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Histology (ie, seminoma versus NSGCT)",
"     </li>",
"     <li>",
"      Presence or absence of metastases (",
"      <a class=\"graphic graphic_table graphicRef61906 \" href=\"UTD.htm?41/46/42732\">",
"       table 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Degree of elevation in serum tumor markers",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The prognosis is excellent for most patients with testicular cancer, regardless of treatment. Treatment options after orchiectomy include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Surveillance",
"      </strong>",
"      &mdash; Active surveillance following orchiectomy is an option specifically for men with stage I seminoma or NSGCT. These patients have an extremely high cure rate following inguinal orchiectomy alone. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/16/3334?source=see_link\">",
"       \"Active surveillance following orchiectomy for stage I testicular germ cell tumors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Radiation therapy (RT)",
"      </strong>",
"      &mdash; RT is an alternative option for men with stage I or II seminoma, although surveillance is the preferred approach for men with stage I disease. If administered to men with stage I seminoma, RT is directed to the paraaortic nodes to a dose of 20 Gy. For men with non-bulky stage II seminoma, 30 to 35 Gy RT to the paraaortic and ipsilateral iliac nodes may be used as an alternative to chemotherapy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/45/22230?source=see_link\">",
"       \"Treatment of stage II seminoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Chemotherapy",
"      </strong>",
"      &mdash; Chemotherapy is an option for men with testicular germ cell tumors regardless of disease stage. It is estimated that up to 20 percent of men will require primary chemotherapy for cure [",
"      <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Single agent",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/61/38873?source=see_link\">",
"       carboplatin",
"      </a>",
"      can be administered to men with stage I seminoma who are not candidates for surveillance (ie, poorly compliant with medical follow-up) and is an alternative to RT.",
"     </li>",
"     <li>",
"      Combination",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      -based chemotherapy generally consists of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/15/39159?source=see_link\">",
"       bleomycin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"       etoposide",
"      </a>",
"      plus cisplatin (BEP) or etoposide plus cisplatin (EP). It may be offered to men with stage II seminoma (as an alternative to RT) or to men with early-stage NSGCT (stage IB to IIB).",
"     </li>",
"     <li>",
"      For men with advanced germ cell tumors, primary treatment consists of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      -based combination chemotherapy (either BEP or EP). Surgery is often used to supplement chemotherapy in select patients with residual disease. (See",
"      <a class=\"local\" href=\"#H876750456\">",
"       'Resection of residual disease following chemotherapy'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Retroperitoneal lymph node dissection",
"      </strong>",
"      &mdash; A primary retroperitoneal lymph node dissection (RPLND) is a treatment option for men with stage I and some patients with non-bulky stage II NSGCT. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/3/9272?source=see_link\">",
"       \"Retroperitoneal lymph node dissection in testicular germ cell tumors\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H876750456\">",
"    <span class=\"h2\">",
"     Resection of residual disease following chemotherapy",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Seminoma &mdash;",
"      </strong>",
"      For men with seminomas, surgery of a residual mass may not be necessary. One-half of men with residual masses will have resolution of these findings during surveillance at a median of one year. However, the routine resection of larger residual masses (&ge;3 cm) is controversial. PET scans may be useful in detecting residual disease in this setting. This topic is discussed in detail elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/45/22230?source=see_link&amp;anchor=H10#H10\">",
"       \"Treatment of stage II seminoma\", section on 'Post therapy residual masses'",
"      </a>",
"      .) For men with residual retroperitoneal adenopathy that demonstrates FDG uptake on PET at the end of treatment, postchemotherapy RPLND is sometimes performed, although this surgery should be restricted to specialized centers where a large number of testicular cancer patients are seen. Following resection of residual masses that contain viable tumor, at least two further course of chemotherapy are generally advised. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/33/38425?source=see_link&amp;anchor=H10#H10\">",
"       \"Surgical management of advanced testicular germ cell tumors\", section on 'Adjuvant chemotherapy after RPLND'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       NSGCT &mdash;",
"      </strong>",
"      Residual masses are commonly seen on postchemotherapy imaging studies in men with NSGCT and standard of care is to resect these lesions. Approximately 60 percent of patients with postchemotherapy residual masses will either have viable cancer or teratoma. As long as tumor markers have normalized, surgical resection is preferred over further chemotherapy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/33/38425?source=see_link&amp;anchor=H5#H5\">",
"       \"Surgical management of advanced testicular germ cell tumors\", section on 'RPLND after chemotherapy'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H536926018\">",
"    <span class=\"h1\">",
"     FOLLOW-UP POSTTREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Follow-up care for men who have successfully completed therapy for testicular cancer consists of periodic history and physical examinations (including testicular examination), assessment of serum tumor markers (&beta;-hCG, AFP, and LDH) if indicated, and radiographic studies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/16/3334?source=see_link&amp;anchor=H900676917#H900676917\">",
"     \"Active surveillance following orchiectomy for stage I testicular germ cell tumors\", section on 'Active surveillance protocols'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/45/9943?source=see_link&amp;anchor=H7#H7\">",
"     \"Posttreatment follow-up for men with testicular germ cell tumors\", section on 'Guidelines for follow-up'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Factors that influence the nature and intensity of follow-up after completion of initial definitive therapy include the histology (seminoma versus nonseminomatous germ cell tumor [NSGCT]), original risk-stratification group (for men presenting with advanced disease (",
"    <a class=\"graphic graphic_table graphicRef61906 \" href=\"UTD.htm?41/46/42732\">",
"     table 2",
"    </a>",
"    )), and treatment (particularly the use of surgery or radiation therapy to treat the retroperitoneal lymph nodes). &nbsp;",
"   </p>",
"   <p>",
"    The intensity of follow-up is guided in part by the probability of relapse over time. For men with seminoma, the median time to relapse is 13 to 16 months (range 2 to 108 months), but up to one-third of relapses occur more than three years after completion of treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. In contrast, over 95 percent of relapses of NSGCT occur within the first two years following orchiectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although most relapses occur within the first five years for both seminoma and NSGCT, late recurrences can occur [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Based upon this type of observation, follow-up is most intensive during the first year or two after treatment and then gradually decreases. There are no guidelines to inform the frequency of routine imaging or blood work for the long-term survivor of testicular cancer, particularly after the first five years has passed. However, most groups now recommend that follow-up continue for at least ten years following successful therapy because of the risk of late relapse. Therefore, cancer surveillance should be coordinated between the primary care provider and the oncology team. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/45/9943?source=see_link\">",
"     \"Posttreatment follow-up for men with testicular germ cell tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2639185\">",
"    <span class=\"h1\">",
"     ORGAN-SPECIFIC EFFECTS OF TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H773414440\">",
"    <span class=\"h2\">",
"     Cardiovascular disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are conflicting data regarding the risk of cardiovascular disease among testicular cancer survivors, including myocardial infarction, angina pectoris, heart failure, and peripheral vascular disease [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/12-16\">",
"     12-16",
"    </a>",
"    ]. However, much of the available literature suggests there is a relationship between treatment for testicular cancer and cardiovascular disease. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a cohort of 2512 five-year testicular cancer survivors, 694 cardiac-related events were recorded in 434 patients [",
"      <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/15\">",
"       15",
"      </a>",
"      ]. The overall standardized incidence ratio (SIR) for myocardial infarction and angina pectoris was 1.17 (95% CI 1.04&ndash;1.31). This increased risk was noted in men &lt;45 years, but not in men &gt;55 years. Combination chemotherapy (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"       vinblastine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/15/39159?source=see_link\">",
"       bleomycin",
"      </a>",
"      [PVB] or bleomycin, cisplatin, and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"       etoposide",
"      </a>",
"      [BEP]) and mediastinal radiation therapy were associated with increased cardiovascular risk. &nbsp;",
"     </li>",
"     <li>",
"      In another study of 992 patients treated between 1982 and 1992 for testicular cancer with a median follow-up time of 10.2 years, RT was associated with an increased risk for cardiac events (relative risk [RR] 2.4, 95% CI 1.0-5.5) [",
"      <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/16\">",
"       16",
"      </a>",
"      ]. The risk was slightly higher when RT was combined with chemotherapy (RR 2.8, 95% CI 1.1-7.1).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H773418274\">",
"    <span class=\"h2\">",
"     Gastrointestinal disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Men treated with RT for testicular cancer are at an increased risk of duodenal or gastric ulcers as a late complication of radiation therapy, although the overall risk is very small [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/17\">",
"     17",
"    </a>",
"    ]. Biliary stenosis was reported in one study, as a result of radiation-induced retroperitoneal fibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H773414634\">",
"    <span class=\"h2\">",
"     Pulmonary toxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Testicular cancer survivors are at an increased risk of long term pulmonary toxicity, especially in those who received",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/15/39159?source=see_link\">",
"     bleomycin",
"    </a>",
"    .",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     Cisplatin",
"    </a>",
"    has also been associated with restrictive lung disease. Pulmonary sequelae are of greatest concern in men who continue to use tobacco.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H773414661\">",
"    <span class=\"h3\">",
"     Bleomycin-induced lung injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/15/39159?source=see_link\">",
"     Bleomycin",
"    </a>",
"    exerts its antitumor effect by inducing programmed cell death, by inhibiting angiogenesis, and by the formation of free radicals. The enzyme required to deactivate bleomycin, bleomycin hydrolase, is not present in lung tissue and results in pulmonary injury. Short-term pulmonary complications (defined as occurring within the first three years) of bleomycin are seen in up to 46 percent of patients but most are mild and self limited; only a small fraction of bleomycin-treated patients develop pulmonary fibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/19\">",
"     19",
"    </a>",
"    ]. However, the risk of fatality in patients who develop bleomycin-associated pulmonary fibrosis is on the order of 10 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. In one series of 835 men with testicular cancer who had been treated with a bleomycin-containing regimen, 57 men (7 percent) developed bleomycin pulmonary toxicity and eight men (14 percent) died as a result. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/31/12794?source=see_link\">",
"     \"Bleomycin-induced lung injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30007340\">",
"    <span class=\"h2\">",
"     Hypogonadism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chemical hypogonadism is reported in 12 to 16 percent of survivors, and is associated with infertility and poor quality of life across multiple domains, including sexual, physical, and role function [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/16,22,23\">",
"     16,22,23",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H1072938524\">",
"     'Sexual dysfunction'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Testosterone levels are generally present after ipsilateral orchiectomy, but may fall in the lower spectrum of normal after",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    -based chemotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/16,22,24,25\">",
"     16,22,24,25",
"    </a>",
"    ]. The risk for hypogonadism is mainly dependent upon pretreatment gonadal function, age at diagnosis and type of treatment, with the greatest risk following the use of chemotherapy. &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of 823 testicular cancer survivors, compared to men who underwent a unilateral orchiectomy, men treated with bilateral orchiectomy had a higher incidence of testosterone deficiency (84 versus 20 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another study involving 680 testicular cancer survivors, follicular stimulating hormone levels were increased following orchiectomy alone (41 percent), radiotherapy (45 percent), chemotherapy (49 percent), and combined chemotherapy and radiation (71 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/16\">",
"       16",
"      </a>",
"      ]. Compared to the group that underwent orchiectomy alone, those who received chemotherapy and radiation had a significantly higher incidence of low testosterone levels (37 versus 6 percent). The risk of radiotherapy-induced hypogonadism is highly technique dependent [",
"      <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/26-28\">",
"       26-28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In addition to testosterone, treatment has an effect on levels of the pituitary hormones, luteinizing hormone (LH) and follicle stimulating hormone (FSH) [",
"      <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/16,25\">",
"       16,25",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1072939285\">",
"    <span class=\"h3\">",
"     Infertility",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of infertility is dependent on prior treatment received. Men treated with chemotherapy and those treated with extended field radiation therapy (RT) are at greatest risk. As an example, in a study involving 1433 men, treatment following orchiectomy consisted of surveillance, retroperitoneal lymph node dissection (RPLND), radiotherapy, low-dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    , or high-dose cisplatin (ie, &gt;850 mg cisplatin) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/29\">",
"     29",
"    </a>",
"    ]. Forty percent of men attempted posttreatment conception with the following findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Successful conception was highest among men who underwent surveillance (81 percent) and RPLND (77 percent). It was lowest in men who received high-dose",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      (38 percent). &nbsp;",
"     </li>",
"     <li>",
"      Among survivors of seminoma treated with radiation, 63 percent successfully conceived. This rate was significantly higher among men who underwent radiation restricted to the paraaortic area (82 percent).",
"     </li>",
"     <li>",
"      Men with dry ejaculation following high-dose chemotherapy or who had undergone a non-nerve-sparing retroperitoneal lymph-node dissection were the least likely to achieve conception.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In light of the significant infertility risk, sperm banking prior to the initiation of therapy is routinely discussed. (See",
"    <a class=\"local\" href=\"#H536925901\">",
"     'Fertility preservation'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1072938524\">",
"    <span class=\"h3\">",
"     Sexual dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sexual function may be affected in testicular cancer survivors due to hypogonadism and other factors, including increasing age, lack of a partner, and heightened anxiety [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/16,25\">",
"     16,25",
"    </a>",
"    ]. Although the incidence of sexual dysfunction was only slightly higher among testicular cancer survivors compared to men without testicular cancer (39 versus 36 percent) in one study, testicular cancer survivors had significantly worse scores pertaining to ejaculatory and sexual problems [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7365631\">",
"    <span class=\"h2\">",
"     Renal impairment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the greatest risk to the kidneys is during active treatment with nephrotoxic agents (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    ), testicular cancer survivors are at risk for impaired renal function after chemotherapy has ended. This was illustrated in a study of 85 patients prospectively followed for a median of 14 years after treatment with surgery alone (n=14), radiation (n=18), or multimodality treatment that included cisplatin-based chemotherapy (n=53) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/31\">",
"     31",
"    </a>",
"    ]. The incidence of renal dysfunction (defined as creatinine level &lt;70 percent of the upper limit of normal) was 29 percent. The cumulative dose of cisplatin was the only risk factor associated with nephrotoxicity. Among those who received chemotherapy, there was a 14 percent loss of renal function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7365638\">",
"    <span class=\"h2\">",
"     Neurotoxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with testicular cancer are at increased risk for persistent peripheral neuropathy and ototoxicity, particularly if they were previously treated with a platinum-based regimen. A 2011 evaluation showed that residual platinum could be detected more than a decade following treatment and that the risk of neurotoxicity was associated with higher levels of residual platinum [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/32\">",
"     32",
"    </a>",
"    ]. Patient risk may vary with polymorphisms in the gene for glutathione S-transferase which detoxifies reactive metabolites [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/33-35\">",
"     33-35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H181279151\">",
"    <span class=\"h2\">",
"     Peripheral neuropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    are at risk for neuropathy that may persist long after treatment has completed. This was illustrated in a cross sectional study of 1409 testicular cancer survivors followed for a median of 11 years [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/36\">",
"     36",
"    </a>",
"    ]. Of those treated with chemotherapy, 39 percent reported Raynaud-like phenomena (defined as white or cold",
"    <span class=\"nowrap\">",
"     hands/fingers",
"    </span>",
"    or",
"    <span class=\"nowrap\">",
"     feet/toes",
"    </span>",
"    on cold exposure) and 29 percent reported paresthesias in the hands or feet. Peripheral nerve damage is a rare complication following RT [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7365645\">",
"    <span class=\"h2\">",
"     Ototoxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    display evidence of cochlear toxicity manifested by high frequency hearing loss (3 to 8 kHz) and tinnitus [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/38\">",
"     38",
"    </a>",
"    ]. In a mail survey of testicular cancer survivors 35 to 44 years of age, the reported incidence of hearing loss was twice the national average for this age range [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prevalence of hearing loss in testicular cancer survivors is illustrated in the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of 86 testicular cancer survivors, 66 percent had abnormal audiograms [",
"      <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/40\">",
"       40",
"      </a>",
"      ]. This was accompanied by tinnitus",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      hearing loss in 20 percent.",
"     </li>",
"     <li>",
"      In a cross-sectional study of 1319 testicular cancer survivors, 21 percent reported hearing impairment and 22 percent reported tinnitus [",
"      <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/36\">",
"       36",
"      </a>",
"      ]. Patients who received chemotherapy were more likely to have hearing impairment and tinnitus than those who did not, and there was greater risk for those who received more than five cycles of chemotherapy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H541715451\">",
"    <span class=\"h2\">",
"     Non-traumatic osteonecrosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Non-traumatic osteonecrosis is most commonly seen as a complication of prolonged corticosteroid use. However, it has been reported as a rare complication of chemotherapy, particularly in men treated for testicular cancer. A 2008 literature review identified 54 cases of non-traumatic osteonecrosis, with 70 percent of these reported in testicular cancer survivors, all of whom were treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/15/39159?source=see_link\">",
"     bleomycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"     vinblastine",
"    </a>",
"    ,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"     etoposide",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/41\">",
"     41",
"    </a>",
"    ]. In these reports, the femoral head was most often affected with 75 percent experiencing bilateral involvement. However, the overall prevalence appears to be on the order of 1.5 to 4 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/42,43\">",
"     42,43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1538072322\">",
"    <span class=\"h1\">",
"     SECONDARY MALIGNANCIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Testicular cancer survivors have an increased risk of secondary malignancies, including solid tumors, nonmelanoma skin cancers, and leukemias [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. Contralateral testicular cancers may occur but are not common. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H773414863\">",
"    <span class=\"h2\">",
"     Solid tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Men treated for testicular cancer have at least a twofold increased risk of developing a second solid tumor in their lifetime, especially if prior treatment consisted of both chemotherapy and radiation therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/46-48\">",
"     46-48",
"    </a>",
"    ]. This was demonstrated in a study involving 40,576 men [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/46\">",
"     46",
"    </a>",
"    ]. For patients who survived at least ten years after diagnosis, the relative risk (RR) of developing a solid tumor compared to the general population was reported as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients treated with radiotherapy, the RR was 2.0 (95% CI 1.9-2.2).",
"     </li>",
"     <li>",
"      For those who received chemotherapy alone, the RR was 1.8 (95% CI 1.3-2.5).",
"     </li>",
"     <li>",
"      For patients who received both radiotherapy and chemotherapy the RR was 2.9 (95% CI 1.9-4.2).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The most common solid tumors arose from lung, colon, bladder, pancreas, and stomach. The risk of developing a solid tumor increased over time and persisted for at least 30 years after treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H368653261\">",
"    <span class=\"h2\">",
"     Skin cancers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Testicular cancer survivors are at risk for nonmelanoma skin cancers. This was illustrated in a study on the risk of second malignancies among 29,511 testicular cancer survivors [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/45\">",
"     45",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The standardized incidence ratio (SIR) for melanoma of the skin was 1.62 (95% CI 1.29-2.01).",
"     </li>",
"     <li>",
"      For nonmelanoma skin cancer, the SIR was 2.26 (95% CI 1.97-2.57).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, one study suggested that testicular cancer survivors were at an increased risk of developing dysplastic nevi compared to healthy controls (37 versus 15 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/49\">",
"     49",
"    </a>",
"    ]. In that same population, two testicular cancer survivors ultimately developed melanoma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H773414870\">",
"    <span class=\"h2\">",
"     Hematologic malignancies",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of leukemia is also increased after treatment for testicular cancer, but not to the same extent as solid tumors. In one study involving 18,567 men treated between 1970 and 1993, 36 men (0.2 percent) developed a secondary leukemia [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/50\">",
"     50",
"    </a>",
"    ]. Compared to matched controls, men who developed a secondary leukemia had received a higher total dose of radiation and were more likely to have received a",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    -based regimen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H773414877\">",
"    <span class=\"h2\">",
"     Contralateral testicular cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Men with a prior history of testicular cancer are at increased risk for contralateral testicular cancer, although the overall risks are low. In several studies, this risk ranged from 1 to 3 percent over 10 to 20 years of follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/51,52\">",
"     51,52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H181279077\">",
"    <span class=\"h1\">",
"     CHRONIC FATIGUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic fatigue, characterized as a subjective sense of tiredness that interferes with usual functioning, has been reported in long term testicular cancer survivors [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. In one study of 1431 testicular cancer survivors followed for an average of 11 years posttreatment, chronic fatigue was noted in 17 percent compared to 10 percent among 1080 age-matched controls [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/54\">",
"     54",
"    </a>",
"    ]. Chronic fatigue was associated with poor quality of life, psychosocial and somatic problems, and neuroticism. In another study, chronic fatigue was also more common in men who were less physically active and those who smoked [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/55\">",
"     55",
"    </a>",
"    ]. A discussion of chronic fatigue is covered separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/29/27098?source=see_link\">",
"     \"Cancer-related fatigue: Treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/21/4440?source=see_link\">",
"     \"Treatment of chronic fatigue syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7365681\">",
"    <span class=\"h1\">",
"     PSYCHOLOGIC DISTRESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term survivors of testicular cancer have a higher incidence of anxiety disorder than seen in the general population, but are not at an increased risk for depression [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. This was illustrated in a study of 1400 testicular cancer survivors evaluated for anxiety and depression using the Hospital Anxiety and Depression Scale (HADS) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/56\">",
"     56",
"    </a>",
"    ]. Compared to age-adjusted norms, testicular cancer survivors reported higher risk of anxiety (relative risk [RR] 1.5; 95% CI 1.3-1.7) but not depression (RR 0.96, 95% CI 0.81-1.14). Factors associated with increased anxiety included: young age, presence of peripheral neuropathy, economic problems, alcohol problems, relapse anxiety, and prior treatment for psychological problems.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H773415445\">",
"    <span class=\"h1\">",
"     FOLLOW-UP FOR LONG-TERM SURVIVORS OF TESTICULAR CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;In view of the number of possible long-term consequences of treatment for testicular cancer and the young age at which many men undergo treatment, long-term follow-up is suggested. However, self reporting of new symptoms by patients is as important as the formal follow-up schedule for testicular cancer survivors, particularly in the detection of secondary malignancies. &nbsp;",
"   </p>",
"   <p>",
"    In a retrospective study of 1057 patients in long-term follow-up (consisting of yearly history, physical examination, germ cell tumor markers, abdominal CT scan, and chest x-ray), 57 men (5.4 percent) developed a secondary malignancy (after a median follow-up of 10 years) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/57\">",
"     57",
"    </a>",
"    ]. Of these, 54, 29, and 27 percent were detected by patients (or their relatives) due to new symptoms, non-oncology providers (in the context of a scheduled clinical visit), and during oncologic follow-up, respectively. Symptoms or signs of a second cancer were present in 71 percent of cases. The diagnosis was made based on new findings on imaging in 30 percent. &nbsp;",
"   </p>",
"   <p>",
"    We suggest the following guidelines for long-term testicular cancer survivors [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/58\">",
"     58",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Complete physical examination, annually",
"     </li>",
"     <li>",
"      Baseline lipid profile",
"     </li>",
"     <li>",
"      Renal function (serum creatinine) and serum magnesium annually (for patients who received",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      -based chemotherapy)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Testicular cancer survivors should undergo a complete physical examination annually, with weight and blood pressure recorded. The examination should include a lymph node survey and examination of the contralateral testicle [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/58\">",
"     58",
"    </a>",
"    ]. An examination of the skin for dysplastic nevi should be performed. Particular attention should be paid to cardiovascular, pulmonary,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    neurologic complaints. There should be a high index of suspicion for second cancers. Patients should be counseled as to the importance of early reporting of new symptoms. Patients should be encouraged to adopt a healthy lifestyle, including a heart-healthy diet, regular exercise, and weight loss when needed to achieve a body mass index &lt;25 [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/13,59\">",
"     13,59",
"    </a>",
"    ]. Patients should also be encouraged to avoid smoking and excess alcohol intake [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients who are suspected of persistent otologic toxicity should be counseled to avoid loud noise. Audiograms should be performed in patients who report hearing loss, with recognition that causes unrelated to treatment may be responsible for hearing impairment.",
"   </p>",
"   <p>",
"    Patients with residual peripheral neuropathy should be counseled to avoid exposure to other potential neurotoxins, such as alcohol.",
"   </p>",
"   <p>",
"    Semen analysis should be performed and the patient referred for fertility evaluation if infertility is an issue.",
"   </p>",
"   <p>",
"    Anxiety disorder is somewhat more prevalent in testicular cancer survivors and should be addressed when present.",
"   </p>",
"   <p>",
"    Oncologic follow-up (with serum tumor markers, chest x-ray, and CT scan of the abdomen and pelvis, as indicated) should be coordinated between the primary oncology team and the primary care provider to ensure that services are not duplicated. Surveillance for the first five years should primarily occur in oncology settings. For long-term cancer survivors (ie, &gt;10 years post-diagnosis), a decision to discontinue cancer surveillance should be based on patient preference and discussion between the primary care and oncology team [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16025/abstract/1,58\">",
"     1,58",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/45/9943?source=see_link&amp;anchor=H7#H7\">",
"     \"Posttreatment follow-up for men with testicular germ cell tumors\", section on 'Guidelines for follow-up'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/6/32873?source=see_link&amp;anchor=H418030689#H418030689\">",
"     \"Overview of cancer survivorship care for primary care and oncology providers\", section on 'Coordination of care'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H181279352\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The prognosis for men with testicular cancer is excellent. Nonetheless, compared with the general population, testicular cancer survivors face a higher risk of death from noncancer causes and long-term complications that may affect long-term quality of life. (See",
"      <a class=\"local\" href=\"#H7365582\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Testicular cancer survivors are at an increased risk for cardiovascular disease, particularly among men who received chemotherapy or were treated with mediastinal radiation therapy (RT). (See",
"      <a class=\"local\" href=\"#H773414440\">",
"       'Cardiovascular disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Testicular cancer survivors are at an increased risk of long term pulmonary toxicity, especially in those who received",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/15/39159?source=see_link\">",
"       bleomycin",
"      </a>",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      and continue to use tobacco. (See",
"      <a class=\"local\" href=\"#H773414634\">",
"       'Pulmonary toxicity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypogonadism can be seen as a long-term complication from treatment of testicular cancer, particularly among men treated with extended field RT or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      -based chemotherapy. It can result in infertility and issues related to sexual dysfunction. (See",
"      <a class=\"local\" href=\"#H30007340\">",
"       'Hypogonadism'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Men treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"       cisplatin",
"      </a>",
"      -based chemotherapy are at increased risk for both renal dysfunction and neurotoxicity. Renal function (with creatinine and magnesium levels) should be assessed annually in men who received cisplatin-based chemotherapy. (See",
"      <a class=\"local\" href=\"#H7365631\">",
"       'Renal impairment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7365638\">",
"       'Neurotoxicity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Men treated for testicular cancer have at least a twofold increased risk of developing a second malignancy in their lifetime, especially if prior treatment consisted of both chemotherapy and RT. (See",
"      <a class=\"local\" href=\"#H1538072322\">",
"       'Secondary malignancies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Testicular cancer survivors should undergo a complete physical examination annually, with weight and blood pressure recorded. Particular attention should be paid to cardiovascular or neurologic complaints. (See",
"      <a class=\"local\" href=\"#H773415445\">",
"       'Follow-up for long-term survivors of testicular cancer'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Oncologic follow-up within the first five years following diagnosis should be coordinated between the primary oncology team and the primary care provider to ensure that services are not duplicated. (See",
"      <a class=\"local\" href=\"#H536926018\">",
"       'Follow-up posttreatment'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/45/9943?source=see_link&amp;anchor=H7#H7\">",
"       \"Posttreatment follow-up for men with testicular germ cell tumors\", section on 'Guidelines for follow-up'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For long-term cancer survivors (ie, &gt;5 to 10 years post-diagnosis), a decision to discontinue cancer surveillance should be based upon patient preference and following a discussion between the primary care and oncology team. (See",
"      <a class=\"local\" href=\"#H773415445\">",
"       'Follow-up for long-term survivors of testicular cancer'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/1\">",
"      Motzer RJ, Agarwal N, Beard C, et al. Testicular cancer. J Natl Compr Canc Netw 2012; 10:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/2\">",
"      Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl J Med 1997; 337:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/3\">",
"      Richie JP, Sheinfeld J. Introduction: International consultation on urologic diseases: testicular cancer: Societe Internationale d'Urologie/International Consultation on Urologic Diseases Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009. Urology 2011; 78:S425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/4\">",
"      Girasole CR, Cookson MS, Smith JA Jr, et al. Sperm banking: use and outcomes in patients treated for testicular cancer. BJU Int 2007; 99:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/5\">",
"      Woodruff TK. The Oncofertility Consortium--addressing fertility in young people with cancer. Nat Rev Clin Oncol 2010; 7:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/6\">",
"      Jacobs LA, Vaughn DJ. Hypogonadism and infertility in testicular cancer survivors. J Natl Compr Canc Netw 2012; 10:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/7\">",
"      Bayens YC, Helle PA, Van Putten WL, Mali SP. Orchidectomy followed by radiotherapy in 176 stage I and II testicular seminoma patients: benefits of a 10-year follow-up study. Radiother Oncol 1992; 25:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/8\">",
"      Ellerbroek NA, Tran LM, Selch MT, et al. Testicular seminoma. A study of 103 cases treated at UCLA. Am J Clin Oncol 1988; 11:93.",
"     </a>",
"    </li>",
"    <li>",
"     Daugaard, G, Roerth, M. Observation and expectant management for low-stage seminoma and nonseminoma. In: Comprehensive Textbook of Genitourinary Oncology, 2nd, Vogelzang, NJ, Scardino, PT, Shipley, WU, Coffey, DS (Eds), Lippincott, Williams and Wilkins, Philadelphia 2000. p.976.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/10\">",
"      Oldenburg J, Alfsen GC, Waehre H, Foss&aring; SD. Late recurrences of germ cell malignancies: a population-based experience over three decades. Br J Cancer 2006; 94:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/11\">",
"      Geldart TR, Gale J, McKendrick J, et al. Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure. BJU Int 2006; 98:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/12\">",
"      Wethal T, Kjekshus J, R&oslash;islien J, et al. Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer. J Cancer Surviv 2007; 1:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/13\">",
"      Feldman DR, Schaffer WL, Steingart RM. Late cardiovascular toxicity following chemotherapy for germ cell tumors. J Natl Compr Canc Netw 2012; 10:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/14\">",
"      Abouassaly R, Fossa SD, Giwercman A, et al. Sequelae of treatment in long-term survivors of testis cancer. Eur Urol 2011; 60:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/15\">",
"      van den Belt-Dusebout AW, Nuver J, de Wit R, et al. Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 2006; 24:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/16\">",
"      Huddart RA, Norman A, Moynihan C, et al. Fertility, gonadal and sexual function in survivors of testicular cancer. Br J Cancer 2005; 93:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/17\">",
"      Hamilton CR, Horwich A, Bliss JM, Peckham MJ. Gastrointestinal morbidity of adjuvant radiotherapy in stage I malignant teratoma of the testis. Radiother Oncol 1987; 10:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/18\">",
"      Stensvold E, Aass N, Gladhaug I, et al. Erroneous diagnosis of pancreatic cancer after radiotherapy of testicular cancer. Eur J Surg Oncol 2004; 30:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/19\">",
"      Sleijfer S. Bleomycin-induced pneumonitis. Chest 2001; 120:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/20\">",
"      Dearnaley DP, Horwich A, A'Hern R, et al. Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up. Eur J Cancer 1991; 27:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/21\">",
"      O'Sullivan JM, Huddart RA, Norman AR, et al. Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours. Ann Oncol 2003; 14:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/22\">",
"      Huddart RA, Birtle AJ. Recent advances in the treatment of testicular cancer. Expert Rev Anticancer Ther 2005; 5:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/23\">",
"      Nord C, Bj&oslash;ro T, Ellingsen D, et al. Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. Eur Urol 2003; 44:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/24\">",
"      Brennemann W, Stoffel-Wagner B, Helmers A, et al. Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer. J Urol 1997; 158:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/25\">",
"      Ondrusova M, Ondrus D, Dusek L, Spanikova B. Damage of hormonal function and bone metabolism in long-term survivors of testicular cancer. Neoplasma 2009; 56:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/26\">",
"      Bang AK, Petersen JH, Petersen PM, et al. Testosterone production is better preserved after 16 than 20 Gray irradiation treatment against testicular carcinoma in situ cells. Int J Radiat Oncol Biol Phys 2009; 75:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/27\">",
"      Petersen PM, Giwercman A, Daugaard G, et al. Effect of graded testicular doses of radiotherapy in patients treated for carcinoma-in-situ in the testis. J Clin Oncol 2002; 20:1537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/28\">",
"      Petersen PM, Daugaard G, R&oslash;rth M, Skakkebaek NE. Endocrine function in patients treated for carcinoma in situ in the testis with irradiation. APMIS 2003; 111:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/29\">",
"      Bryd&oslash;y M, Foss&aring; SD, Klepp O, et al. Paternity following treatment for testicular cancer. J Natl Cancer Inst 2005; 97:1580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/30\">",
"      Dahl AA, Bremnes R, Dahl O, et al. Is the sexual function compromised in long-term testicular cancer survivors? Eur Urol 2007; 52:1438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/31\">",
"      Foss&aring; SD, Aass N, Winderen M, et al. Long-term renal function after treatment for malignant germ-cell tumours. Ann Oncol 2002; 13:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/32\">",
"      Sprauten M, Darrah TH, Peterson DR, et al. Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancer. J Clin Oncol 2012; 30:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/33\">",
"      Travis LB, Beard C, Allan JM, et al. Testicular cancer survivorship: research strategies and recommendations. J Natl Cancer Inst 2010; 102:1114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/34\">",
"      Niitsu Y, Takahashi Y, Ban N, et al. A proof of glutathione S-transferase-pi-related multidrug resistance by transfer of antisense gene to cancer cells and sense gene to bone marrow stem cell. Chem Biol Interact 1998; 111-112:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/35\">",
"      Peklak-Scott C, Smitherman PK, Townsend AJ, Morrow CS. Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin. Mol Cancer Ther 2008; 7:3247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/36\">",
"      Bryd&oslash;y M, Oldenburg J, Klepp O, et al. Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors. J Natl Cancer Inst 2009; 101:1682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/37\">",
"      Gikas PD, Hanna SA, Aston W, et al. Post-radiation sciatic neuropathy: a case report and review of the literature. World J Surg Oncol 2008; 6:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/38\">",
"      Bauer CA, Brozoski TJ. Cochlear structure and function after round window application of ototoxins. Hear Res 2005; 201:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/39\">",
"      Stava C, Beck M, Schultz PN, Vassilopoulou-Sellin R. Hearing loss among cancer survivors. Oncol Rep 2005; 13:1193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/40\">",
"      Bokemeyer C, Berger CC, Hartmann JT, et al. Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer. Br J Cancer 1998; 77:1355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/41\">",
"      Shim K, MacKenzie MJ, Winquist E. Chemotherapy-associated osteonecrosis in cancer patients with solid tumours: a systematic review. Drug Saf 2008; 31:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/42\">",
"      Cook AM, Dzik-Jurasz AS, Padhani AR, et al. The prevalence of avascular necrosis in patients treated with chemotherapy for testicular tumours. Br J Cancer 2001; 85:1624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/43\">",
"      Winquist EW, Bauman GS, Balogh J. Nontraumatic osteonecrosis after chemotherapy for testicular cancer: a systematic review. Am J Clin Oncol 2001; 24:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/44\">",
"      Fung C, Fossa SD, Beard CJ, Travis LB. Second malignant neoplasms in testicular cancer survivors. J Natl Compr Canc Netw 2012; 10:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/45\">",
"      Richiardi L, Sc&eacute;lo G, Boffetta P, et al. Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries. Int J Cancer 2007; 120:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/46\">",
"      Travis LB, Foss&aring; SD, Schonfeld SJ, et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 2005; 97:1354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/47\">",
"      Wander&aring;s EH, Foss&aring; SD, Tretli S. Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients. Eur J Cancer 1997; 33:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/48\">",
"      van den Belt-Dusebout AW, de Wit R, Gietema JA, et al. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 2007; 25:4370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/49\">",
"      Raghavan D, Zalcberg JR, Grygiel JJ, et al. Multiple atypical nevi: a cutaneous marker of germ cell tumors. J Clin Oncol 1994; 12:2284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/50\">",
"      Travis LB, Andersson M, Gospodarowicz M, et al. Treatment-associated leukemia following testicular cancer. J Natl Cancer Inst 2000; 92:1165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/51\">",
"      Foss&aring; SD, Chen J, Schonfeld SJ, et al. Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men. J Natl Cancer Inst 2005; 97:1056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/52\">",
"      Andreassen KE, Grotmol T, Cvancarova MS, et al. Risk of metachronous contralateral testicular germ cell tumors: a population-based study of 7,102 Norwegian patients (1953-2007). Int J Cancer 2011; 129:2867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/53\">",
"      Mock V, Atkinson A, Barsevick A, et al. NCCN Practice Guidelines for Cancer-Related Fatigue. Oncology (Williston Park) 2000; 14:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/54\">",
"      Orre IJ, Foss&aring; SD, Murison R, et al. Chronic cancer-related fatigue in long-term survivors of testicular cancer. J Psychosom Res 2008; 64:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/55\">",
"      Thorsen L, Nystad W, Stigum H, et al. The association between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men in a general population sample. Support Care Cancer 2005; 13:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/56\">",
"      Dahl AA, Haaland CF, Mykletun A, et al. Study of anxiety disorder and depression in long-term survivors of testicular cancer. J Clin Oncol 2005; 23:2389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/57\">",
"      Buchler T, Kubankova P, Boublikova L, et al. Detection of second malignancies during long-term follow-up of testicular cancer survivors. Cancer 2011; 117:4212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/58\">",
"      Vaughn DJ, Gignac GA, Meadows AT. Long-term medical care of testicular cancer survivors. Ann Intern Med 2002; 136:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16025/abstract/59\">",
"      Rock CL, Doyle C, Demark-Wahnefried W, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 2012; 62:243.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14236 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-189.41.172.26-C9598D4138-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_41_16025=[""].join("\n");
var outline_f15_41_16025=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H181279352\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7365582\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H773414376\">",
"      OVERVIEW OF TREATMENT FOR TESTICULAR CANCER",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H876749810\">",
"      Primary surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H536925901\">",
"      Fertility preservation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H876750257\">",
"      Primary treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H876750456\">",
"      Resection of residual disease following chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H536926018\">",
"      FOLLOW-UP POSTTREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2639185\">",
"      ORGAN-SPECIFIC EFFECTS OF TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H773414440\">",
"      Cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H773418274\">",
"      Gastrointestinal disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H773414634\">",
"      Pulmonary toxicity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H773414661\">",
"      - Bleomycin-induced lung injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30007340\">",
"      Hypogonadism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1072939285\">",
"      - Infertility",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1072938524\">",
"      - Sexual dysfunction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7365631\">",
"      Renal impairment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7365638\">",
"      Neurotoxicity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H181279151\">",
"      Peripheral neuropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7365645\">",
"      Ototoxicity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H541715451\">",
"      Non-traumatic osteonecrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1538072322\">",
"      SECONDARY MALIGNANCIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H773414863\">",
"      Solid tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H368653261\">",
"      Skin cancers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H773414870\">",
"      Hematologic malignancies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H773414877\">",
"      Contralateral testicular cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H181279077\">",
"      CHRONIC FATIGUE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7365681\">",
"      PSYCHOLOGIC DISTRESS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H773415445\">",
"      FOLLOW-UP FOR LONG-TERM SURVIVORS OF TESTICULAR CANCER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H181279352\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/14236\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/14236|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/13/36061\" title=\"table 1\">",
"      TNM staging testicular CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/46/42732\" title=\"table 2\">",
"      Risk strat system advancted TGCTs",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/16/3334?source=related_link\">",
"      Active surveillance following orchiectomy for stage I testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/31/12794?source=related_link\">",
"      Bleomycin-induced lung injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/29/27098?source=related_link\">",
"      Cancer-related fatigue: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/6/32873?source=related_link\">",
"      Overview of cancer survivorship care for primary care and oncology providers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/7/13432?source=related_link\">",
"      Overview of the treatment of testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/45/9943?source=related_link\">",
"      Posttreatment follow-up for men with testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/3/9272?source=related_link\">",
"      Retroperitoneal lymph node dissection in testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/33/38425?source=related_link\">",
"      Surgical management of advanced testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/21/4440?source=related_link\">",
"      Treatment of chronic fatigue syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/45/22230?source=related_link\">",
"      Treatment of stage II seminoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/49/20250?source=related_link\">",
"      Treatment-related toxicity in men with testicular germ cell tumors",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_41_16026="Surgical female urogenital anatomy";
var content_f15_41_16026=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Surgical female urogenital anatomy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/41/16026/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/41/16026/contributors\">",
"     Matthew D Barber, MD, MHS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/41/16026/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/41/16026/contributors\">",
"     Linda Brubaker, MD, FACS, FACOG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/41/16026/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/41/16026/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?15/41/16026/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H26037959\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gynecologic and urologic surgery is frequently performed using a vaginal or perineal approach. Pelvic surgery requires a comprehensive knowledge of the pelvic anatomy to safely attain access, maximize exposure, ensure hemostasis, and avoid injury to viscera, blood vessels, and nerves.",
"   </p>",
"   <p>",
"    The anatomy of the female lower genital and urinary tract that is clinically pertinent to the pelvic surgeon when operating from a vaginal or perineal approach is reviewed here. Also included is a discussion of the contemporary understanding of female pelvic organ support, with an emphasis on the functional and surgical anatomy of the vagina, urethra, and pelvic floor. The anatomy of the female genital tract and lower urinary and gastrointestinal tracts relevant to the surgeon performing laparotomy or laparoscopy is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/27/41400?source=see_link\">",
"     \"Surgical female pelvic anatomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7744471\">",
"    <span class=\"h1\">",
"     SURGICAL PEARLS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anatomic features that are clinically applicable to female pelvic surgery are indented and bulleted throughout the text.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26037966\">",
"    <span class=\"h1\">",
"     PELVIC BONES",
"    </span>",
"    &nbsp;&mdash;&nbsp;At birth, the bones that make up the pelvis are the ilium, ischium, pubis, sacrum, and coccyx. The ilium, ischium and pubis fuse by age 16 to 18 years to form a single bone, referred to as the pelvic bone. Thus, in an adult, the bones of the pelvis consist of the right and left pelvic bones, the sacrum and the coccyx (",
"    <a class=\"graphic graphic_figure graphicRef87086 \" href=\"UTD.htm?17/30/17895\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef87087 \" href=\"UTD.htm?10/37/10834\">",
"     picture 1",
"    </a>",
"    ). The bony pelvis is the rigid foundation to which all of the pelvic ligaments and muscles are anchored.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26037973\">",
"    <span class=\"h2\">",
"     Ilium",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most superior component of the pelvic bone is the ilium. The upper part of the ilium expands to form a flat fan-shaped \"wing,\" which provides support for the lower abdomen, and is also called the false pelvis. The medial surface of the ilium has two concavities forming the lateral borders of the pelvic outlet (the inferior opening of the pelvis). The superior and larger of these two concavities is the greater sciatic notch (boundaries are the sacrum, ilium, and ischial spine).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26037980\">",
"    <span class=\"h2\">",
"     Ischium",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ischium is the posterior and inferior part of the pelvic bone. The posterior margin of the bone is marked by prominent projection called the ischial spine, an important surgical landmark. (See",
"    <a class=\"local\" href=\"#H527761\">",
"     'Ischial spine'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26037987\">",
"    <span class=\"h2\">",
"     Sacrum",
"    </span>",
"    &nbsp;&mdash;&nbsp;The sacrum is composed of five sacral vertebrae that are fused together. Nerve foramina are positioned anterior and laterally, through which run the sacral nerves. Overlying the middle of the sacrum is a rich neurovascular bed. The coccyx is attached inferiorly and is the posterior border of the pelvic outlet.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26037994\">",
"    <span class=\"h2\">",
"     Pubis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The anterior and inferior part of the pelvic bone is the pubis. The superior and inferior pubic rami are located anteriorly and articulate in the midline at the pubic symphysis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      During pregnancy, there is increased mobility at the pubic symphysis, which may result in pain. Pubic symphysis is an uncommon peripartum complication. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/1/2074?source=see_link&amp;anchor=H12#H12\">",
"       \"Musculoskeletal changes and pain during pregnancy and postpartum\", section on 'Pregnancy related pelvic joint pain'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038043\">",
"    <span class=\"h2\">",
"     Orientation of the bony pelvis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although pelvic surgeons often visualize the orientation of the pelvis in the supine or dorsal lithotomy position, it is important to understand and discuss the bony pelvis from the perspective of a standing woman. In the standing woman, the pelvis is oriented such that the anterior superior iliac spines and the front edge of the pubic symphysis are in the same vertical plane, perpendicular to the floor (",
"    <a class=\"graphic graphic_figure graphicRef87092 \" href=\"UTD.htm?10/1/10262\">",
"     figure 2",
"    </a>",
"    ). As a consequence, the pelvic inlet is tilted anteriorly and ischiopubic rami and urogenital hiatus (the gap between the anteromedial borders of the pubococcygeus muscle through which the vagina and urethra pass) (",
"    <a class=\"graphic graphic_figure graphicRef62230 \" href=\"UTD.htm?31/63/32756\">",
"     figure 3",
"    </a>",
"    ) are parallel to the ground. In the upright position, the bony arches of the pelvic inlet are oriented in an almost vertical plane. This directs the pressure of the intraabdominal and pelvic contents toward the bones of the pelvis instead of toward the muscles and endopelvic fascia attachments of the pelvic floor. Thus, in the standing position, the bony pelvis is oriented such that forces are dispersed to minimize the pressures on the pelvic viscera and musculature and transmit the forces to the bones that are better suited to the long-term, cumulative stress of daily life. Where the pubic rami articulate in the midline, they are nearly horizontal. Much of the weight of the abdominal and pelvic viscera is supported by this bony articulation inferiorly.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H527753\">",
"    <span class=\"h2\">",
"     Surgical landmarks of the bony pelvis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The bones of the pelvis provide a number of important fixed anatomic landmarks that are important to the pelvic surgeon, including the ischial spine, coccyx, pubic arch, pectineal line, and obturator foramen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H527761\">",
"    <span class=\"h3\">",
"     Ischial spine",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ischial spine is a sharp bony projection on the medial surface of the ischium that separates the greater sciatic notch from the lesser sciatic notch. The ischial spine is important clinically and anatomically, as it can be palpated easily via the vagina, rectum, or retropubic space and serves as a point of fixation for many structures that are important for pelvic organ support. The tendinous lateral attachments of the levator ani muscle (arcus tendineus levator ani) and the vagina (arcus tendineus fascia pelvis) insert posteriorly onto the ischial spine (",
"    <a class=\"graphic graphic_figure graphicRef62230 \" href=\"UTD.htm?31/63/32756\">",
"     figure 3",
"    </a>",
"    ); these tendinous structures overlap, but are distinct structures. &nbsp;Similarly, the ischial spine represents the lateral attachment site of the sacrospinous ligament (",
"    <a class=\"graphic graphic_figure graphicRef87086 \" href=\"UTD.htm?17/30/17895\">",
"     figure 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H26038106\">",
"     'Arcus tendineus lavator ani'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H26038234\">",
"     'Endopelvic fascia'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The sacrospinous ligament attaches to the ischial spine, and the spine is an important landmark during sacrospinous ligament suspension for the repair of prolapse of the vaginal apex. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35914?source=see_link&amp;anchor=H8286292#H8286292\">",
"       \"Pelvic organ prolapse in women: Surgical repair of apical prolapse (uterine or vaginal vault prolapse)\", section on 'Sacrospinous ligament suspension'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      When performing a paravaginal repair, either vaginally or retropubically, the ischial spine can be palpated to identify the proximal location of the lateral vaginal attachment (arcus tendineus fascia pelvis), which is also the most proximal location of the repair.",
"     </li>",
"     <li>",
"      When a pudendal block is administered, the ischial spine is palpated and the anesthetic is injected medial and posterior to it (",
"      <a class=\"graphic graphic_figure graphicRef57711 \" href=\"UTD.htm?5/18/5411\">",
"       figure 4",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/31/40439?source=see_link&amp;anchor=H5#H5\">",
"       \"Pudendal and paracervical block\", section on 'Technique'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      During labor and delivery, the ischial spine is palpated to determine the station of the presenting fetal part.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H527790\">",
"    <span class=\"h3\">",
"     Coccyx",
"    </span>",
"    &nbsp;&mdash;&nbsp;The coccyx is the terminal portion of the sacrum and consists of four fused coccygeal vertebrae. It is palpable transvaginally or transrectally and is a useful landmark surgically during sacrospinous ligament suspension for repair of prolapse of the vaginal apex, since it marks the inferior-medial border of the sacrospinous ligament (",
"    <a class=\"graphic graphic_figure graphicRef87086 \" href=\"UTD.htm?17/30/17895\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H527798\">",
"    <span class=\"h3\">",
"     Pubic arch",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two pubic bones form an arch beneath the pubic symphysis. The pubic arch serves as the upper and lateral borders of the urogenital triangle under which the distal urethra and vagina exit (",
"    <a class=\"graphic graphic_figure graphicRef87091 \" href=\"UTD.htm?43/5/44118\">",
"     figure 5",
"    </a>",
"    ). The mean pubic arch angle is 75 degrees",
"    <span class=\"nowrap\">",
"     (plus/minus",
"    </span>",
"    12 degrees); however, wide variability can be seen (range 44 to 110 degrees) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A narrow pubic arch is a recognized risk factor for failed vaginal hysterectomy [",
"      <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/2\">",
"       2",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/36/35401?source=see_link&amp;anchor=H11#H11\">",
"       \"Vaginal hysterectomy\", section on 'Ancillary procedures for complicated cases'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H527806\">",
"    <span class=\"h3\">",
"     Pectineal line",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ridge along the superior, medial surface of the superior pubic rami is called the pectineal line. Anteriorly, this line is continuous with the pubic crest. Overlying the pectineal line is the pectineal ligament, also called Cooper's ligament.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The pectineal ligament is an important point of attachment for the Burch colposuspension procedure, a surgery to correct female stress urinary incontinence. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/10/43177?source=see_link\">",
"       \"Stress urinary incontinence in women: Choosing a primary surgical procedure\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H527814\">",
"    <span class=\"h3\">",
"     Obturator foramen",
"    </span>",
"    &nbsp;&mdash;&nbsp;The obturator foramen is bordered superiorly by the grooved obturator surface of the superior pubic ramus, medially by the body and inferior ramus of the pubis, inferiorly by the ramus of the ischium, and laterally by the anterior border of the body of the ischium. In women, its shape is nearly triangular. The area of the obturator foramen is on average 12.2 cm",
"    <sup>",
"     2",
"    </sup>",
"    , but can vary considerably (range 7.4 to 18.2 cm",
"    <sup>",
"     2",
"    </sup>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/1\">",
"     1",
"    </a>",
"    ]. The obturator vessels and nerve pass through the obturator foramen.",
"   </p>",
"   <p>",
"    Transobturator midurethral slings for treatment of stress urinary incontinence are inserted through the obturator foramens bilaterally and exit through the skin of the groin area. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33401?source=see_link\">",
"     \"Stress urinary incontinence in women: Transobturator midurethral slings\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038050\">",
"    <span class=\"h1\">",
"     PELVIC LIGAMENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two major ligaments link the pelvic bones to the sacrum and coccyx, the sacrotuberous ligament and the sacrospinous ligament (",
"    <a class=\"graphic graphic_figure graphicRef87086 \" href=\"UTD.htm?17/30/17895\">",
"     figure 1",
"    </a>",
"    ). These ligaments also convert the two notches on the pelvic bones into foramina on the lateral pelvic walls, the greater and lesser sciatic foramen. The ligaments of the sacro-iliac joint are rarely encountered during pelvic surgery and are not addressed here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038057\">",
"    <span class=\"h2\">",
"     Sacrospinous ligament",
"    </span>",
"    &nbsp;&mdash;&nbsp;The sacrospinous ligament is a strong, triangular-shaped ligament; the apex attaches to the ischial spine laterally and the base attaches to the distal sacrum and coccyx medially. Its average length is 5.3 cm (range 4.4 to 6.6 cm) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/3\">",
"     3",
"    </a>",
"    ]. This ligament divides the lateral pelvic outlet into two foramina, the greater sciatic foramen superiorly and the lesser sciatic foramen inferiorly. The coccygeus muscle is located on the superior surface of the sacrospinous ligament.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The sacrospinous ligament is a common attachment point for the vaginal apex for procedures that treat prolapse of the vaginal apex (ie, sacrospinous ligament fixation). Similarly, several commercially available &ldquo;mesh kits&rdquo; for treating apical vaginal prolapse place trocars or other fixation devices through the sacrospinous ligament. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35914?source=see_link&amp;anchor=H8286292#H8286292\">",
"       \"Pelvic organ prolapse in women: Surgical repair of apical prolapse (uterine or vaginal vault prolapse)\", section on 'Sacrospinous ligament suspension'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/62/26602?source=see_link&amp;anchor=H314234#H314234\">",
"       \"Overview of transvaginal placement of reconstructive materials (surgical mesh or biografts) for treatment of pelvic organ prolapse or stress urinary incontinence\", section on 'Transvaginal mesh kits'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are a number of neurovascular structures in close proximity to the sacrospinous ligament. These must be avoided when placing sutures or trocars in the ligament (",
"    <a class=\"graphic graphic_figure graphicRef87093 \" href=\"UTD.htm?4/59/5050\">",
"     figure 6",
"    </a>",
"    ). The pudendal neurovascular passes behind the ischial spine and lateral aspect of the sacrospinous ligament as it exits the pelvis and enters the ischioanal fossa (see",
"    <a class=\"local\" href=\"#H573709\">",
"     'Pudendal neurovascular bundle'",
"    </a>",
"    below). The S3 sacral nerve root",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the pudendal nerve course parallel over the superior border of the sacrospinous ligament. The inferior gluteal artery, a branch of the posterior trunk of the internal iliac, is located, on average, 2.4 cm from the ischial spine and a mean vertical distance of 3.4 mm (range 1 to 5 mm) above the superior border of the sacrospinous ligament [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given the close proximity of these structures, the recommended location for suture or trocar placement is at least two fingerbreadths medial to the ischial spine and ideally in the lateral one-third of the ligament safely below its superior border (",
"    <a class=\"graphic graphic_figure graphicRef87094 \" href=\"UTD.htm?28/32/29189\">",
"     figure 7",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35914?source=see_link&amp;anchor=H8286292#H8286292\">",
"     \"Pelvic organ prolapse in women: Surgical repair of apical prolapse (uterine or vaginal vault prolapse)\", section on 'Sacrospinous ligament suspension'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35914?source=see_link&amp;anchor=H8286391#H8286391\">",
"     \"Pelvic organ prolapse in women: Surgical repair of apical prolapse (uterine or vaginal vault prolapse)\", section on 'Iliococcygeus suspension'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038064\">",
"    <span class=\"h2\">",
"     Sacrotuberous ligament",
"    </span>",
"    &nbsp;&mdash;&nbsp;The sacrotuberous ligament is also a triangular-shaped ligament (",
"    <a class=\"graphic graphic_figure graphicRef87086 \" href=\"UTD.htm?17/30/17895\">",
"     figure 1",
"    </a>",
"    ). It has a broad base that extends from the posterior superior iliac spine along the lateral margin of the sacrum and coccyx. The apex of the ligament is attached to the medial margin of the ischial tuberosity. The sacrotuberous ligament forms the lateral-inferior border of the lesser sciatic foramen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038071\">",
"    <span class=\"h1\">",
"     PELVIC MUSCLES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pelvic muscles include the muscles of the pelvic sidewall and of the pelvic floor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038078\">",
"    <span class=\"h2\">",
"     Muscles of the pelvic sidewall",
"    </span>",
"    &nbsp;&mdash;&nbsp;The obturator internus and piriformis are the muscles of the pelvic sidewalls (",
"    <a class=\"graphic graphic_figure graphicRef62230 \" href=\"UTD.htm?31/63/32756\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038085\">",
"    <span class=\"h3\">",
"     Obturator internus muscle",
"    </span>",
"    &nbsp;&mdash;&nbsp;The obturator internus muscle lies on the superior (intrapelvic) side of the obturator membrane. The obturator internus origin is on the inferior margin of the superior pubic ramus and the pelvic surface of the obturator membrane. Its tendon passes through the lesser sciatic foramen to insert onto the greater trochanter of the femur to laterally rotate the thigh. The obturator internus is innervated by the obturator nerve, which originates from L5 to S2.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038092\">",
"    <span class=\"h3\">",
"     Piriformis muscle",
"    </span>",
"    &nbsp;&mdash;&nbsp;The piriformis muscle is part of the pelvic sidewall and is located dorsal and lateral to the coccygeus. It extends from the anterolateral sacrum to pass through the greater sciatic foramen and insert on the greater trochanter. Lying on top of the piriformis is a particularly large neurovascular plexus, the lumbosacral plexus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038099\">",
"    <span class=\"h2\">",
"     Muscles of the pelvic floor",
"    </span>",
"    &nbsp;&mdash;&nbsp;The skeletal muscles of the pelvic floor include the levator ani muscles, the coccygeus muscle, the external anal sphincter, the striated urethral sphincter and the deep and superficial perineal muscles (",
"    <a class=\"graphic graphic_figure graphicRef62230 \" href=\"UTD.htm?31/63/32756\">",
"     figure 3",
"    </a>",
"    ). The levator ani muscle complex consists of the pubococcygeus (also called pubovisceral), the puborectalis, and iliococcygeus muscles [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The fusion of levator ani in the midline creates the so-called &ldquo;levator plate.&rdquo; The urogenital hiatus is the space between the levator ani musculature through which the urethra, vagina, and rectum pass.",
"   </p>",
"   <p>",
"    The muscles of the pelvic floor, particularly the levator ani muscles, provide support to the pelvic visceral organs and play an integral role in urinary, defecatory, and sexual function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038106\">",
"    <span class=\"h3\">",
"     Arcus tendineus lavator ani",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a linear thickening of the fascial covering of the obturator internus muscle called the arcus tendineus levator ani. This thickened fascia forms an identifiable line from the ischial spine to the posterior surface of the ipsilateral superior pubic ramus. The muscles of the levator ani originate from this musculofascial attachment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H204504\">",
"    <span class=\"h3\">",
"     Puborectalis muscle",
"    </span>",
"    &nbsp;&mdash;&nbsp;The puborectalis muscle originates on the pubic bone, and its fibers pass posteriorly, forming a sling around the vagina, rectum and perineal body. This results in the anorectal angle and promotes closure of the urogenital hiatus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038113\">",
"    <span class=\"h3\">",
"     Pubococcygeus muscle",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pubococcygeus muscle originates on the posterior inferior pubic rami and inserts on the midline-visceral organs and the anococcygeal raphe.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038127\">",
"    <span class=\"h3\">",
"     Iliococcygeus muscle",
"    </span>",
"    &nbsp;&mdash;&nbsp;The iliococcygeus originates from the arcus tendineus levator ani and inserts in the midline onto the anococcygeal raphe and coccyx.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Like the sacrospinous ligament, the fascia overlying the iliococcygeus muscle can be used as a fixation point for suspension of the vaginal apex in the treatment of vaginal vault prolapse. Sutures are typically placed 1 to 2 cm medial and 1 cm inferior to the ischial spine in the iliococcygeus fascia bilaterally (",
"      <a class=\"graphic graphic_figure graphicRef87094 \" href=\"UTD.htm?28/32/29189\">",
"       figure 7",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038148\">",
"    <span class=\"h3\">",
"     Pelvic floor muscle function and shape",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pelvic floor muscles have a constant resting tone except during voiding, defecation, and the Valsalva maneuver. This activity serves to close the urethral and anal sphincters, narrow the urogenital hiatus, and provide a constant support for the pelvic viscera. The levator muscles and the skeletal components of the urethral and anal sphincters all have the ability to contract quickly at the time of an acute intraabdominal pressure, such as a cough or sneeze, in order to maintain continence and to relax during evacuation.",
"   </p>",
"   <p>",
"    The levator ani muscles are depicted in most anatomy figures shaped like a bowl or &ldquo;funnel-shaped,&rdquo; but this is the uncontracted state of the muscles as might be seen in a cadaver dissection. In a woman with normal pelvic floor function, the levator ani muscle complex is in a tonically contracted state and has an intricate three-dimensional structure. The anterior portion of the muscle complex (pubococcygeus and puborectalis muscles) is oriented vertically as a sling around the mid-urethra, vagina and anorectum, and the posterior portion (iliococcygeus muscle) has a horizontal upwardly biconvex shape resembling the appearance of a &ldquo;butterfly wing&rdquo; (",
"    <a class=\"graphic graphic_figure graphicRef87156 \" href=\"UTD.htm?37/60/38854\">",
"     figure 8",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/7\">",
"     7",
"    </a>",
"    ]. Thus, the anterior portion of the levator ani complex serves to close the urogenital hiatus and pull the urethra, vagina, perineum and anorectum toward pubic bone, while the horizontally oriented posterior portion (levator plate) serves as a supportive diaphragm or &ldquo;backstop&rdquo; behind the pelvic viscera.",
"   </p>",
"   <p>",
"    Loss of normal levator ani tone, through denervation or direct muscle trauma, results in a more open urogenital hiatus, loss of the horizontal orientation of the levator plate, and a more bowl-like configuration. These changes can be bilateral or asymmetric [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/8\">",
"     8",
"    </a>",
"    ]. Such configurations are seen more often in women with pelvic organ prolapse than in women with normal pelvic organ support [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H573741\">",
"    <span class=\"h1\">",
"     PELVIC NERVES AND VASCULATURE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H573839\">",
"    <span class=\"h2\">",
"     Levator ani nerve",
"    </span>",
"    &nbsp;&mdash;&nbsp;The levator ani nerve originates from S3, S4,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    S5 and innervates both the coccygeus muscle and the levator ani muscle complex [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/3,9\">",
"     3,9",
"    </a>",
"    ]. After exiting the sacral foramina, it travels 2 to 3 cm medial to the ischial spine and arcus tendineus levator ani across the superior (intrapelvic) surface of the coccygeus, iliococcygeus, pubococcygeus, and puborectalis muscles (",
"    <a class=\"graphic graphic_figure graphicRef87159 \" href=\"UTD.htm?2/18/2345\">",
"     figure 9",
"    </a>",
"    ). In some women, a separate nerve comes directly from S5 to innervate the puborectalis muscle independently [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/9\">",
"     9",
"    </a>",
"    ]. There is some controversy about whether the pelvic floor muscles also receive some of their innervation from branches from the pudendal nerve [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/9-14\">",
"     9-14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Given its location, the levator ani nerve is susceptible to injury through parturition and some pelvic reconstructive surgery. Specifically, the fixation points used in the sacrospinous ligament fixation and the iliococcygeus vaginal vault suspensions are in close proximity to the course of the levator ani nerve. However, the impact that potential injury has on the long-term anatomic and functional success of these procedures is currently unknown. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35914?source=see_link&amp;anchor=H8286285#H8286285\">",
"       \"Pelvic organ prolapse in women: Surgical repair of apical prolapse (uterine or vaginal vault prolapse)\", section on 'Vaginal procedures'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H573709\">",
"    <span class=\"h2\">",
"     Pudendal neurovascular bundle",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pudendal nerve innervates the striated urethral and anal sphincters, as well as the deep and superficial perineal muscles, and provides sensory innervation to the external genitalia. The pudendal nerve originates from S2 to S4 (with S3 providing the largest contribution) sacral nerve trunks.",
"   </p>",
"   <p>",
"    The internal pudendal artery is the main arterial supply of the perineum. The pudendal artery courses inferiorly from its origins in the anterior trunk of the internal iliac artery (",
"    <a class=\"graphic graphic_figure graphicRef87093 \" href=\"UTD.htm?4/59/5050\">",
"     figure 6",
"    </a>",
"    ). The internal pudendal artery and a contribution from the external pudendal artery, which originates from the femoral artery, provide a rich blood supply to the perineum (",
"    <a class=\"graphic graphic_figure graphicRef81882 \" href=\"UTD.htm?25/59/26547\">",
"     figure 10",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It is this rich collateral anastomosis that allows a Martius flap to be utilized by pelvic surgeons. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32951?source=see_link&amp;anchor=H13#H13\">",
"       \"Rectovaginal, anovaginal, and colovesical fistulas\", section on 'Modified Martius graft'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/47/44792?source=see_link\">",
"       \"Urogenital tract fistulas in women\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Together, the pudendal vessels and nerve follow a complex course as they leave the pelvis. With the nerve oriented medially and the vessels laterally, the pudendal neurovascular bundle travels behind the sacrospinous ligament just medial to the ischial spine to exit the pelvis through the greater sciatic foramen (",
"    <a class=\"graphic graphic_figure graphicRef87086 \" href=\"UTD.htm?17/30/17895\">",
"     figure 1",
"    </a>",
"    ). The nerves and vessels then enter the ischioanal fossa through the lesser sciatic foramen, travel through the pudendal canal (Alcock canal) on the medial aspect of the obturator internus muscles before emerging in the perineum, where each separates into several branches that terminate within the muscles and skin of the perineum and the clitoris.",
"   </p>",
"   <p>",
"    The anterior branches of the pudendal nerve include the perineal nerve and the dorsal nerve of the clitoris (",
"    <a class=\"graphic graphic_figure graphicRef74742 \" href=\"UTD.htm?8/58/9126\">",
"     figure 11",
"    </a>",
"    ). These anterior branches enter the perineum just medial to the ischial tuberosity on either side. The posterior branch, the inferior rectal nerve, provides innervation to the external anal sphincter and perianal skin. The inferior rectal nerve and vessels traverse the ischioanal fossa medially as they course toward the anus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H576035\">",
"    <span class=\"h1\">",
"     OBTURATOR ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is an increasing number of procedures used to correct female stress urinary incontinence and pelvic organ prolapse that access the pelvis using a transobturator approach. As such, it is important that the surgeons using these techniques have a thorough understanding of the anatomy of this region. The obturator foramen has been described above.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H576043\">",
"    <span class=\"h2\">",
"     Obturator membrane",
"    </span>",
"    &nbsp;&mdash;&nbsp;The obturator membrane is a thick, flat connective tissue membrane that spans the obturator foramen. A small opening in the membrane, known as the obturator canal, is found in the anterior-superior edge of the obturator foramen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H576051\">",
"    <span class=\"h2\">",
"     Obturator canal",
"    </span>",
"    &nbsp;&mdash;&nbsp;At the top of the obturator foramen is the obturator canal. The obturator canal is bordered anteriorly by the inferior surface of the superior pubic ramus and elsewhere by the obturator membrane and adductor muscles of the thigh. The obturator neurovascular bundle passes from the pelvic cavity to the medial compartment of the thigh via the obturator canal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H576059\">",
"    <span class=\"h2\">",
"     Muscles of the obturator space",
"    </span>",
"    &nbsp;&mdash;&nbsp;The muscles of the medial thigh and adductor compartment are, from superficial to deep: the gracilis, adductor longus, adductor brevis, adductor magnus, and obturator externus muscles (",
"    <a class=\"graphic graphic_figure graphicRef87168 \" href=\"UTD.htm?37/13/38099\">",
"     figure 12",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/15\">",
"     15",
"    </a>",
"    ]. Deep to this is the obturator membrane. The obturator internus muscle lies on the superior (intrapelvic-pelvic) side of the obturator membrane (see above). The adductor longus tendon originates from a triangular depression just inferior to the pubic crest and lateral to the pubic symphysis. This tendon is readily palpable when a patient is in dorsal lithotomy position and serves as an important landmark for the placement of transobturator slings for treatment of stress urinary incontinence. Transobturator sling trocars are inserted just lateral to the inferior pubic ramus in the area just below the adductor longus tendon.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H576067\">",
"    <span class=\"h2\">",
"     Obturator neurovascular bundle",
"    </span>",
"    &nbsp;&mdash;&nbsp;The obturator artery and vein originate as branches of the internal iliac vessels. As they emerge from the cranial side of the obturator membrane via the obturator canal and enter the obturator space, they divide into many small branches supplying the muscles of the adductor compartment of the thigh. The vessels are predominantly small (&lt;5 mm",
"    <strong>",
"    </strong>",
"    diameter) and splinter into variable courses [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/15\">",
"     15",
"    </a>",
"    ]. In contrast to the vessels, the obturator nerve emerges from the obturator membrane and bifurcates into anterior and posterior divisions traveling distally down the thigh to supply the muscles of the adductor compartment. With the patient in the dorsal lithotomy position, the nerves and vessels follow the thigh and course laterally away from the ischiopubic ramus [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/15\">",
"     15",
"    </a>",
"    ]. The distance from the mid-point of the ischiopubic ramus to the obturator canal ranges from 4.2 to 5.5 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/15\">",
"     15",
"    </a>",
"    ]. Variability in obturator foramen size and shape likely has a direct effect on this distance [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038169\">",
"    <span class=\"h1\">",
"     PERINEUM",
"    </span>",
"    &nbsp;&mdash;&nbsp;The area between the vagina and anus is often clinically referred to as the &ldquo;perineum;&rdquo; however, anatomically, the perineum is the entirety of the pelvic outlet inferior to the pelvic floor. The area between the vagina and anus is more aptly termed &ldquo;the perineal body.&rdquo;",
"   </p>",
"   <p>",
"    The borders of the anatomic female perineum are the ischiopubic rami, ischial tuberosities, sacrotuberous ligaments, and coccyx. An imaginary line connecting the ischial tuberosities divides the perineum into the urogenital triangle anteriorly and the anal triangle posteriorly. In the standing position, the urogenital triangle is oriented horizontally and the anal triangle is tilted upward so that it faces more posteriorly (",
"    <a class=\"graphic graphic_figure graphicRef74060 \" href=\"UTD.htm?28/57/29588\">",
"     figure 13",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038176\">",
"    <span class=\"h2\">",
"     Perineal membrane",
"    </span>",
"    &nbsp;&mdash;&nbsp;The perineal membrane is a thick fibrous sheet that spans the urogenital triangle (",
"    <a class=\"graphic graphic_figure graphicRef87160 \" href=\"UTD.htm?7/20/7494\">",
"     figure 14",
"    </a>",
"    ). It attaches laterally to the pubic arch and has a free posterior margin anchored in the midline by the perineal body. Although anatomists and clinicians have historically used the term urogenital diaphragm to describe this structure, this term has been abandoned, as it erroneously implies a muscular diaphragm rather than a thick sheet of connective tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The urethra and vagina penetrate through a hiatus in the perineal membrane (the urogenital hiatus) to exit at the vestibule. The perineal membrane, therefore, provides fixation of distal urethra, distal vagina and perineal body to the pubic arches.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038183\">",
"    <span class=\"h2\">",
"     Urogenital triangle",
"    </span>",
"    &nbsp;&mdash;&nbsp;The urogenital triangle is divided into a superficial and deep perineal space by the perineal membrane. The superficial perineal space contains the superficial perineal muscles (ischiocavernosus, bulbospongiosus, superficial transverse perineal muscles), the erectile tissue of the clitoris, the vestibular bulbs, and Bartholin glands (",
"    <a class=\"graphic graphic_figure graphicRef74060 \" href=\"UTD.htm?28/57/29588\">",
"     figure 13",
"    </a>",
"    ). The deep perineal space lies just deep to the perineal membrane and inferior to the levator ani muscles.",
"   </p>",
"   <p>",
"    Within the deep perineal space lie the external urethral sphincter and the urethrovaginalis, compressor urethrae, and deep transverse perineal muscles (",
"    <a class=\"graphic graphic_figure graphicRef87161 \" href=\"UTD.htm?3/50/3875\">",
"     figure 15",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/16,18\">",
"     16,18",
"    </a>",
"    ]. The urethrovaginalis and compressor urethrae muscles provide accessory sphincter function to the urethra [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/18\">",
"     18",
"    </a>",
"    ]. The urethrovaginalis muscles surround the distal urethra and vagina without passing between them, and therefore act as a sphincter to the vagina as well the distal urethra [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The deep transverse perineal muscle, along with its superficial counterpart, serves to stabilize the position of the perineal body and inferior border of the perineal membrane. However, there is some dispute as to whether the deep transverse perineal muscle is present in females [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038190\">",
"    <span class=\"h2\">",
"     Perineal body",
"    </span>",
"    &nbsp;&mdash;&nbsp;The perineal body marks the point of convergence of the bulbospongiosus muscles, superficial and deep transverse perinei, perineal membrane, external anal sphincter, posterior vaginal muscularis and fibers from the puborectalis and pubococcygeus muscles. The perineal body plays an important role in support of the distal vagina and in normal anorectal function. The vascular and nerve supply to the perineum, including the deep and superficial perineal spaces, is provided by the pudendal neurovascular bundle.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038197\">",
"    <span class=\"h2\">",
"     Anal triangle",
"    </span>",
"    &nbsp;&mdash;&nbsp;The anal triangle is formed laterally by the medial margins of the sacrotuberous ligaments, anteriorly by the inferior edge of the perineal membrane and perineal body, and posteriorly by the coccyx. The superior extent of the anal triangle is the levator ani muscles. The anal canal and anal sphincter muscles are located in the middle of the anal triangle. Lateral to the anal sphincter, complex on each side, is the ischioanal fossa.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H575902\">",
"    <span class=\"h2\">",
"     Ischioanal fossa",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ischioanal fossa, previously termed the ischiorectal fossa, is the space inferior to the levator ani muscles and superior to the perineum [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/19\">",
"     19",
"    </a>",
"    ]. This fossa resembles two inverted wedge-shaped gutters, filled primarily with adipose tissue, that lie on either side of the anal aperture and urogenital hiatus. The lateral wall of each fossa is formed by the ischium, obturator internus muscle, and sacrotuberous ligament. The medial wall is the levator ani muscle. The ischioanal fossa allows movement of the pelvic floor and expansion of the anal canal during defecation. Along the lateral border of the ischioanal fossa is the pudendal canal, a fascial tunnel approximately 4 cm in length along the obturator internus muscle [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Clinically, infections of the anal canal sinuses or crypts can spread into the ischioanal fossa, resulting in large abscesses. Additionally, some commercially available kits for correction of pelvic organ prolapse use trocars that pass through this space toward the sacrospinous ligament to suspend the vaginal apex.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H574029\">",
"    <span class=\"h1\">",
"     LOWER GENITAL TRACT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The female lower genital tract consists of the vulva and vagina.",
"   </p>",
"   <p>",
"    The anatomy of the upper genital tract, comprised of the cervix, uterine corpus, fallopian tubes, and ovaries, is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/27/41400?source=see_link&amp;anchor=H25506221#H25506221\">",
"     \"Surgical female pelvic anatomy\", section on 'Genital tract viscera'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H574016\">",
"    <span class=\"h2\">",
"     Vulva",
"    </span>",
"    &nbsp;&mdash;&nbsp;The female external genitalia or vulva includes: labia majora, labia minora, clitoris, vulvar vestibule, external urethral meatus, and vaginal orifice (",
"    <a class=\"graphic graphic_figure graphicRef72614 \" href=\"UTD.htm?24/50/25379\">",
"     figure 16",
"    </a>",
"    ). &nbsp;",
"   </p>",
"   <p>",
"    The labia minora bifurcate anteriorly to form medial and lateral folds. The lateral folds unite ventrally over the clitoris to form the prepuce of the clitoris. The labia minora fuse posterior to the vestibule to form the posterior fourchette or frenulum of the labia minora. The labia majora are lateral to the labia minora and unite anteriorly to form the mons pubis. The mons pubis is a fat pad that overlies the inferior aspect of the pubic symphysis.",
"   </p>",
"   <p>",
"    The vulvar vestibule is the area enclosed by the labia minora into which the urethra and vagina open. Within the vestibule, the ducts of the Skene&rsquo;s (paraurethral) glands open on each side of the lateral margin of the urethra. The ducts of the Bartholin&rsquo;s glands (greater vestibular glands) open on the posterior lateral margin of the vaginal opening at the four and eight o&rsquo;clock positions (",
"    <a class=\"graphic graphic_figure graphicRef66162 \" href=\"UTD.htm?17/44/18126\">",
"     figure 17",
"    </a>",
"    ). Blockage of the Skene&rsquo;s or Bartholin&rsquo;s glands ducts can result in cysts or abscesses. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22375?source=see_link\">",
"     \"Disorders of Bartholin gland\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The hymen is a ring-like membrane that surrounds the vaginal orifice and typically has one or more central perforations (",
"    <a class=\"graphic graphic_figure graphicRef57977 \" href=\"UTD.htm?8/20/8514\">",
"     figure 18",
"    </a>",
"    ). After rupture of the hymen, from sexual intercourse or trauma, fringe-like hymenal remnants persist surrounding the vaginal opening. Congenital anomalies of the hymen, such as imperforate hymen, can occur which may require surgical correction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12473?source=see_link\">",
"     \"Diagnosis and management of congenital anomalies of the vagina\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038204\">",
"    <span class=\"h2\">",
"     Vagina",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vagina is a hollow, distensible, fibromuscular tube with rugal folds that extends from the vestibule to the uterine cervix. The longitudinal shape of the vagina resembles a trapezoid, narrowest at the introitus and becoming progressively wider as it approaches the vaginal apex and cervix. In the transverse plane, the vagina has a box-like configuration at its distal end (toward the introitus) and is flattened proximally. In the sagittal plane, the vagina has a distinct angulation. The upper two-thirds of the vagina angles toward the third and fourth sacral vertebrae and is almost horizontal in the standing position (",
"    <a class=\"graphic graphic_figure graphicRef87164 \" href=\"UTD.htm?41/62/42983\">",
"     figure 19",
"    </a>",
"    ). In contrast, the lower one-third is nearly vertical as it passes through the perineal membrane to the vestibule. The angle between the upper and lower axis of the vagina is approximately 130&deg; [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Histologically, the vaginal wall is composed of three layers: mucosa, muscularis, and adventitia [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. The vaginal mucosa is the most superficial layer and consists of stratified squamous epithelium and a lamina propria. The vaginal muscularis is a well-developed fibromuscular layer consisting primarily of interdigitating smooth muscle bundles with smaller amounts of collagen, elastin and vascular tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. The outermost adventitia is a variably discrete layer of collagen, elastin, and adipose tissue containing blood vessels, lymphatics, and nerves. The adventitia represents an extension of the visceral endopelvic fascia that surrounds the vagina and adjacent pelvic organs and allows for their independent expansion and contraction.",
"   </p>",
"   <p>",
"    The terms pubocervical fascia and rectovaginal fascia have been used to describe the layer separating the vagina from the bladder and rectum, respectively. Although these terms are widely used, the use of the term &ldquo;fascia&rdquo; is a misnomer, as it does not accurately reflect the histology of the vagina. Numerous histological analyses of the vaginal wall have failed to identify a distinct &ldquo;fascial&rdquo; layer [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/17,21,22\">",
"     17,21,22",
"    </a>",
"    ]. Between the adjacent pelvic organs is primarily vaginal muscularis. The &ldquo;fascia&rdquo; often noted by pelvic surgeons during vaginal dissection, in fact, refers to layers that are developed as a result of separating the vaginal epithelium from the muscularis, or by splitting the vaginal muscularis layer [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/21\">",
"     21",
"    </a>",
"    ]. The only area in which there does appear to be dense connective tissue separating the vagina from an adjacent organ is the distal posterior vaginal wall. The connective tissue of the perineal body extends 2 to 4 cm cephalad from the hymenal ring along the posterior vaginal wall between the smooth muscle layers of the vagina and the rectum [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/17\">",
"     17",
"    </a>",
"    ]. This layer does not, however, extend the full length of the posterior vaginal wall.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H574323\">",
"    <span class=\"h1\">",
"     LOWER URINARY TRACT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The structures of the urinary system located within the pelvis include the urethra, bladder, and distal portion of the ureters (",
"    <a class=\"graphic graphic_figure graphicRef87166 \" href=\"UTD.htm?19/7/19569\">",
"     figure 20",
"    </a>",
"    ). &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H574331\">",
"    <span class=\"h2\">",
"     Urethra",
"    </span>",
"    &nbsp;&mdash;&nbsp;The female urethra connects the bladder to the vulva (",
"    <a class=\"graphic graphic_figure graphicRef59561 \" href=\"UTD.htm?2/13/2259\">",
"     figure 21",
"    </a>",
"    ). It averages about 2 to 3 cm in length and 6 mm in diameter. The junction of the urethra to the bladder is called the bladder neck, or vesical neck. The urethra then continues its course fused to the vagina for its distal two-thirds, and terminates at the external urethral meatus in the vulvar vestibule directly above the vaginal introitus. The female lumen is slightly curved as it passes from the bladder in the retropubic space, perforates the perineal membrane.",
"   </p>",
"   <p>",
"    Histologically, the urethra has four distinct layers: mucosa, submucosa, internal urethral sphincter (smooth muscle) and striated external urethral sphincter. The submucosal layer is highly vascular. The blood supply of the urethra derives from extensions of the pudendal vessels and the vesical vessels [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/23\">",
"     23",
"    </a>",
"    ]. These vascular cushions, along with the urethral mucosa, account for approximately a third of the urethral resting tone, while the internal and external urethral sphincters account for the remainder [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The internal urethral sphincter is primarily composed of oblique and longitudinal smooth muscle fibers, with a few circularly oriented outer fibers. The precise function of this longitudinal smooth muscle is not known, however, it has been suggested that these longitudinal fibers serve as &ldquo;filler volume&rdquo; within the circular smooth muscle and striated urethral sphincter, whose presence improves the efficiency of the sphincter mechanism by allowing closure of the urethral lumen with only a small amount of circular muscle shortening [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The skeletal muscle component of the urethral sphincter consists of the external urethral sphincter (also called sphincter urethrae), as well as the compressor urethrae and the urethrovaginalis muscle described previously (",
"    <a class=\"graphic graphic_figure graphicRef87165 \" href=\"UTD.htm?32/37/33364\">",
"     figure 22",
"    </a>",
"    ). These three muscles, which function as a single unit, have been called the striated urogenital sphincter [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/18\">",
"     18",
"    </a>",
"    ]. Together, they are approximately 2.5 cm in length and encircle the urethra in its mid-portion from just below the bladder neck to the perineal membrane within the deep perineal space. The striated urogenital sphincter provides approximately one-third of urethral resting tone and is responsible for the voluntary and reflex increases in intraurethral pressure needed to maintain continence. The smooth muscle portion of the urethra is innervated by the autonomic nerves of the pelvic plexus, while the striated urethral sphincter is innervated by branches of the pudendal nerve [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Normal urethral function depends upon normal support of the urethra, as well as its intrinsic sphincter mechanism. As with vaginal support, dynamic interaction between the levator ani muscle complex and the connective tissue supports of the urethra is essential. The urethra lies on a hammock-like supportive layer composed of periurethral endopelvic fascia and anterior vaginal wall [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/27\">",
"     27",
"    </a>",
"    ]. Increased intraabdominal pressure, as with a cough or sneeze, causes compression of the urethra against this hammock-like layer thereby compressing and closing the urethral lumen. The stability of the suburethral layer depends upon the intact connection of the anterior vaginal wall and its connective tissue attachments to the arcus tendineus fascia pelvis and levator ani muscles. These attachments allow the pelvic floor muscle's normal resting tone to maintain the position of the urethra and bladder neck. They are also responsible for the posterior movement of the vesical neck seen at the onset of micturition (when the pelvic floor relaxes) and for the elevation noted when a patient is instructed to arrest her urinary stream. Defects in these attachments can result in proximal urethral support defects (urethral hypermobility) and anterior vaginal prolapse (cystocele), and contribute to stress urinary incontinence. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/14/29929?source=see_link\">",
"     \"Clinical presentation and diagnosis of urinary incontinence\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/8/7306?source=see_link\">",
"     \"Pelvic organ prolapse in women: Surgical repair of anterior vaginal wall prolapse\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H574339\">",
"    <span class=\"h2\">",
"     Bladder",
"    </span>",
"    &nbsp;&mdash;&nbsp;The bladder is located in the midline, posterior to the pubic bone. The bladder is separated from the pubic bone by a potential space, called the retropubic space, or the space of Retzius, which contains the venous plexus of Santorini.",
"   </p>",
"   <p>",
"    The boundaries of the bladder include the pubic symphysis anteriorly, the pelvic sidewalls laterally, and the lower uterine segment and vagina posteriorly. The inferior boundary of the bladder is the lower uterine segment and anterior cervix. The superior border of the bladder roughly corresponds to the obliterated umbilical arteries and urachus. In the fetus, the urachus connects the developing bladder to the umbilicus. Postnatally, the urachus involutes and becomes the median umbilical ligament, which anchors the apex of the bladder to the anterior abdominal wall. Occasionally, the urachus remains patent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/47/41721?source=see_link&amp;anchor=H16#H16\">",
"     \"Care of the umbilicus and management of umbilical disorders\", section on 'Urachal anomalies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The dome of the bladder is contiguous with the parietal peritoneum of the anterior abdominal wall. Inferiorly, the peritoneum sweeps off the bladder into the vesicouterine pouch. The remainder of the bladder is retroperitoneal.",
"   </p>",
"   <p>",
"    The bladder is quite distensible. When empty, the bladder is pyramid-shaped, with the apex pointed toward the pubic bone. When full, the bladder is spherical, with normal capacities ranging from 400 to 500 mL, and can transform from being a pelvic organ to an abdominal one, rising above the pubic bone.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      When the bladder is distended, the musculature of the dome can become relatively thin. Thus, prior to initiating a pelvic surgical procedure, decompression of the bladder using a bladder catheter can help avoid injury.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The regions of the bladder include the dome, superiorly, and the base, inferiorly. The base of the bladder lies directly on the anterior vaginal wall and consists of the trigone and detrusor loop, a thickening of the detrusor muscle, the thickness of which does not vary with filling of the bladder.",
"   </p>",
"   <p>",
"    The bladder trigone is a triangular area at the base of the bladder bounded by the internal urethral meatus and the two ureteric orifices. The ureteric orifices and the internal urethral meatus are equidistant from each other with each side of the trigone measuring approximately 3 cm (",
"    <a class=\"graphic graphic_figure graphicRef87167 \" href=\"UTD.htm?11/59/12210\">",
"     figure 23",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/28\">",
"     28",
"    </a>",
"    ]. The superior border of the trigone between the ureteric orifices is raised and known as the intraureteric ridge. During hysterectomy, inadvertent bladder injury may occur during dissection of the vesicovaginal space. Such injuries are commonly located just superior to the intraureteric ridge in the midline.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Injury to the bladder dome may occur during peritoneal entry for laparotomy or suprapubic port placement during a laparoscopy.",
"     </li>",
"     <li>",
"      Injury to the inferior regions of the bladder may occur during hysterectomy when the bladder is dissected off the lower uterine segment and cervix. The most common site of injury during this dissection is in the midline just superior to the intraureteric ridge. Risk factors for this type of injury include conditions that cause scar tissue in the vesicouterine pouch, such as cesarean delivery, bladder surgery (eg, anterior colporrhaphy), pelvic infection, endometriosis, distorted anatomy from fibroids or malignancy, or prior pelvic radiation. An elongated cervix may also predispose the patient to bladder injury, as the surgeon may not dissect the bladder as far caudally as necessary prior to performing the colpotomy or placing the vaginal cuff sutures, or by necessitating repeat dissections of the vesicovaginal space.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Histologically, the bladder is lined by three layers: mucosa, muscle, and adventitia. The bladder mucosa consists of a transitional cell epithelium and underlying lamina propria, and is also known as the urothelium. The muscular layer, or the detrusor muscle, consists of interlacing bundles of smooth muscle. This plexiform arrangement of detrusor muscle bundles is ideally suited to reduce all dimensions of the bladder lumen on contraction. The outer adventitial layer primarily consists of adipose tissue and loose connective tissue.",
"   </p>",
"   <p>",
"    The blood supply to the bladder includes the superior and inferior vesical arteries, which are branches of the anterior trunk of the internal iliac artery. Bladder innervation is provided by the parasympathetic and sympathetic autonomic fibers of the pelvic and hypogastric nerve plexuses, respectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H574355\">",
"    <span class=\"h2\">",
"     Ureters",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ureters are retroperitoneal structures that run from the renal pelvis to the bladder. They are approximately 25 to 30 cm in length from the renal pelvis to the trigone of the bladder. The pelvic brim divides them into abdominal and pelvic segments, each of which is approximately 12 to 15 cm in length.",
"   </p>",
"   <p>",
"    The pelvic ureters can be injured during pelvic surgery (",
"    <a class=\"graphic graphic_figure graphicRef76515 \" href=\"UTD.htm?43/47/44790\">",
"     figure 24",
"    </a>",
"    ). The pelvic course of the ureters and most common sites of injury from superior to inferior can be summarized as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/29-31\">",
"     29-31",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The ureters enter the pelvis at the pelvic brim where they cross from lateral to medial, as well as anterior to the bifurcation of the common iliac arteries (",
"      <a class=\"graphic graphic_picture graphicRef83005 \" href=\"UTD.htm?20/63/21493\">",
"       picture 2",
"      </a>",
"      ). The left ureter is often obscured by the sigmoid colon, and visualization can be facilitated by sharply incising the sigmoid colon attachments to the left pelvic sidewall.",
"      <br/>",
"      <br/>",
"      The ureters travel into the pelvis along with the ovarian vessels (",
"      <a class=\"graphic graphic_picture graphicRef51215 \" href=\"UTD.htm?39/21/40287\">",
"       picture 3",
"      </a>",
"      ), making the identification of the ureter imperative prior to performing an oophorectomy [",
"      <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The ureter usually lies posterior and medial to the infundibulopelvic ligament, but in cases where it lies in close proximity to the ovarian vessels, it may be necessary to open the retroperitoneal space lateral to the infundibulopelvic ligament and create a window between the ovarian vessels and the ureter in order to safely secure the ovarian vascular pedicle.",
"     </li>",
"     <li>",
"      In the case of salpingo-oophorectomy at the time of hysterectomy, opening the broad ligament between the round ligament and the infundibulopelvic ligament provides excellent retroperitoneal access and opportunity to identify the ureter.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The ureters then descend into the pelvis within a peritoneal sheath (ureteric fold) attached to the medial leaf of the uterine broad ligament and the lateral pelvic sidewall (",
"      <a class=\"graphic graphic_figure graphicRef76698 \" href=\"UTD.htm?13/34/13859\">",
"       figure 25",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef64999 \" href=\"UTD.htm?15/44/16069\">",
"       figure 26",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Just inferior to the internal cervical os, the ureter passes under the uterine arteries (&ldquo;water under the bridge&rdquo;), along the lateral side of the uterosacral ligament, approximately 1.5 cm lateral to the internal cervical os (",
"      <a class=\"graphic graphic_figure graphicRef76515 \" href=\"UTD.htm?43/47/44790\">",
"       figure 24",
"      </a>",
"      ). The ureter then courses medially as the uterosacral ligament is traced from the sacrum toward the vagina. At the level of the ischial spine, the ureter is approximately 2.3 cm lateral to the uterosacral ligament [",
"      <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/33\">",
"       33",
"      </a>",
"      ]. The ureter is closest to the uterosacral ligament at its distal end, approximately 1 cm.",
"     </li>",
"     <li>",
"      The ureter passes through the areolar tissue of the tunnel of Wertheim (ie, the cardinal",
"      <span class=\"nowrap\">",
"       ligament/anterior",
"      </span>",
"      bladder pillar) to the anterolateral surface of the cervix (",
"      <a class=\"graphic graphic_figure graphicRef57777 \" href=\"UTD.htm?26/20/26948\">",
"       figure 27",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The ureters then pass close to the anterolateral fornix of the vagina and enter the posterior aspect of the bladder 5 to 6 cm apart and run obliquely through the bladder wall for 1.5 cm before terminating at the trigone.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The ureter is supplied by the blood vessels it crosses, ie, the ovarian, internal iliac, superior vesical, and inferior vesical arteries. Above the pelvic brim, the blood supply enters from the medial side while below the pelvic brim the blood supply enters laterally.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      During ureterolysis, the surgeon can avoid ischemic injuries by staying outside of the adventitial sheath surrounding the ureter, although this may be difficult to do in the setting of malignancy, or significant scarring or fibrosis as a result of endometriosis or prior pelvic radiation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Partial or complete duplication of the ureter may be present in approximately 1 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/34\">",
"     34",
"    </a>",
"    ]. Duplications may be partial or complete. Partial duplications are characterized by the duplicate ureters joining before entering the bladder. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/60/22472?source=see_link&amp;anchor=H12936677#H12936677\">",
"     \"Overview of congenital anomalies of the kidney and urinary tract (CAKUT)\", section on 'Duplication'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The existence of a urinary tract anomaly may not even be known prior to undertaking pelvic surgery, but every effort should be made to identify the ureter in the normal location. If the patient has a history of a M&uuml;llerian or urinary tract anomaly (eg, a solitary kidney), preoperative imaging with an intravenous pyelogram may prepare the surgeon's expectations of what or where",
"      <span class=\"nowrap\">",
"       he/she",
"      </span>",
"      may find the ureters intraoperatively [",
"      <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Prevention, evaluation, and management of ureteral injury during gynecologic surgery are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/46/14056?source=see_link\">",
"     \"Urinary tract injury in gynecologic surgery: Prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/27/7609?source=see_link\">",
"     \"Urinary tract injury in gynecologic surgery: Evaluation and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038218\">",
"    <span class=\"h1\">",
"     MECHANISMS OF PELVIC ORGAN SUPPORT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038227\">",
"    <span class=\"h2\">",
"     Support of the vagina and uterus",
"    </span>",
"    &nbsp;&mdash;&nbsp;The normal axis of the pelvic organs in the standing woman places the upper two-thirds of the vagina directly over the levator plate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038234\">",
"    <span class=\"h3\">",
"     Endopelvic fascia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The endopelvic fascia is the loose connective tissue network that envelops all of the organs of the pelvis and connects them loosely to the supportive musculature and bones of the pelvis. Histologically, it is composed of collagen, elastin, adipose tissue, nerves, vessels, lymph channels, and smooth muscle. This connective tissue network tethers the vagina and uterus in their normal anatomic location, yet allows for the mobility of the viscera to permit storage of urine and stool, coitus, parturition, and defecation.",
"   </p>",
"   <p>",
"    Several areas of the endopelvic fascia (and its associated peritoneum) have been named by anatomists. These are really condensations of the endopelvic fascia and not true ligaments: uterosacral ligament, cardinal ligament, broad ligament, mesovarium, mesosalpinx, and the round ligament. The broad ligament, mesovarium, mesosalpinx, and round ligament do not play a role in support of the pelvic organs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038241\">",
"    <span class=\"h3\">",
"     Level I support",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three levels of connective tissue supports of the vagina have been described (",
"    <a class=\"graphic graphic_figure graphicRef60888 graphicRef61643 \" href=\"UTD.htm?18/51/19257\">",
"     figure 28A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/36\">",
"     36",
"    </a>",
"    ]. The",
"    <span class=\"nowrap\">",
"     uterosacral/cardinal",
"    </span>",
"    ligament complex, which comprises level I support, is an intricate three-dimensional connective tissue structure that originates at the cervix and upper vagina and inserts at the pelvic sidewall and sacrum. Magnetic resonance images of healthy women reveal that the uterosacral ligament inserts in the area of the coccygeus muscle and sacrospinous ligament in most women, with only 7 percent actually inserting into the sacrum [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/37\">",
"     37",
"    </a>",
"    ]. The",
"    <span class=\"nowrap\">",
"     uterosacral/cardinal",
"    </span>",
"    ligament complex suspends the uterus and upper vagina in its normal orientation. It serves to maintain vaginal length and keep the vaginal axis nearly horizontal in a standing woman so that it can be supported by the levator plate. Loss of Level I support contributes to prolapse of the uterus",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    vaginal apex.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038248\">",
"    <span class=\"h3\">",
"     Level II support",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contiguous with the",
"    <span class=\"nowrap\">",
"     uterosacral/cardinal",
"    </span>",
"    ligament complex at the location of the ischial spine is Level II support, the paravaginal attachments. The anterior vaginal wall is suspended laterally to the arcus tendineus fascia pelvis (ATFP) or &ldquo;white line,&rdquo; which is a thickened condensation of fascia overlying the iliococcygeus muscle. The ATFP originates on the ischial spine and inserts on the inferior aspect of the pubic symphysis. The ATFP overlaps the arcus tendineus levator ani proximally from the ischial spine, but they diverge distally as they approach the pubic symphysis. The anterior Level II supports suspend the mid-portion of the anterior vaginal wall creating the anterior lateral vaginal sulci. Detachment of these lateral supports can lead to paravaginal defects and prolapse of the anterior vaginal wall.",
"   </p>",
"   <p>",
"    Similar to the anterior paravaginal supports, there are posterior lateral supports at Level II, as well. The posterior vaginal wall is attached laterally to the pelvic sidewall in a slightly more complex arrangement than the anterior vaginal wall. The distal half of the posterior vaginal wall fuses with the aponeurosis of the levator ani muscle from the perineal body along a line referred to as the arcus tendineus rectovaginalis. It converges with the ATFP at a point approximately midway between the pubic symphysis and the ischial spine [",
"    <a class=\"abstract\" href=\"UTD.htm?15/41/16026/abstract/38\">",
"     38",
"    </a>",
"    ]. Along the proximal half of the vagina, the anterior and posterior vaginal walls are both supported laterally to the ATFP. Thus, in the proximal vagina, the lateral supports for the anterior and posterior vaginal wall are identical. This arrangement accounts for the H-shape or box-like configuration of distal vagina when viewed in cross-section and the flattened tube configuration seen in upper vagina (",
"    <a class=\"graphic graphic_figure graphicRef60888 graphicRef61643 \" href=\"UTD.htm?18/51/19257\">",
"     figure 28A-B",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038255\">",
"    <span class=\"h3\">",
"     Level III support",
"    </span>",
"    &nbsp;&mdash;&nbsp;Level III support is provided by the perineal membrane, the muscles of the deep perineal space and the perineal body. These structures support and maintain the normal anatomical position of the urethra and distal one-third of the vagina, which, in a standing woman, is perpendicular to the floor. Anteriorly, the vagina fuses with the urethra at Level III, and posteriorly, with the perineal body. Disruption of Level III support anteriorly can result in urethral hypermobility and stress incontinence, and disruption posteriorly may result in distal rectoceles",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    perineal descent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26038262\">",
"    <span class=\"h2\">",
"     Interactions between the muscular and connective tissue supports",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal pelvic organ support and function depend upon dynamic interaction between the pelvic floor musculature and the endopelvic fascia. In a standing woman, the endopelvic fascia suspends the upper vagina, the bladder, and the rectum over the levator plate while the pelvic floor muscles close the urogenital hiatus and provide a stable platform on which the pelvic viscera rests. Intraabdominal and gravitational forces are applied perpendicular to the vagina and pelvic floor while the pelvic floor musculature counters those forces with its constant tone by closing. With proper tone of the pelvic floor muscles, stress on the connective tissue attachments is minimized. Furthermore, in times of acute stress, such as a cough or sneeze, there is a reflex contraction of the pelvic floor musculature countering and further stabilizing the viscera.",
"    <strong>",
"    </strong>",
"    The urogenital hiatus also responds by narrowing to maintain Level III support. With pelvic floor weakness, such as neuropathic injury or mechanical muscular damage, there is loss of the horizontal orientation of the levator plate, the urogenital hiatus opens, and pelvic floor assumes a more bowl-like configuration. The endopelvic fascia then becomes the primary mechanism of support. Over time, this stress can overcome the endopelvic fascial attachments and result in loss of the normal anatomical position through breaks, stretching, or attenuation of these connective tissue supports. This can result in changes in the vector forces applied to the viscera and may lead to pelvic organ prolapse",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    dysfunction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H576197\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pelvic surgery in women requires a comprehensive knowledge of the pelvic anatomy to safely attain access, maximize exposure, ensure hemostasis, and avoid injury to viscera, blood vessels, and nerves. (See",
"      <a class=\"local\" href=\"#H26037959\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The bones of the pelvis consist of the right and left pelvic bones, the sacrum and the coccyx (",
"      <a class=\"graphic graphic_figure graphicRef87086 \" href=\"UTD.htm?17/30/17895\">",
"       figure 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef87087 \" href=\"UTD.htm?10/37/10834\">",
"       picture 1",
"      </a>",
"      ). The bony pelvis is the rigid foundation to which all of the pelvic ligaments and muscles are anchored. (See",
"      <a class=\"local\" href=\"#H26037966\">",
"       'Pelvic bones'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The obturator internus and piriformis are the muscles of the pelvic sidewalls (",
"      <a class=\"graphic graphic_figure graphicRef62230 \" href=\"UTD.htm?31/63/32756\">",
"       figure 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H26038078\">",
"       'Muscles of the pelvic sidewall'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The skeletal muscles of the pelvic floor include the levator ani muscles, the coccygeus muscle, the external anal sphincter, the striated urethral sphincter and the deep and superficial perineal muscles (",
"      <a class=\"graphic graphic_figure graphicRef62230 \" href=\"UTD.htm?31/63/32756\">",
"       figure 3",
"      </a>",
"      ). The levator ani muscle complex consists of the pubococcygeus (also called pubovisceral), the puborectalis, and iliococcygeus muscles. (See",
"      <a class=\"local\" href=\"#H26038099\">",
"       'Muscles of the pelvic floor'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The levator ani nerve originates from S3, S4,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      S5 and innervates both the coccygeus muscle and the levator ani muscle complex (",
"      <a class=\"graphic graphic_figure graphicRef87159 \" href=\"UTD.htm?2/18/2345\">",
"       figure 9",
"      </a>",
"      ). The pudendal nerve innervates the striated urethral and anal sphincters, as well as the deep and superficial perineal muscles, and provides sensory innervation to the external genitalia. The pudendal nerve originates from S2 to S4 (with S3 providing the largest contribution) sacral nerve trunks (",
"      <a class=\"graphic graphic_figure graphicRef87093 \" href=\"UTD.htm?4/59/5050\">",
"       figure 6",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H573741\">",
"       'Pelvic nerves and vasculature'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The female lower genital tract consists of the vulva and vagina. (See",
"      <a class=\"local\" href=\"#H574029\">",
"       'Lower genital tract'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The structures of the urinary system located within the pelvis include the urethra, bladder, and distal portion of the ureters (",
"      <a class=\"graphic graphic_figure graphicRef87166 \" href=\"UTD.htm?19/7/19569\">",
"       figure 20",
"      </a>",
"      ). The ureters are retroperitoneal structures that run from the renal pelvis to the bladder. Knowledge of their course is important to avoid injury during pelvic surgery. (See",
"      <a class=\"local\" href=\"#H574323\">",
"       'Lower urinary tract'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/1\">",
"      Ridgeway BM, Arias BE, Barber MD. Variation of the obturator foramen and pubic arch of the female bony pelvis. Am J Obstet Gynecol 2008; 198:546.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/2\">",
"      Harmanli OH, Khilnani R, Dandolu V, Chatwani AJ. Narrow pubic arch and increased risk of failure for vaginal hysterectomy. Obstet Gynecol 2004; 104:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/3\">",
"      Roshanravan SM, Wieslander CK, Schaffer JI, Corton MM. Neurovascular anatomy of the sacrospinous ligament region in female cadavers: Implications in sacrospinous ligament fixation. Am J Obstet Gynecol 2007; 197:660.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/4\">",
"      Kearney R, Sawhney R, DeLancey JO. Levator ani muscle anatomy evaluated by origin-insertion pairs. Obstet Gynecol 2004; 104:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/5\">",
"      Lawson JO. Pelvic anatomy. I. Pelvic floor muscles. Ann R Coll Surg Engl 1974; 54:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/6\">",
"      Meeks GR, Washburne JF, McGehee RP, Wiser WL. Repair of vaginal vault prolapse by suspension of the vagina to iliococcygeus (prespinous) fascia. Am J Obstet Gynecol 1994; 171:1444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/7\">",
"      Singh K, Jakab M, Reid WM, et al. Three-dimensional magnetic resonance imaging assessment of levator ani morphologic features in different grades of prolapse. Am J Obstet Gynecol 2003; 188:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/8\">",
"      DeLancey JO, Kearney R, Chou Q, et al. The appearance of levator ani muscle abnormalities in magnetic resonance images after vaginal delivery. Obstet Gynecol 2003; 101:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/9\">",
"      Barber MD, Bremer RE, Thor KB, et al. Innervation of the female levator ani muscles. Am J Obstet Gynecol 2002; 187:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/10\">",
"      Snooks SJ, Swash M. The innervation of the muscles of continence. Ann R Coll Surg Engl 1986; 68:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/11\">",
"      Percy JP, Neill ME, Swash M, Parks AG. Electrophysiological study of motor nerve supply of pelvic floor. Lancet 1981; 1:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/12\">",
"      Pierce LM, Reyes M, Thor KB, et al. Innervation of the levator ani muscles in the female squirrel monkey. Am J Obstet Gynecol 2003; 188:1141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/13\">",
"      Bremer RE, Barber MD, Coates KW, et al. Innervation of the levator ani and coccygeus muscles of the female rat. Anat Rec A Discov Mol Cell Evol Biol 2003; 275:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/14\">",
"      Grigorescu BA, Lazarou G, Olson TR, et al. Innervation of the levator ani muscles: description of the nerve branches to the pubococcygeus, iliococcygeus, and puborectalis muscles. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/15\">",
"      Whiteside JL, Walters MD. Anatomy of the obturator region: relations to a trans-obturator sling. Int Urogynecol J Pelvic Floor Dysfunct 2004; 15:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/16\">",
"      Mirilas P, Skandalakis JE. Urogenital diaphragm: an erroneous concept casting its shadow over the sphincter urethrae and deep perineal space. J Am Coll Surg 2004; 198:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/17\">",
"      DeLancey JO. Structural anatomy of the posterior pelvic compartment as it relates to rectocele. Am J Obstet Gynecol 1999; 180:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/18\">",
"      Oelrich TM. The striated urogenital sphincter muscle in the female. Anat Rec 1983; 205:223.",
"     </a>",
"    </li>",
"    <li>",
"     Federative Committee on Anatomical Terminology. Terminologia Anatomica: International Anatomic Terminology. Thieme, New York 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/20\">",
"      Funt MI, Thompson JD, Birch H. Normal vaginal axis. South Med J 1978; 71:1534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/21\">",
"      Weber AM, Walters MD. Anterior vaginal prolapse: review of anatomy and techniques of surgical repair. Obstet Gynecol 1997; 89:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/22\">",
"      Boreham MK, Wai CY, Miller RT, et al. Morphometric analysis of smooth muscle in the anterior vaginal wall of women with pelvic organ prolapse. Am J Obstet Gynecol 2002; 187:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/23\">",
"      Rahn DD, Bleich AT, Wai CY, et al. Anatomic relationships of the distal third of the pelvic ureter, trigone, and urethra in unembalmed female cadavers. Am J Obstet Gynecol 2007; 197:668.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/24\">",
"      Bump RC, Friedman CI, Copeland WE Jr. Non-neuromuscular determinants of intraluminal urethral pressure in the female baboon: relative importance of vascular and nonvascular factors. J Urol 1988; 139:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/25\">",
"      Sch&auml;fer W. Some biomechanical aspects of continence function. Scand J Urol Nephrol Suppl 2001; :44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/26\">",
"      Colleselli K, Stenzl A, Eder R, et al. The female urethral sphincter: a morphological and topographical study. J Urol 1998; 160:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/27\">",
"      DeLancey JO. Structural support of the urethra as it relates to stress urinary incontinence: the hammock hypothesis. Am J Obstet Gynecol 1994; 170:1713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/28\">",
"      Rahn DD, Bleich AT, Wai CY, et al. Anatomic relationships of the distal third of the pelvic ureter, trigone, and urethra in unembalmed female cadavers. Am J Obstet Gynecol 2007; 197:668.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/29\">",
"      Sorinola O, Begum R. Prevention and management of ureteric injuries. Hosp Med 2005; 66:329.",
"     </a>",
"    </li>",
"    <li>",
"     DeLancey J. Surgical anatomy of the female pelvis. In: Te Linde's Operative Gynecology, 10th, Rock JA, Thompson JD (Eds), Lippincott-Raven, 1997. p.82.",
"    </li>",
"    <li>",
"     Underwood P. Operative injuries to the ureter. In: Te Linde's Operative Gynecology, 10th, Rock JA, Thompson JD (Eds), Lippincott-Raven, 1997. p.960.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/32\">",
"      Hofmeister FJ. Pelvic anatomy of the ureter in relation to surgery performed through the vagina. Clin Obstet Gynecol 1982; 25:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/33\">",
"      Buller JL, Thompson JR, Cundiff GW, et al. Uterosacral ligament: description of anatomic relationships to optimize surgical safety. Obstet Gynecol 2001; 97:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/34\">",
"      Fernbach SK, Feinstein KA, Spencer K, Lindstrom CA. Ureteral duplication and its complications. Radiographics 1997; 17:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/35\">",
"      Fernbach SK, Feinstein KA, Spencer K, Lindstrom CA. Ureteral duplication and its complications. Radiographics 1997; 17:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/36\">",
"      DeLancey JO. Anatomic aspects of vaginal eversion after hysterectomy. Am J Obstet Gynecol 1992; 166:1717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/37\">",
"      Umek WH, Morgan DM, Ashton-Miller JA, DeLancey JO. Quantitative analysis of uterosacral ligament origin and insertion points by magnetic resonance imaging. Obstet Gynecol 2004; 103:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/41/16026/abstract/38\">",
"      Leffler KS, Thompson JR, Cundiff GW, et al. Attachment of the rectovaginal septum to the pelvic sidewall. Am J Obstet Gynecol 2001; 185:41.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14186 Version 1.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-210.101.131.232-0D05C0E861-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_41_16026=[""].join("\n");
var outline_f15_41_16026=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H576197\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26037959\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7744471\">",
"      SURGICAL PEARLS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26037966\">",
"      PELVIC BONES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26037973\">",
"      Ilium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26037980\">",
"      Ischium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26037987\">",
"      Sacrum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26037994\">",
"      Pubis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26038043\">",
"      Orientation of the bony pelvis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H527753\">",
"      Surgical landmarks of the bony pelvis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H527761\">",
"      - Ischial spine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H527790\">",
"      - Coccyx",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H527798\">",
"      - Pubic arch",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H527806\">",
"      - Pectineal line",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H527814\">",
"      - Obturator foramen",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26038050\">",
"      PELVIC LIGAMENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26038057\">",
"      Sacrospinous ligament",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26038064\">",
"      Sacrotuberous ligament",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26038071\">",
"      PELVIC MUSCLES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26038078\">",
"      Muscles of the pelvic sidewall",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26038085\">",
"      - Obturator internus muscle",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26038092\">",
"      - Piriformis muscle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26038099\">",
"      Muscles of the pelvic floor",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26038106\">",
"      - Arcus tendineus lavator ani",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H204504\">",
"      - Puborectalis muscle",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26038113\">",
"      - Pubococcygeus muscle",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26038127\">",
"      - Iliococcygeus muscle",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26038148\">",
"      - Pelvic floor muscle function and shape",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H573741\">",
"      PELVIC NERVES AND VASCULATURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H573839\">",
"      Levator ani nerve",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H573709\">",
"      Pudendal neurovascular bundle",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H576035\">",
"      OBTURATOR ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H576043\">",
"      Obturator membrane",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H576051\">",
"      Obturator canal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H576059\">",
"      Muscles of the obturator space",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H576067\">",
"      Obturator neurovascular bundle",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26038169\">",
"      PERINEUM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26038176\">",
"      Perineal membrane",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26038183\">",
"      Urogenital triangle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26038190\">",
"      Perineal body",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26038197\">",
"      Anal triangle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H575902\">",
"      Ischioanal fossa",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H574029\">",
"      LOWER GENITAL TRACT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H574016\">",
"      Vulva",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26038204\">",
"      Vagina",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H574323\">",
"      LOWER URINARY TRACT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H574331\">",
"      Urethra",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H574339\">",
"      Bladder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H574355\">",
"      Ureters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26038218\">",
"      MECHANISMS OF PELVIC ORGAN SUPPORT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26038227\">",
"      Support of the vagina and uterus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26038234\">",
"      - Endopelvic fascia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26038241\">",
"      - Level I support",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26038248\">",
"      - Level II support",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26038255\">",
"      - Level III support",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26038262\">",
"      Interactions between the muscular and connective tissue supports",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H576197\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/14186\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/14186|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/30/17895\" title=\"figure 1\">",
"      Female pelvic bones ligaments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/1/10262\" title=\"figure 2\">",
"      Female pelvic bones sagittal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/63/32756\" title=\"figure 3\">",
"      Female pelvic muscles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/18/5411\" title=\"figure 4\">",
"      Pudendal block",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?43/5/44118\" title=\"figure 5\">",
"      Transverse female pelvis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/59/5050\" title=\"figure 6\">",
"      Female pelvis vessels nerves sagittal view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/32/29189\" title=\"figure 7\">",
"      Suture site transvaginal suspension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/60/38854\" title=\"figure 8\">",
"      Female levator muscle 3D form",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/18/2345\" title=\"figure 9\">",
"      Levator ani nerve",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/59/26547\" title=\"figure 10\">",
"      Perineal vessels",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/58/9126\" title=\"figure 11\">",
"      Nerves of the female perineum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/13/38099\" title=\"figure 12\">",
"      Muscles obturator space",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/57/29588\" title=\"figure 13\">",
"      Female perineum muscles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/20/7494\" title=\"figure 14\">",
"      Female perineal membrane",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/50/3875\" title=\"figure 15\">",
"      Urethrovaginal sphincter",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/50/25379\" title=\"figure 16\">",
"      Vulvar anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/44/18126\" title=\"figure 17\">",
"      Location Bartholin gland",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/20/8514\" title=\"figure 18\">",
"      Hymen anatomic variations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/62/42983\" title=\"figure 19\">",
"      Female pelvic anatomy sagittal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/7/19569\" title=\"figure 20\">",
"      Female genitourinary system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/13/2259\" title=\"figure 21\">",
"      Female pelvis - Sagittal view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/37/33364\" title=\"figure 22\">",
"      Urethral sphincter",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/59/12210\" title=\"figure 23\">",
"      Bladder trigone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?43/47/44790\" title=\"figure 24\">",
"      Identifying ureter at hysterect",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/34/13859\" title=\"figure 25\">",
"      Ureter and uterine artery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/44/16069\" title=\"figure 26\">",
"      Ureter and blood vessels",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/20/26948\" title=\"figure 27\">",
"      Ureter entering bladder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/61/43987\" title=\"figure 28A\">",
"      DeLancey levels pelvic support",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/4/26693\" title=\"figure 28B\">",
"      Delancey levels pelvic support 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/14186|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?10/37/10834\" title=\"picture 1\">",
"      Female pelvic bones 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?20/63/21493\" title=\"picture 2\">",
"      Ureter at female pelvic brim",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/21/40287\" title=\"picture 3\">",
"      Ureteral course",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/47/41721?source=related_link\">",
"      Care of the umbilicus and management of umbilical disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/14/29929?source=related_link\">",
"      Clinical presentation and diagnosis of urinary incontinence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12473?source=related_link\">",
"      Diagnosis and management of congenital anomalies of the vagina",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22375?source=related_link\">",
"      Disorders of Bartholin gland",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/1/2074?source=related_link\">",
"      Musculoskeletal changes and pain during pregnancy and postpartum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/60/22472?source=related_link\">",
"      Overview of congenital anomalies of the kidney and urinary tract (CAKUT)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/62/26602?source=related_link\">",
"      Overview of transvaginal placement of reconstructive materials (surgical mesh or biografts) for treatment of pelvic organ prolapse or stress urinary incontinence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/8/7306?source=related_link\">",
"      Pelvic organ prolapse in women: Surgical repair of anterior vaginal wall prolapse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35914?source=related_link\">",
"      Pelvic organ prolapse in women: Surgical repair of apical prolapse (uterine or vaginal vault prolapse)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/31/40439?source=related_link\">",
"      Pudendal and paracervical block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32951?source=related_link\">",
"      Rectovaginal, anovaginal, and colovesical fistulas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/10/43177?source=related_link\">",
"      Stress urinary incontinence in women: Choosing a primary surgical procedure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33401?source=related_link\">",
"      Stress urinary incontinence in women: Transobturator midurethral slings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/27/41400?source=related_link\">",
"      Surgical female pelvic anatomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/27/7609?source=related_link\">",
"      Urinary tract injury in gynecologic surgery: Evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/46/14056?source=related_link\">",
"      Urinary tract injury in gynecologic surgery: Prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/47/44792?source=related_link\">",
"      Urogenital tract fistulas in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/36/35401?source=related_link\">",
"      Vaginal hysterectomy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_41_16027="Questionnaire for diagnosis SLE";
var content_f15_41_16027=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F51827&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F51827&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Questionnaire for the diagnosis of systemic lupus erythematosus",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Have you ever had arthritis or rheumatism for more than 3 months?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Do your fingers become pale, numb, or uncomfortable in the cold?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Have you had any sores in your mouth for more than 2 weeks?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Have you been told that you have low blood counts (anemia, low WBC count, or low platelet count)?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Have you ever had a prominent rash on your cheeks for more than 1 month?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Does your skin break out after you have been in the sun (not sunburn)?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Has it ever been painful to take a deep breath for more than a few days (pleurisy)?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Have you ever been told that you have protein in your urine?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Have you ever had rapid loss of lots of hair?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Have you ever had a seizure, convulsion, or fit?",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_41_16027=[""].join("\n");
var outline_f15_41_16027=null;
var title_f15_41_16028="Indications for speech and language evaluation";
var content_f15_41_16028=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F75364&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F75364&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Indications for speech and language evaluation in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Concern by the parent, teacher, professional, or other caregiver about the child's speech or language",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Slowed or stagnant speech and language development",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Excessive drooling",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Difficulty sucking, chewing, or swallowing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Difficulty coordinating movements of lips, tongue, and jaw",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No babbling by 9 months",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No first words by 15 months",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No consistent words by 18 months",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No word combinations by 24 months",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Speech is difficult for parents to understand at 24 months",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Speech is difficult for strangers to understand at 36 months",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dysfluencies (stutters) consist of more than tension-free whole-word repetitions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Child is frustrated by communication difficulty",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Child is teased by peers for \"talking funny\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Child avoids talking situations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Child acquires vocabulary and sentence structure but does not use language appropriately for communicative purposes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Language is unusual or confused, or ideas are not expressed clearly",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Child cannot follow instructions without supplemental visual cues",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Loss of milestones",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Poor memory skills at 5 to 6 years",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Flax JF, Rapin I. Evaluating children with delayed speech and language. Contemp Pediatr 1998; 15:164.",
"       </li>",
"       <li>",
"        Sturner RA, Howard BJ. Preschool development. 1: Communicative and motor aspects. Pediatr Rev 1997; 18:291.",
"       </li>",
"       <li>",
"        Johnson CP, Blasco PA. Infant growth and development. Pediatr Rev 1997; 18:224.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_41_16028=[""].join("\n");
var outline_f15_41_16028=null;
var title_f15_41_16029="Clinical findings of ciguatera fish poisoning";
var content_f15_41_16029=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F88891&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F88891&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical findings of ciguatera fish poisoning by geographical region",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"3\">",
"        Clinical features",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"4\">",
"        Relative frequency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\" colspan=\"4\">",
"        Geographical region (Ocean)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3\">",
"        Caribbean",
"       </td>",
"       <td class=\"subtitle3\">",
"        Atlantic",
"       </td>",
"       <td class=\"subtitle3\">",
"        Pacific",
"       </td>",
"       <td class=\"subtitle3\">",
"        Indian",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Gastrointestinal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Diarrhea",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vomiting",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Abdominal pain",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        Not reported",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Neurologic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Extremity paresthesia",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Circumoral paresthesia",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Temperature dysesthesia",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        Not reported",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pruritus",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dental pain or teeth feeling loose",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        Not reported",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        Not reported",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Headache",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vertigo",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        Not reported",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Myalgia or arthralgia",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Weakness",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        ++",
"       </td>",
"       <td>",
"        +++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hallucinations",
"       </td>",
"       <td>",
"        Not reported",
"       </td>",
"       <td>",
"        Not reported",
"       </td>",
"       <td>",
"        0/+",
"       </td>",
"       <td>",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Giddiness",
"       </td>",
"       <td>",
"        Not reported",
"       </td>",
"       <td>",
"        Not reported",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Cardiovascular",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bradycardia",
"       </td>",
"       <td>",
"        Not reported",
"       </td>",
"       <td>",
"        Not reported",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        Not reported",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hypertension",
"       </td>",
"       <td>",
"        Not reported",
"       </td>",
"       <td>",
"        Not reported",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        Not reported",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Estimates of relative frequencies are based upon reports from series with at least 100 patients.",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Friedman MA, Fleming LE, Fernandez M, et al. Ciguatera fish poisoning: treatment, prevention and management. Mar Drugs 2008; 6:456.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_41_16029=[""].join("\n");
var outline_f15_41_16029=null;
var title_f15_41_16030="Estimates of effective doses of standard MPI protocols";
var content_f15_41_16030=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F70759&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F70759&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Estimates of effective doses of standard MPI protocols",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"3\">",
"        Protocol",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\" rowspan=\"2\">",
"        Injected activity (mCi)",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"4\">",
"        Effective doses, mSv",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\" colspan=\"2\">",
"        From ICRP tables",
"       </td>",
"       <td class=\"subtitle2\" colspan=\"2\">",
"        From manufacturers' Pls",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3\">",
"        Rest",
"       </td>",
"       <td class=\"subtitle3\">",
"        Stress",
"       </td>",
"       <td class=\"subtitle3\">",
"        <em>",
"         E",
"         <sub>",
"          1",
"         </sub>",
"        </em>",
"       </td>",
"       <td class=\"subtitle3\">",
"        <em>",
"         E",
"         <sub>",
"          2",
"         </sub>",
"        </em>",
"       </td>",
"       <td class=\"subtitle3\">",
"        <em>",
"         E",
"         <sub>",
"          1",
"         </sub>",
"        </em>",
"       </td>",
"       <td class=\"subtitle3\">",
"        <em>",
"         E",
"         <sub>",
"          2",
"         </sub>",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <sup>",
"         99m",
"        </sup>",
"        Tc sestamibi rest-stress",
"       </td>",
"       <td>",
"        10.0",
"       </td>",
"       <td>",
"        27.5",
"       </td>",
"       <td>",
"        11.3",
"       </td>",
"       <td>",
"        11.4",
"       </td>",
"       <td>",
"        14.6",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <sup>",
"         99m",
"        </sup>",
"        Tc sestamibi stress only",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        27.5",
"       </td>",
"       <td>",
"        7.9",
"       </td>",
"       <td>",
"        8.0",
"       </td>",
"       <td>",
"        10.0",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <sup>",
"         99m",
"        </sup>",
"        Tc sestamibi 2-day",
"       </td>",
"       <td>",
"        25.0",
"       </td>",
"       <td>",
"        25.0",
"       </td>",
"       <td>",
"        15.7",
"       </td>",
"       <td>",
"        15.6",
"       </td>",
"       <td>",
"        20.6",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <sup>",
"         99m",
"        </sup>",
"        Tc tetrofosmin rest-stress",
"       </td>",
"       <td>",
"        10.0",
"       </td>",
"       <td>",
"        27.5",
"       </td>",
"       <td>",
"        9.3",
"       </td>",
"       <td>",
"        9.9",
"       </td>",
"       <td>",
"        9.7",
"       </td>",
"       <td>",
"        12.9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <sup>",
"         99m",
"        </sup>",
"        Tc tetrofosmin stress only",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        27.5",
"       </td>",
"       <td>",
"        6.6",
"       </td>",
"       <td>",
"        7.1",
"       </td>",
"       <td>",
"        6.7",
"       </td>",
"       <td>",
"        8.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <sup>",
"         99m",
"        </sup>",
"        Tc tetrofosmin 2-day",
"       </td>",
"       <td>",
"        25.0",
"       </td>",
"       <td>",
"        25.0",
"       </td>",
"       <td>",
"        12.8",
"       </td>",
"       <td>",
"        13.5",
"       </td>",
"       <td>",
"        13.7",
"       </td>",
"       <td>",
"        18.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <sup>",
"         201",
"        </sup>",
"        Tl stress-redistribution",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        3.5",
"       </td>",
"       <td>",
"        22.0",
"       </td>",
"       <td>",
"        22.0",
"       </td>",
"       <td>",
"        <p>",
"         28.7 (PI 1)",
"        </p>",
"        <p>",
"         9.3 (PI 2)",
"        </p>",
"        <p>",
"         28.4 (PI 3)",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         46.6 (PI 1)",
"        </p>",
"        <p>",
"         NR (PI 2)",
"        </p>",
"        <p>",
"         46.6 (PI 3)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <sup>",
"         201",
"        </sup>",
"        Tl stress-reinjection",
"       </td>",
"       <td>",
"        1.5",
"       </td>",
"       <td>",
"        3.0",
"       </td>",
"       <td>",
"        31.4",
"       </td>",
"       <td>",
"        31.5",
"       </td>",
"       <td>",
"        <p>",
"         43.0 (PI 1)",
"        </p>",
"        <p>",
"         14.0 (PI 2)",
"        </p>",
"        <p>",
"         42.6 (PI 3)",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         69.9 (PI 1)",
"        </p>",
"        <p>",
"         NR (PI 2)",
"        </p>",
"        <p>",
"         69.9 (PI 3)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dual isotope",
"        <sup>",
"         201",
"        </sup>",
"        Tl-",
"        <sup>",
"         99m",
"        </sup>",
"        Tc sestamibi",
"       </td>",
"       <td>",
"        3.5",
"       </td>",
"       <td>",
"        25.0",
"       </td>",
"       <td>",
"        29.2",
"       </td>",
"       <td>",
"        29.3",
"       </td>",
"       <td>",
"        <p>",
"         37.8 (PI 1)",
"        </p>",
"        <p>",
"         18.4 (PI 2)",
"        </p>",
"        <p>",
"         37.5 (PI 3)",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         NR (PI 1)",
"        </p>",
"        <p>",
"         NR (PI 2)",
"        </p>",
"        <p>",
"         NR (PI 3)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <sup>",
"         99m",
"        </sup>",
"        Tc-labeled erythrocytes",
"       </td>",
"       <td>",
"        22.5",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        5.7",
"       </td>",
"       <td>",
"        5.8",
"       </td>",
"       <td>",
"        2.3",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <sup>",
"         82",
"        </sup>",
"        Rb",
"       </td>",
"       <td>",
"        50.0",
"       </td>",
"       <td>",
"        50.0",
"       </td>",
"       <td>",
"        13.5",
"       </td>",
"       <td>",
"        12.6",
"       </td>",
"       <td>",
"        3.0",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <sup>",
"         13",
"        </sup>",
"        N-ammonia",
"       </td>",
"       <td>",
"        15.0",
"       </td>",
"       <td>",
"        15.0",
"       </td>",
"       <td>",
"        2.4",
"       </td>",
"       <td>",
"        2.2",
"       </td>",
"       <td>",
"        NA",
"       </td>",
"       <td>",
"        NA",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <sup>",
"         15",
"        </sup>",
"        O-water*",
"       </td>",
"       <td>",
"        29.7",
"       </td>",
"       <td>",
"        29.7",
"       </td>",
"       <td>",
"        2.5",
"       </td>",
"       <td>",
"        2.4",
"       </td>",
"       <td>",
"        NA",
"       </td>",
"       <td>",
"        NA",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <sup>",
"         18",
"        </sup>",
"        F-FDG",
"       </td>",
"       <td>",
"        10.0",
"       </td>",
"       <td>",
"        0.0",
"       </td>",
"       <td>",
"        7.0",
"       </td>",
"       <td>",
"        7.0",
"       </td>",
"       <td>",
"        NA",
"       </td>",
"       <td>",
"        NA",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <em>",
"     E",
"     <sub>",
"      1",
"     </sub>",
"    </em>",
"    indicates effective dose estimated from tissue dose coefficients, using ICRP Publication 60 tissue weighting factors. Calculations were performed with the use of the \"splitting rule,\"",
"    <sup>",
"     [1]",
"    </sup>",
"    arithmetic averaging rather than mass averaging of individual remainder organ dose contributions,",
"    <sup>",
"     [2]",
"    </sup>",
"    and upper large intestine rather than extrathoracic airways as a remainder organ, as was originally specified in ICRP Publication 60. If dose to the colon was not specified in a data source, then the average of the upper large intestine and lower large intestine doses was substituted.",
"    <em>",
"     E",
"     <sub>",
"      2",
"     </sub>",
"    </em>",
"    indicates effective dose estimated from effective dose coefficients, using ICRP Publication 60 tissue weighting factors.",
"    <div class=\"footnotes\">",
"     NR: not reported in PI (total body dose provided rather than effective dose); NA: not available for cyclotron-produced tracers.",
"     <br>",
"      * American Society of Nuclear Cardiology guidelines",
"      <sup>",
"       [3]",
"      </sup>",
"      do not prescribe a recommended dose. Stress and rest doses of 1100 MBq (29.7 mCi) used, as per European Association of Nuclear Medicine/European Society of Cardiology guidelines",
"      <sup>",
"       [4]",
"      </sup>",
"      .",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        1990 Recommendations of the International Commission on Radiological Protection: ICRP Publication 60 Ann ICRP 1991; 21:1.",
"       </li>",
"       <li>",
"        Conversion coefficients for use in radiological protection against external radiation: ICRP Publication 74. Ann ICRP 1996; 26:1.&nbsp;",
"       </li>",
"       <li>",
"        DePuey EG, ed. Imaging guidelines for nuclear cardiology procedures. J Nucl Cardiol 2006; 13:e21.",
"       </li>",
"       <li>",
"        EANM/ESC Group. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging 2005; 32:855.",
"       </li>",
"      </ol>",
"      Reproduced with permission from: Einstein AJ, Moser KW, Thompson RC, et al. Radiation Dose to Patients From Cardiac Diagnostic Imaging. Circulation 2007; 116:1290. Copyright &copy; 2007 Lippincott Williams &amp; Wilkins.",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_41_16030=[""].join("\n");
var outline_f15_41_16030=null;
var title_f15_41_16031="Early postpneumonectomy PA";
var content_f15_41_16031=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F72520&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F72520&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Expected chest radiographic changes in the early postpneumonectomy period",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 255px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAD/AWgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5ZLGp43B2+vUk1BtNKvynHrQBJMc42/WoTkEAfpU2AVI6HGKbKhL8dAKAIOc0pPtTiCOopyqGHvQBEelSRkH5WHvSEFcZBpvTGaAHt/s/lQxY5wOM9qkLhgCwJJ70+Mf7AK+xoAhRtoGRz61IBuI2nGR61diQFfl5J7Gp4raB2/eREfTjFAFFoQMKWweO1VymFPzKT0xn9a3VsQJi0Mw+bqHFVri1aEnzIsL644JoAyGUrkZz9KROXGTj3q2YCQSFqLyiGPqaACNdzDHNXI4hgU2GBgqkA5PatSzg3MCwwB096AI4rY7gCB7iphAA1WxBjkdakEWTwPqKAI7aHA5xmtuywY9u3c3Y+lZ6QMq/dP5VsadGERd3G4Z9TQBE4EfL4C+9JYlF2gKSHYn9eKm1a12w5Vjg4NZECSZwJWABzgdqAN9iynPTHrVWcuxy447CrUVurKHdmOR1Jqd7Tep2ocevrQBhXLlVxhSe3FZk0gycY963bi0GPnBNUHtQckIWoAxphuBzVO4jZRkcitiS1LS9CD0wRTZrF9mCrbT7UAc3OmRmqLAgmtye0ZGKOp5PBxVZrMucY+b6UAZZB2+1MrXOnPs/+tUf9nkdeaAM2jmtKLT5ZThIjj+92H41bXR1GPNcn2X/ABoAwuakWORhwpI9a3vsUaZEMI57k5ND2rD7/wCVAGKIHIySo/GkMRXqeK0pURR1UfjVOQAnjJoArkEdqMnPpTmBz7e1IEPBGaAHb27Ggu2eTTdp4wM9qmS1fqwwPQ0AMZm44/OipnVgOM4ooAgKg+/tTGAB4pQ/yhT90c4z0pCQexxQA6HLk8VaEYO07cnpioLIZZ+M+1aMa/KRjvQBD9nR8lflNRm1dTyOParuzBxip4923BAYe9AFBbcScOPlHcUw2IBGAT7itRUBJZVIbOCKu2sCAhpR0/hoA58WC7AQx/Gq81u8XynPPQ10t1bqx/dD5e3aqggLIVYE+maAMiEyqyhT+laVtdyLxLGkq+/B/OkW3w23b3q1FbkAZXOaALMEltPjaDG/91/8avJbMeCMofUcGqkFru7ZrWs4pImAjPy/3TyD+FAGfc6TFKf3aGN/Ufd/KqbaNLExaROP7w6V29pFHJwU2v8Ap+Fatnp3mNwvy9MHoaAPPLTSWbBIP09a1LfSJSchM49BXeJosbPvVdrfTiq9zatEcSMqIPQ5oA5T+zdqneucdhzTIrRcsuGHPcV1LC2VflOalhihP3SuT6igDllgG7g/0rUsYyAAVB9Dit9dNt5s7owreo71btNIWNxtBIPbNAHK6jb7oCeDk96zbGzHnFiAQOxr0K/0aI2xILBhjI7Vz0WlvE7bGVgT3OaAFSyjSJQucYGM+lWEidYGVeB6YrQ06wllDGQrgLwFHStGSxSKNgEZnHU9s0AcZPaBjyMDtjvVR7RsfKCq9ST0xXVT2+084yO57VkXu1FYglx0OOaAMT7MPMGHB47irawRscMFA9asINsaSlRtYkdcYI//AF083NtkB1Ye4oAz7nSYmXDxgjsfSsu60VUIZFzXbaSsd0fKgcOp6K3GDWouiRqx3jc+On8NAHmMOjzS/cj+T+8eBXUaZ4W063sUub5EmdxuJkzsUE4AAFbtxa+UWDDaPQDimrrC2MPkSxM4X7pQ4YD0+lAHKeI9EitHjMCbEckFAc7SPT2rmroQwfeO4/3Rya6jXtSl1GUfuRDAudqA8/ie9c9NFGDgxkD1BoAxpruQ5EMaxr69TVOQyOTuJOewrcktYmBIYD6jFVZbMjlRn3FAGI0I7Crlvp6bVeb+LkKPT3qyLViw3LhcjPatHyAdpbBB6bfSgDLa2iY7BEo9OKryaUwcgqU77fWugWKFSCz/APAQOTVpVLKS4HPQEdKAOajsBEOE+Y8c0LZPIxwpx69hW5c26gblHP8AdqlKGI24wB2oAoNYIqkswJ+tFTFM9cciiplfoByjMO1CnoDnBNOI4wTxSRBjMijJYsBiqAtWCHzHz7c1qxLuOMVn6MoYSg+1a0S7c4oAURdx+tSpEQORipEXcy4br71dgj3cYyBQBVSEROsmMnG3mrUUfnDcBn1qaSIOUHc5NW9Mtf8ASxHxtbvQBQNsc45qcWIMW9hwO4rrF0eB1X5ueuajnsAuAhBUen+FAHGtp77920nJ7VahsCAN/T0rrUhQcbNp+nWnjTxIxI4Pp2oA523shnhSBWnb2ygYIOK0RZlXC7fm7AVcgswnzSYJH5CgCrbWKkjfnnoMcmtlZ4bJVSUlvRV6j61mXV8sZMcOQe7d6omYSN82Rz3NAGze6m0sREbYQnlV44qg8gYHOSvvVSYxtbFQWOe/SmWV0FO2aPcvc55FAD2t1lwYGCsf4T0P0qxBDNCcSLgYyc9Kt2saFVeLbx2IrTi5XZLyD0BoAgsWU4CPg/3T3ratQfm5I4zj096zxaRFhhMe61sW1vlF5z9TzQBblhElm4VQCVzWNaWW6SVmJCp1HrXSRqzJhCCSOPeucuLma2mmUR5Vj1H1oA0bC2Mbtgk57n9KvNGRERjd2z3rI066uJ5AXQqvHIHQV0m1fJAd9hIzjHSgDjdStw0m1F981gX9qUidFPzEZ57V31zYpgSMxAbkisS4htopBJIitg8ZORQBxa2M72k4CEBcOGboOcH9DWeUijky7eaQOnRa6x7s/a/LONjZQg9OeOlchqdxHbkmUL5mfugc0Aa+nXO6VQOAP4QK6uy1YELHcHI6DP3q8yh1cg4CbM9gTzV6DVdpBRiPY0Aei3i/aEYxHdGeo/iFczdWBidigLRn15IqzpurrJEgZir4yGBrTjdJ1w/BPRx0P19KAOPurbcMgfhWXPbnptrvLjTxk8AH+7/hVCfTwDuEYPc7ulAHCGykc4UHFSJZbDkBiw9q6i6UIpAwSOy8Csy5aQ/xYX0AoAyZPRwH9gP61NawJJ+7+SJW9+RRMpIIJbH1qGFNpH8xQBbi0gxNuZ1fuB2ou4fs0e5u/Sr8TiSAY6iql47SHaTx6UAZkSlnZ25IGMVXuYwG4q1dTxWcDS3DFU3BcgZ5P0qt/aNhMMC7jB7bgV/mKAKjxkjpzRV1wGhDxnKkZDA5BFFZVJwi/fGjz5jjoTUljH517CgYLuYDJ6CtV9AQD5da0d/pOw/moqhcWv2CVHM9tOM/8sJQ351qIu+HrfzUkfegwehPJre+wyBFCmMnqcOKpeGLQyWJjddksj5Qnqw44rXeBYSvnELk9D1/KgCCOylViD5Y+sijr9TWtHps6W6F0I384BycV5rqJJv7nJJPmNyfrXU+AppLiSe2klZljQMik52jODj8xQB1K2FwWB8luOKvWdhMr58pxzn7tTw27EDBYD61p2UTr/Gw56ZoAdEGWIb0YEj0qNkDkHkCtFpplwFkbHcHmnCeRgA6Rv8A7yigDPCumNrH2Bq5aIrMQycd2FTxiCQjzLbB7lHIrUt7K3K4Rnj4yQy55+tAESW1uI97ZCdCcck+grK1WN1B8ogqOwPI/wA+tbN/F5IBWSN2UYVN2Me/Ncjqd1KjnzIHPU7xQBmXM3lHJPHv1rPmvVDEBifSob+d5ctuLAd6zHJ3ENge5PSgDbh1B5R8vBBpzTuS53sHHAx3qlYpgbient0q4diLu+Zgzde9AGhpd1LGQQ5BHZq6izvPOG7J3dCtYOnRQNjzlzx94NXS6ZbRkkruC4xwKALdvdyccAgHrtrb06ZJSquuMmqsNomxCGyMDk961bG03sp4yDigC7bwKEB5JHesO8ss3khGQuefzrs7SApHh0JwM59azriOLMwcY3MD19KAOctYW38FsA9zW9JGklsz4JbsMU1XjMzhAvJzWpFCXtjhcDp0oA5nUJgICiZLY4z/ACrjNQecuVzkH2r0e801eCwGevFctq+lspfYy7TxwOcUAcFrV20ZxAxBIzuHauM11fL1Bn3MRIBIuT68/wA813t1Ywxr+8ctIORgfKK4nxNDmSOVXHy/uzx26j+tAGO106DG4ntzT47xty7sGqsyEjtVV2KcEUAdhY6gpwqMfTBrqNN1TlBu2v0wehry61mwcA9e1blhe4GHPHvQB67aX0LBI5MMH5Ck4x9DVm7t/MA+bfEfusBx+XauN0uUT2SmMhnQ4KnsK7zRGF1YKh5YfrQByuo2RQEBQR16VjSwH0r0a9sA8J46cjNczfacUkY7eKAOSmt8jI61XMJU4IORXR3FoQenaqkltkEhaAKFguCQepFPuIAJM9atW8BEh46VYePPBHFAHFeMVEemQ9t8oz9ADXFhuDh9zAdCuK7f4hARixjP3SHkP6CuNgw8yqrhgzAYI56igDvY7XyrSGPbwsar09hRXQmGKd2VSPM9O5oqZRuBwYi3Nz07VbisM4O0EnpXbeD9BimtVupI9zEk5IBHHGOaq+NPs9ndRx2mBK6nfjjjsce/9KoDmGYWrBYeZuu7+7TrqIyzRznJMq7j/vd6SOHcc9/U1qwwg2AI6pJjr2IoA808QReTrF0uMZbd+Yz/AFrY+HTlfEBUfxQsP1B/pVfxvF5etA4xvhRv5j+lN8Cy+V4qscnAdjGffcpH86APY4I9ycdc1pWcPf8AGoLJQBhq1raLLcfjQBUmiOeORT44fkwRzWnLbqQMfnRFbFmIAOPQDk0AQ21tnHy5z29a2TGlvG0khGB/ninw24giLv26n+grB1fUDOSinbEOhHegDB8T3TXMx8vt29a5CWZ43OJHVh79K6O/IYMV6dzmuW1KRPnIGW9aAIZ9VmGd3luOhDKKpyX9nMMtbsjDqY3/AKGqF1u5znA5qrsYsDjA96AOgttQtkCbJguOMSKRn8qtXE00hXyvLIPPyMDXORwDje3TnipkSMkMS2R6NigDsdGubiMES5Qrx8y111pO5VVcjHAz0z9a4TQtRa1dCZHaInBDncD+deh6TdwXyBTbwknGNvy5/GgDViuiCoZCeOxrotElDsq8qSeARWfHaWjlAvnJx1Vga39I0qPehS4HX+IYoA3oY2WJiuRjBrKu7VJXIZTnPGBXUfY8QgBkJPUg1Sexk3khCRn60AYVtYoGG1cYHJxXQC3MNuUQbQox0605bBhJ9xsEccVea3doQMNj6UAYF9F8mABz3xiuR1aylltnHKhuAcdfau9ntJH52NhfY1zupWVwx5R8jgDBAH0oA8h1uxkgEhZspg4AHNeZ6vcqzSq28MRleO45/wAa981uwm3BSoIPLfL2rxDx5pz2GoeYiELu5yP89qAOYM+4cZA71GSDxmoSjJIwIbg//qo+b0P5UAToAGyfWtCMnHyHNZcW7IyrEfStO2w6rhXEg9AcUAbOiXcttcBgxVe4z1r07QtVRljbhR3PpXltvFKWGYpD77TXTaT9qix5cUrDI6Kf1oA9iXbeW+5CDn0qncWe5CrjkdfaqPhm4ubdlDwStA3VSvI+ldkbUTRBlUlT0NAHn15ppySv6VmS2JU8jvXoNxZbGOVI9sVn3NgrH7vNAHGraYU/1qGW3yePzrqZ7DaCOelZVxbrGpyPegDgPFegS6pcwSx3McPlxlAroTk7ic5Fc9B4TvoL6CSWW3khWRWYqxBwDk8EV6PcRhiWxtqjOg6flQBVdhu3Zwc5FFSNCD1NFAE1zrr6TbfZLJEGeSG+bB9a55rx7idpJoonkY5LsCSfxqEh7mVnY5ZjnNSRR7eAP0oAtxTk9YLcj/rnW1Z3kUdhKZLOFwx2DAxg461jQoSM4xWqFP2GNVUkmQn9MUAeffEmNPtdhKilS0TIT64bP/s1c/4ZO3xFpZw7YuovlT7x+ccD3r2KXQG1SNY5bBrlc5G6MkA+xra0PwhFplzFcC00yzlQghpCqsP5mgDpW8MFrZri1aaLaSdtwoG4exUkfnioLaFk2lhwe3pXRatd2YghaOYF0AHlRvuU++P61jQsWHzdepoAl2Hbxz+FXbC3IjBbgt3I+6KIIzLIgK9TWm8ey3lcjC4xQBz+s3Hy4ywTsPauP1O4wpLn5R2re166VWZ2xkj5VrjL4vOSz8qe9AGVf3bOcJn6CsuVA4Jc4OOma1JtiI+IwVH3i3AH41iXc8AJMRJ92HT6UARNwrbUIqoyqXzuGfTNOkleRflYE+nSqZ5bOMYPOKALTOACoUAnoe1MidwWXYmR6ikALFCOc9KuQRtJMpC/N344oAIpmERyF9MYxXW+FL0Miqz7MHHzN0/Gubk0+RmyiggAdBWx4ftCpbjd6r70AevaJcJOVjL5bOAccGvRtFtFjiUMAT1JNeR+EhNJeJksFT5io6fSvXNCuGbajY+poA2p4kwq4IyO1UhAwc7T+taZ3MuzAJxkVCkZ357ZoAWKJ3UHcRjA61eZNqjljg+tJbxbX45qa4OF6DrQBTlUhCS7fnXPajLKImO8g+x6V0M2ZAeRg8VzmoxK2UdkH1oA4TWrid/NxOVJGF5ryX4kzSzWTt9pZmjwrDHXFez6zFbWsTzL+8YdM9z/AIV4/wCMYt+n3e4DLr/49mgDy6V5HRHMhP8ACefT/wCtUJLE/eI/GnlR86nr1H4f5NRA4PagB4aQdHbH1q3a3k8WALiSNQc5B5H9ap7gR6U5TzyM0AblveXC8rJc46ktkCuh0e9k3hhM5J7Fz1rjrd8E71Z+mCW6Vt2Ts8ymKMA8cJk0Aev6FLKu3Msnr944Nd5pc0sRwZGaMjP3v5e9eV+GNTDwpFPhShxnODXe2N8jsER168DNAHVSq7LxIScZHfIqonmM3zBGx6rVu1B+zoT1ycfSpGjVC3A9QKAMK9jjYHfAv1Xg1zepW8Eg2h2jPX5hXX36DYc8fSuavYgSSVzn26UAc9eaVMlt9oXa8O4JkHvWHcWreZkDJ9K6aaNkXCsQvUjt9frVhdVYWS209paTxqMKZIvmH4igDjHiIHTmit25XTpwdyzWzkfw/vE/xorKpWjTdpDSueMeIrsRWkUaTeW7NllVsErz+ma54X04/wCXqYA8f6w1Y8VMDew47RD/ANCNYlaiNZdSuR/y/T/9/W/xq0us3kezZqVyCvIInbg/nXP0UAem+B/E2p3esNbXWtXcsUkRwk1yWDPkYAyevXgV3yRkjLct614d4KXd4s0gY63Kfzr6Chi9uaAC1yFwMVs2K4PzdSarQwZAI4P0rTtYiWHH0oA2NJiDSrx75q1rTrBpc0jDKgcL6n0qXT4QqJtHLe1V/EuPJCYOFB49TQB5hfM07vLKck87fUdvwrHvHVFLy7gD/AO4/pWzrUgtWLFcyHlV/u+5rlLoS3JZyxLdyTQBl6jNJKSG4j7KO1Y0iPvKoDjNb00KoTnDHvnoapTgMuWfZjjJ4BoAyfs7btzHYfQVIkceDkFj6+tJPLGhIQlvfFV/tbZAAwaANAyrtOEyvTipraVCDl8Htk1kRZaTkEqeCPSkOY3KtggcUAdVpd1uuEAfaW4YZrtNLtE/dspDOxORjpXlloMyR7QcZ616JoRm8pShII7d6APW/DVqlrbjIXe564wcdq7LTojlT94A153o12wAMhZSvYjrXc6VehY1ZzzQB0kQYscjP41ZSPnPFQ2Tq8KyZBUjOauQ4KscDigBy8bfp2onXcMdaXK4AxTn+4DQBW2YArF1KOGQvvwMd62ZXCKQDz61zepttLjigDi9et1Vm8xXGR1PFeYeMVhjt3UkDPPJrvvFFxeQRsUYsOoVmOB7/rXlXiiR7id1j+cwJmZmGAHJ5AB9OnvQBwOqRLHN5kYyM56VnzRBJCB908r9D0rV1BiYWUgZX27Vmkhof9pD+h/wP86AKxQgGlRiG9qk4NJtGaALlucnII9cGtWxLSPHEriMM3PYfU1ixocBkPPpWxpkm+ZC/wAkikfjQB2NvENqCNwSOAFU8D1ru9EtWmZCScAdc8muask82JVRtoPyjAA/PFei+GLB4rKIyqVLE9aAOn03mJUfPTAq1c/eHPNMtI9q5btTnGST1oAz70ZTPv0rEuk46fhWzdH5unFZt0o6joaAMC5jJO05GetJ/ZvnR7kmgDf3XcA1ZulGTgfjWLduV3c8fSgBbrRLsqdsYf3RwaKxribaSR1oqJQUtwueFeJTm/j9ogP1NZNauvkPe5BAwij69ayj1qwClI6YOSabS0AdB4BXd4z0cH/n5Wvoy3i6HB+tfPPw6UHxtowBB/fg/oa+kIF4A9qAJrePkY5HQ1pW0BJ4HfGKr28dbFhETJGADyRQBrWiBVyR8qDrmud1u7CxNJIMk5CKf4jXTkBLOXsB1rg9VYXUju/+qHAH07UAcneQmaZpH+Ytyc96xbu0GT5TbQoycjoPWuhu3WPc0xxAOpHX6D1rmdWnNwNqEKg+6n+PrQBh6jexRSlYkDv/AH26A+wrBuZjLIXlBLE9c81p3aEHlWz9M8VnTRF/nBwOlAFG4Ultw79hUTgn7qAn1FWWQhvulhnrTwy5+c4PSgBmnW80rHDAADkHuK6O00Zb3bwsYHGTyT71zyufMDiQKewFa6eZHD5tuzLkevT6UAbMOiwC8+zCQB8cH1rr9ALWG2N4VbPRs1xfh6WSa9haQM3X5jXb6NbyTXHl7Gw579KAOisrhw4O1U56k5/Gus0yR3MaOq49RXMadbiOXynztVuMnk13Wj2e/wAvaV/H0oA6DTBthVeozxW5b8L9ap2cGxBx+Xer6Dtg0ABXB9ajmYquBU+Mjge1RyRk5HagDLnJPPTHvWJqqPncBXRTRhlx3rPuoQVK45xQB5n4o/e2UysmCUI614lezzzBhKSR5hkPux4yT3r6J8RW0TWs6FMkDqa8hvtGMLn5ML1AI5oA8v1EbSxx65rIT5H5+70P0NeharpSvE58sqwB5ArknswARIuSp69KAMeRNjsmc4PB9aFJHXkVo3NtuVSpxtGPwqqYGA6UATWYV2wvBPYmtOGPJwy9P0rGRdrg1r2V0FZVlGR/e7j/ABoA7bwlftDLHDN99f8AVucHn0Oa9r8LL5unQu+4k8E+/U14Hp42MJMhkPRh0Ne5fD68E+lRB+COM5znFAHWouyD5h83es68uoLK1kuLueKCBOWklYKo+pPStm5BMZ4+bH51xPjTwVoviyBF1i3kkeIYjkjkZGT6YOPzBoA5a4+KXhubXbPSrK4lvLi6mWASQr+7VmOBljjPJ7ZrqpmIUj2ryVvgpFYeILG6s9QS506KdJJra7jBZkDZK5HDZxjBArvZPCvhwDI0DSR7fY4/8KAJ7ttqkHPrXMX0pLsBVq/8NaAinbomljjtaxj+lczdaHpCsdulWA/7dk/woAfN15oqomj6ajiWDT7SORDlWWFQQfbiigDx7VSHvDkH7o6fSqDIR/OtS7Kl8kHHA96psYc4JJ79OtAFX6UcU4gdRnFNAoA6j4ZDd460cf8ATUn/AMdNfSluvOPavnD4XKD4+0fuN7E/9+2r6Xtl+UHHagC3bx5A9M4rc0+ICRT2FZtonKqFPrnFdBax4WPA5PJoAj1NT/ZboMguQT64HWuG1FVYMWYrGgyT6Cu+1gbYgi9hXn3iLORBEDs6n0J96AOT1KY3TsFUqAPkUdAP8feuZu7cxN8+Seu0c5rqLmPywygMWI64rn9ReOIBp2YEjgDq3/1qAMSQNKxXaxTrg8YFVJ44U3eZIM/3F60l5cSFjsyik/j+dZ0jYUlixbtigBl1NjKRptXsTVQozHBzn61ISxznGPelCO24qCVFACRRDPv6V0OkSq0YgIDKwx71hwxSu4VI2JJ7CvQPBfg+5urlWmiKxqCSW4z7UAZukQiF1ZSRj0rtNJadBvViO2RnpVfUNElsr1o2i25+7gggitrR7G68t2Ma+Vt5IbmgDV0tl89GJcnOM9ea9I0TaVUDIJ7Y/SvP9JtSsqDBGecetejaJEAiHkkdRQB08W0Rrg444FTxdcc1Ao+VSBViPg9DmgCTp3qOQDb15zUgGaVkyuMGgChKo6iqM8ea1pI8A8Emq8kQIx7UAcpq9gjLuIGemTXmXi+wKeWxL8kg817NqFvuXA6YrhfFOnmZTGAOBuGaAPFtXhMdvKysx69Ca4y53o2Mlh3zXrGraRMIJQsTNkHAAzXBXNk27DxspBwQVoA5wgJIvmISueR6iop7cJIQGJGMq3qD0NdUlkk0LRsmSOR9KzrjSzLC0cP+tTLRgnqO6/1H4+tAGCIQzAMM571J5BDZX8qkg4lUOCcHvwa04YVkyUGfUdxQBJoly1u+1wWjY/Mh/mPQ17B4Eu4/s22FgVDbgf8APevJobbd1GCK6vwXqB0vVUMhPkPxIP6igD6CtJBKgYkZA5z3qteR/eYDAJpmkyAxhlIKkAgjoRV29IK4A+U0ActfoV3EH3rIdhkAn8PWtrUFZSwYYIHesG44b6Hg0AZGrv8AKcHtXL3DgsQevb3rotX6cdxXL3X3jxxQBX84o3XjuKKp3bEZIooA8cmmeRjk8cYAqE9eKdt3HAySabigBKU9M479aT/CjpQB2HwlXd8QdIHo0h/8htX07aRjjgYx3r5o+DS7viJpXt5p/wDIbV9R2ScAdfr2oA0bKIYyOK3rWIblHYYrOsosR5xW9Em0JjqeaAMDWXwjMcE9B9a4m9Q7GGBuI+bNdjr4xIRxlP51xmszi1tPMwPMPAU9M+/tQBx+uXIskYbi7EcAjp7muJ1C485y0gBI6muh1SRZGkdmL568cmuau4eCVyR1KnrQBQllXqiqceoqlLGzoeQD6GrTLsOOmeeKgmcnbgYAoAo7NhJP5YqRZCAADgdeBUjSK2Qw3e9MW2klOYmKqDg54oAuWE7x3KMOGB6V6HpOrX0cQu43ChRt25+U1wmn6YYpYzISS2eRzXbabEkdqsMgHlod2OpNAHUy3a6tb2zuGjkQENkgECprC5e1K26kyCXOxl5XjsfSuVupXkdQgZFB5APFdD4BlW81G4WUgYA5A4wKAPRtJ05XjRiCGJB6V2GmWyxMo3HPesXTo1jZBGDjOeO1dHYltw6igDVjjyvHNTolNT7oJPJFTjpQA1VzTyvFC089OtAFdkyBmo2jGCOOlWSOmc0x14NAGZcQ8ckYrm9bts4YsuemM11txCGU1ianY74COeOaAPPtRsyoLAjHt1rl9T0NJwZYVAkPX0avRrrT0dCGGSBxnsKx304xn5c4Jxg9KAPL30tUc748OD6YIrO1DSWQiSA4JOQPQ16lf6WJQWK/MO+OtZE1ihQoyjafbpQB5HrWllj9pjjCknDgDAVv8D1H41nWxaN8kEEdx1FeqT6b5MjB0LxMNrr6j1+vcVzereHNkxMPpuVwOGHY0AZNtLHPxgiU9PRv/r1r2EB8wGUYxztx3rMhtPKbDKQR61vae4uBtcnzF7/3h/jQB6Z4Mv28sWkpIIH7vNdV526Mo4JdeRz2rgPDcieXuZv3qfdz6V2UMonKTByCOD70AVNQBYF/QYNc1qGFGc8d66fUFzGwHA5P1rk9TBB78jNAGLeMHiYE8iucvO9bdy20kE9qxLzhiBnFAGLesQhopt5gBsH60VMlJ7OwHjpNIaeeaQLlsZAzxmqARmyAO2BTadt2t1HHelwN+ecduKAO6+CqH/hYWnZ6eXMf/HCK+pLBeMd8V8wfBMFvH1lk5CwTY9hs/wDr19QacxwAPQUAdFaqCqge1bUaBpUx0FZmnKG2etbNsAI3Y9uKAOQ13aLqYNwFJya8r8UXDXFwzoegwuPSvTPGbmNWKdZOvtivL9XXaGIHJ5+npQByd5sO7OWPcVnTFQMSJtHr1rQ1ICNfMJPoFBzmsK8nIwzk4PQCgCO8EcSBhtJ6hjWTd3rEhSoYDpmrE0wcnGQD681WZFH3gDk9B2oAiF62R8vTj04p6O7PlmIDdR7VOlqz4zHkfStLTdNFxPhonwvXHGKAF0mIrdKryM2PQnp7V1tkcygTL8ueB/jT9G0i0ZnnOE8vqSTgn+tSxvDczYWJVGeGPOMUAVPEeo+RCkcfG4Zyo4xXQ/Da3kLGeZSu/G0YxxSWuinUygljARSC7AcV6Z4b8PrDHES0beV/Dnk0AdfoFri1RmOc9wK2oIBuXA/SmWEXkxKpII4rTjA4+tAChelOB6jB/EU8DilAoAao4p4pQPXpUgHpQBFijaKmwRRjNAFWSMEcVVuLfeh4z2rSI9+1RkDHXNAHNT2Oeg/SqEtiCDleOldc8fFQmAHqKAOLm07IOMZ7VkX+jhgeMHrxXoktspB4zzVC6tskgJzjr2oA8um07cCpHzDpnis57JXQwSjbzmMt/CfT6GvQNS0/OHAy1c/f2LuhKrlh1Hc0AeearorbjtX5geQf5VgEGGTcuQVPHqDXprgXAMUmfPQcHu49PqP5Vy2tWIjczKBg9ff3oAfpV6sipKgCyDhh7/4V2mmT5k3H5Q/5D3rzrTG+yXWSf3bDac9hXY6VcYwg57UAdNcLnAbkEVyWoKW8w4GVPPtXYPlreF26jgiuY1UeW7NgYyTkevYf1oA4u8OGNZN4dxyD1rZ1ZNu0g9Rn6Vz105XI54oAyL5uT70VDqLDqO1FAHlQxjpn1pMEnhevSkBHTipLfDTorNgE9RQAzy5CeFpwgnbohP5VuWGnx3BG6eRSeM4BrpLHwjBcAE30yn/rmKAJ/gjp12viz7cbd/s0MMkbycYVmX5R+NfR2mNudTnn0rzDwHo8OhwTQxTvM0zh3dwB0GAAK9N0f7wzj60AdnpgJKZJ6dq21UpakHAz14rG0oZkXnjHpWvdyCOzkfI4oA4nxIvnmRTzt6c96801oLHHJJNxt4C9yfSvSNXIEfUncc15r4qnWdiIOdmRkn71AHBalIzyFt3zn8B0rFlhlYjAySe9bF1C0xZicP3HNUpkjjQqHYseuKAM0277vmAz+lTRW8ecbWds8heKtQwbiAX564GelWJfI06MBZFaTGcDnFAC29q4TeSYo84BJxWtChgRkRhIz9yeQK5eTUJpm+c5wcqPT61pWt/tCBUwVUAkjqaAOjjmi8rEhZioxwcAmmxXcUFxuLM3H3P4RWIupyqIZR5L7HyFkjDKcHow7j1FMtZTPcxxqN245KqOgHWgD13w+1lb6aqu2wPzgH7xNd5oPlwhMfLns3WvMPCunT3k8ZnDiFR2GBXqllBudFXGQQOOaAOntpMgFTxjFatozMBkj8qzbK2Iwc8/yrXhVUANAE46U8L700Y45p4IycUAAB9vyp4+tIMU6gBpFGOe2MU6igBhHvTSD6ipSARSbfegCArwBTMVZK0xlxQBWdc5qrImWPIxV5l69qiKAk0AZV1bLJnI+lY82nNGzMACfX0rqmRe+Kq3Ea4PT8aAPP8AU9CEkplUbWHJI6j3rA1XSnkikDKucHcB/wChD+temTxLjAA5446Vi3dv5Uu4Dp0zQB4lLG8TGKQYI45rZ0C4JKo5zIh25Ppjg11mraJb38LDYI2zwR1U+n09K5zS9LktNVVZSGUcFgMAj/GgDtV/49ogOpTOK5vU/mtyW/vGt55MFlzjC4rltUmIgmVSAVGcmgDnNXG7dk4PQACuPvnOee1ddcvmBXY5bHPPWuQ1VSWJTBJz7Z/+vQBh3cnysSeaKz7+cAkZ6frRQBwIK9xmnRMFkVvf1o2HFM570AdFo0wD4x3xXfaNLlQBXmNhIUlBHcZ613eiXBwvP40Aej6TLtdOfSvQ9EO7YeemTXlukzEkcivSPDUxeJTxQB6Joyjeh/z0q5qRH9nPnuwzVHR5O5xwOtWdXDf2eyjrtzj3oA4LxBciMOM8sdo9q871JRHKwPzuecY4FdTrl08tyyxjLKMADnnuaz7Hw7c3DkzZ8scDB70AcdfxS8DaAzjPA5/+vWbLpUkamV4WbK/KMYNevL4ZhjwEjXcB95udo/xpy+Fprp8eQzKeowTge1AHhz2t3kL5fyk9iQTVCbTpnf58jnkAc19Et4AkaMZt4x7MeQKrJ8NLiaTAtolTPJDdRQB89pajzxtyAG5IHU1oThApjtvnY8lgM7favd7j4TREjzRIvHSMDA/SpIvhnZQptEDNxyWFAHhunaeZ0jWTIwc8ng/hXY+GNPWK/V0twxUFi23pmu9j8EQQzMUt2GeORnH0rWtPD32ZMKix7uXIGCaAK2lWVxxkiMH1OOPauv0qBdygtyDk/WqVnb7Bg4c9Ccc4rYtyImAUc0Ab9sAq89atREH6Vm20hwNwyK0YuxFAFjjjinj6U0A8fSn0ALS0nNKPwoAOPSlpORRzQApxRx6UhBxR1FAC0hxS0lAEbgHPU1GR1ODU5zyMUxlPPJ/E0AVXHNU58Ac5rQkX6VRuUIoAz5QGztxk+tU7lVYMGAPuRVyRcHg89uazLyYoThcmgDFv4zGS6ccfn9aoMsTr5qoNrZBB6g1Yv7ttpYqMf3axU1BIHbzDiJxg59f8aAGT3IEyKvOCM/Suf8SR7vtSJwWHH0zV15P9IkQt+8yCMemaqa64MhfOMgg4oA4ya7MbPGeQpxXPa1dRxg+Zja38Pv6irWolmmlKEqC3Brn9U/eT7HO5gCSfSgDn9auXch4lAyO/f3opmocA44H9aKAOdORj/ORTXAOfXFBxn0pGxgetAFi05BA+8vzD6V1OjXBG3npXHwv5bhgORXQWBCOjL9xuR7e1AHpmjXGdvJ7cV6X4WmJjA3HrXj2hz8qAa9T8InMec4oA9W0iQi3PXOQtXfEEvlW0pHJUBVHuaztDXfBCDyC+4/gBV64QXdwsROAzF2+meKAOW0rQFEzM65LnIPtXXWOh7QCw25/StSys0VVO3GzpWlHGDQBRttLt4RxGGJ6lhmrvkDGFGPwqwsYqZIR3oAqrajIyPwqwkAHAFWPLAx9adt5oAr+SMc0jQqTyAfrVgik2jJoAz5LSNwRsA+gqlcaahB2gY9K2ig7UxlHpQBzLWAjf5eOgIpXhHmg7enP4V0EkCuOnNV3tOc9aAK0A4XINaMAB21CsBAHA/Op4k5HNAE4HA6U+mhQMU4igBaUU3ApQKAFNFLjpSEUALSUUYoAXtSUY4ooAPWmnFKe9MbvQA2TGfeqdwAQRirEh5xmq033Sc8igDHuWKv7Vl3r7lwBz0rUvflOMd6ybtGKkDgUAc3qWH3Jj5gM5x19q5HVpf3cyEYKDcMdxXYahHsU9SQODXHayu9vOIO5PlPb60AULG7Fw9vIDmRCEfPcf5/nR4gfEUwY/6s7gfasnTGNrq5U58qTK4+tXvEZURZbO11KPjpxx/I0AcJeTq9yyqTgfN9TXPXuVvcnuCDSLctBqLwud2GI/AdKXUyJLlAvGB0zQBz2pH5mFFJqnDE0UAc6f880hOevNPZRimkDPFACdjjmtnSbn5ik5LRtjPcj3rHxjtzVyz4brQB3+lK0EibuVPKsOhr1PwdN+75PX3ryLw9dtFhJAJIT1Q/09K9X8IxpLHvs5N/PMZ+8P8aAPZNBciCH3AUfU960dPOb2V15DNtH0FYOhylIbdWyGC7sHt2FbdlIsWf727GKAOjhbGAp/Orqc9uayLOTKAfhmtSBgRQBaj6jjirC9OlQJUqt70AS/hR36UlL9KAEpO9BOM4ozzQAgGT0pp6dM0opM8UAIT+FIxyMEUhb8qVhgd6AInTjgcUsYwRxUg6fjRt6UAPHQYFO79KaOMU6gBcmlFNpRQAvpS0go7daAE7dKM0E0meKAFzRTd4A5pN/uKABuh4qFzjJp5frULnOaAK9xLg9DVZrpcEMPxzTrrjOKzHkJJBHFADNScDDAZU96ouwJbAzVmdh5YU4xnjNZ8kqruHHFAGdqKZBGT9a4jWwY587eCMN9K7y6w6Egc1zGu26sjAqM/wA6AOIu4t+14wcxEEbevB4qLxBObjRp2GDLEVkKj06Zq8yGDzeSWxgDGOKx7h1XzvMPyMhRh7H/AANAHmOsITfRyhfvHdn1p0wEk28d1zzV7xLCbeKNCQWRSAR3Oax7KfdBIc55x9BQBmakvytx70U7UOjUUAYOAV5P41GR6VIRjPOeM0w9KAEKqAuJA2QCcZG325qa2++PrVY9f0qxanEg9OlAHUaU4G3nmvS/CczIiEZB6A15fpvDLzxXovhiTmEZ6cn8KAPcNC1B/s+WIdY8R5YZ6VuQ3ULXAUowxz8rd64Xw/MUs41bneTIa6K0mLjfzkGgDt7KWFgNpfn3rZtypXjNcnpkpJXGMD/PFdBby4APtmgDXRhxipVb14+lUY5RtDN0PQVOj7jQBaDZI5pxIzwagDjgdqeG5oAf260d+tMLDFLu5PpQAo+tNI4H1oDfU0gbjn1oANvvSlfek3flS7uh5oAMcDnvSqPc0AjFKD0oAXB65p2Pemk0uaAF/Gl/GmU4GgB340h+tJ6Um4UAKfrUbMB1NDuMd6zrq5IyF4oAsSSqvLMBUL3PHynisuaUnnnrioVmO72oA1hcEkjtUu/3rJ83hqdbz5JQ5weRQBdmIOe5rKuhtJIHHWrrv+tVZyGH1oAzbtwsDt2ArAkuHZmII/xro7mIPDIvbHNczJF8xz2oAfJN8g57VkakdwzuHSrVw6gcDms67l+Ug/WgDm9TlUOuRgA8+9c7qqM9vcEEbgm4fTNdFqzKY8jp9Kw1bcoJ5Dfuj70AcB4qPnWVtMWyyADA9O35Hj8q5GykZJZo2PUZrs/EarCHiPKRgq30zXBzlre7cE/MMg+9AE12f3Y9xRVQylrcZOeKKAP/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Immediately after surgery, a chest tube is in place, the postpneumonectomy space (arrow) is empty, and the ipsilateral hemidiaphragm is slightly elevated.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Richard Irwin, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_41_16031=[""].join("\n");
var outline_f15_41_16031=null;
